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Abstract 
The number of proteins being included in the lipocalin structural family has been 
steadily increasing since the solution of the structures of beta -lactoglobulin and 
retinol- binding protein. The family now comprises some 23 proteins and these come 
from many different sources and display a variety of characteristics. The work 
described here focused on two of those proteins, beta -lactoglobulin (Big) and 
apolipoprotein D (apo D). 
The structure of bovine beta -lactoglobulin (Monaco, et al., 1987)from the trigonal 
crystals grown at pH 7.8, space group P3221, presents several aspects that are in 
disagreement with previous work, in particular the positioning of the bound retinol 
in the surface of the protein and the observation that the protein was in its 
monomeric form. We have checked these findings independently by extending the 
resolution of a 6 A x -ray structure (Green, et al., 1979). A 3.0 A model is now 
available though still in the refinement stages. Not surprisingly it was found that the 
protein is indeed in the dimeric form and that the arrangement of the dimer is very 
similar to the one found in BIgY (orthorhombic crystal form)(Papiz, et al., 1986), 
the other independently determined structure. Changes were observed in the 
threading of the sequence, in particular between residues 75 and 32 where 
movements of as much as five residues are found, and in the C- terminus between 
141 and 150 where a shift of two residues is observed along a n- strand. These 
changes result in an overall increase of the hydrophobicity of the pocket. 
In parallel, cocrystallization of Blg with a variety of ligands has been successful in 
at least one case where density is evident in the binding cavity. 
Human apolipoprotein D is present in the fluid of cysts formed during gross- cystic- 
disease, which is the most common breast disease in premenopausal women, and is a 
potential biological marker for breast cancer. The protein is found as well, 
associated with the lipoproteic system in the blood and is produced in high amounts in 
regenerating rat peripherial nerves. Several structural aspects of the protein from 
breast cysts were investigated; four of the cysteines were shown to be forming 
disulphide bridges and the fifth is not present as a free -cysteine. The influence of the 
pH on the conformational transitions (investigated by CD) and monomer -multimer 
balance (investigated by gel filtration) shows occurring parallelism with changes on 
Blg and in particular the transition seen between pH 6.5 and 5.5 could be due to the 
onset of the dissociation of the tetramer that populates the higher pHs. From the CD 
studies a 15% a -helix content was determined, more than the 7 -10% found for Blg 
or the 7% for Rbp but very close to the content on insectocyanin, with which shares 
30 -40% residue identity. We examined too, the association of this globular protein 
with lipid vesicles, and electron- micrographs showed the formation of rouleaux 
structures, an effect commonly observed with other apolipoproteins; CD showed a 
small change in the amount of a -helix of the bound -protein . 
The binding of several hydrophobic molecules was monitored by fluorescence and it 
was shown that arachidonic acid, a fatty acid with intense biological activity, binds 
with a association constant of 4.1x107M -1. This ligand provides a possible link 
between the diverse biological situations where apo D is present. A synthetic 
antagonist to the thromboxane A2 receptor was shown to bind too but with slightly 
less affinity. 
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1. Introduction 
This chapter describes the characteristics of the lipocalin family of which beta - 
lactoglobulin and apolipoprotein D are members. Blg will be discussed only briefly in 
the next sections because several extensive reviews are available (Tilley, 1960; 
Townend, et al., 1969; McKenzie, 1971; Hambling, et al., 1992). The introduction to 
apolipoprotein D is more extensive since no publication collecting all of the work done 
so far is yet available. 
1.1 Lipocalin family 
The continuous emergence of three -dimensional protein structures from nuclear 
magnetic resonance or X -ray crystallographic studies has increased the knowledge of 
the structural organization of these biological molecules and has brought insight to the 
relationship between function and structure. In the particular case of the lipocalins, it 
was with the solution of the structures of human retinol- binding protein (Rbp) 
(Newcomer, et al., 1984) and of bovine beta -lactoglobulin (Blg) (Sawyer, et al., 1985) 
that the then disparate and apparently unrelated proteins were recognized as sharing not 
only the same fold but were probably also functionally and genetically related. 
A trait of the lipocalin family is the polypeptide fold. The structures share the 
same calyx shape composed of two orthogonal ß- sheets of four antiparallel strands each 
and an a- helix, forming a "sheltered" pocket, shown in FIG 1.1. There are six such 
structures described in the literature: the above mentioned Rbp and Blg, insecticyanin 
(Ins) (Holden, et al., 1987), bilin- binding protein (Bbp) (Huber, et al., 1987a,b), 
major urinary protein (Mup) and urinary a2- globulin (A2u) (Böcskei, et al., 1992). 
These structures are highly superimposable, FIG. 1.2, and for example the r. m. s . 
deviation of 97 core Ca between Bbp and Rbp is 1.65 A (Cowan, et al., 1990). 
A simple gathering of the known and proposed functional roles of these 
proteins raises another common 'characteristic in that all of the members bind or are 
thought to bind small hydrophobic molecules. The crystal structures of Rbp, Ins, Bbp, 
Mup and A2u have in fact revealed the presence of a protein specific ligand in the 
pocket, establishing a strong relationship between the fold and the functional role of the 
proteins. 
Another distinct structural family of hydrophobic molecule -binding proteins 
exists, to which the fatty acid binding proteins (Veerkamp, et al., 1991) belong, that 
has a similar arrangement of pleated sheet surrounding a pocket but differing from the 
lipocalin family in that they are intracellular with an average molecular weight of 12 -15 
kDa and are formed by 10 strands of 13-sheet whereas the lipocalins are extracellular, 
have an average weight of 18 -20 kDa and contain 8 strands of sheet. 
Another common trait among the lipocalins is the primary structure. Although 
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FIG. 1.1 Rbp - the structural characteristics of lipocalins 
Top: view of the two crossed Ps-sheets and the a- helix. 
Bottom: view into the pocket. 
Green arrows are the 13-strands, red cylinder is the a- helix, yellow tube are non - 
defined secondary structure stretches and space -filled molecule is the bound 
retinol. 
FIG. 1.2 Rbp and Mup superimposed. 
Rbp and Mup main -chain are represented by a yellow and a green tube, 
respectively . The two structures were superimposed with the LSQ facility in O. 
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sequence alignment of the proteins shows low homology with an the average identity of 
25 -30% (Godovac- Zimermann, 1988) the following sequence motif is detected 
(Sawyer, 1987). 
--u-x-x-G-x-W-y--//--C--//--T-D-Y-y-x-x-y-- 
u - basic residue 
y - aromatic residue 
x - either 
Interestingly these conserved residues are found to be clustered at the base of 
the calyx (North, 1989) raising the hypothesis that this arrangement forms the 
recognition zone for the protein receptor, while demonstrating enough changes to 
permit specificity. 
The motif, when applied to a search of protein sequence data bases, has allowed 
the extention of the lipocalin family to include other proteins of unknown three - 
dimensional structure. The family currently comprises some 23 different proteins listed 
in TABLE 1.1, of diverse provenance and role. 
A further common aspect of the lipocalin family members is the primary 
organization of the genes. Work done by Ali and Clark, (1988) on the intron/exon 
organization of ovine Blg and comparison with four other proteins of the family 
demonstrated the parallelism of the exon size and on the relation between the exons and 
the particular tertiary elements encoded. It was suggested that the proteins compose a 
divergent but evolutionarily related gene family. 
Only common features have been mentioned, however the group is perhaps 
more interesting in its diversity some details of which will now be described. All of the 
proteins are soluble in aqueous media but apolipoprotein D is capable of forming 
interactions with lipid vesicles (McConathy and Alaupovic, 1976; Steyrer and Kostner, 
1988) and therefore possibly exists in equilibrium between lipidic and aqueous media 
(Holmquist, 1990). Also the very diverse sequences allow for different post - 
translational modifications, for example, al -acid glycoprotein (Bennett and Schmid, 
1980) and apolipoprotein D ( McConathy and Alaupovic, 1976) are highly glycosylated. 
Some ligands are specific for a particular protein but that protein may present a broad 
affinity (Blg has numerous known ligands as outlined in section 1.2). Finally 
prostaglandin D synthase (Nagata, et al., 1991) is known to have enzymatic activity - a 
property not observed for any of the other members. 
Thus, a particular fold seems to have evolved and been applied with a "free 
hand" to the role of binding small hydrophobic molecules. 
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TABLE 1.1 Members of the Lipocalin family 
Protein Source Putative function Ref. 
Bovine Blg Milk Transport/transfer in gut 
a -PEG Human amniotic 
of young? (1) 
fluid (2) 
Human Rbp Serum Retinol transport in complex 
with transthyretin (3) 
Purpurin Neural retina Transport retinol across 
interphotoreceptor matrix (4) 
a 1-Microglobulin Human serum,urine Regulation of immune 
response (5) 
Frog Bowman's Nasal mucosa Presentation of odorants to 
gland protein receptors (6) 
Cow nasal protein Nasal mucosa Presentation of odorants to 
receptors (7) 
Rat odorant binding Nasal mucosa Presentation of odorants to 
protein receptors (8) 
Aphrodisin Hamster vaginal ? 
discharge (9) 
Apolipoprotein D Human blood and 
breast cyst 
Growth modulation? 
al -Acid glycoprotein Human serum, urine Acute phase protein (10) 
Rat epididymal Epididymal luminal Binds retinoic 
protein for sperm maturation (11) 
A2u Rat urine, serum Binds pheromones? (12) 
Mup Mouse urine, serum Binds pheromones? (13) 
Complement - Serum Involved in complement 
-C8y complex (14) 
Crustacyanin -A Crustaceous Colouration by binding 
and -C carapace astaxanthin (15) 
Insectocyanin Insect hemolynph Binds biliverdin IX (16) 
Bbp Insect hemolynph Binds biliverdin IX (17) 
Prostaglandin - Rat and human Converts prostaglandin -H2 
-D sinthase brains to prostaglandin -D2 (18) 
Tear pre- Human tear Involved in the formation 
-prealbumin of the air /tear thin lipid film? (19) 
Condrocyte 21 
protein 
Skeletal tissue Stabilization of mature cells (20) 
Probasin Prostate epithelial Linked to the state of cell 
cells differentiation (21) 
(1) Godovac -Zimmermann and Braunitzer, (1987);(2) Julkunen, etal., (1988);(3) Rask, et al., (1979);(4) 
Berman, et al., (1987);(5) Akerström and Lögdberg, (1990);(6) Pervaiz and Brew, (1985);(7) Lee, et al., 
(1987);(8) Pevsner, et al., (1988);(9) Henzel, et al., (1988);(10) Cooper, et al., (1987);(11) Brooks, et 
al., (1986);(12) Unterman, et al., (1981);(13) Clark, et al., (1987);(14) Haefliger, et al., (1987);(15) 
Keen, et al., (1990);(16) Riley, et al., (1984);(17) Sutor, et al., (1988);(18) Nagata, et al. (1991);(19) 
Redl, et al., (1992);(20) Cancedda, et al., (1990);(21) Spence, et al., (1989) 
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1.2 Beta -lactoglobulin 
This protein is secreted as a major component of the milk of several ruminants 
like cow and sheep, as well as other mammals like pig and dolphin (Hambling, et al., 
1992). 
Bovine Blg is a protein of 162 residues (Braunitzer, et aí.,1972), 18kDa. It 
does not present any chemical post -translational modification in the most common 
variants. The sequence variability induces differences in its behaviour in solution in that 
some variants form dimers under physiological conditions while others are present as 
monomers. In fact, in the same animal, genetic polymorphism can produce molecules 
that have different properties as is the case with bovine variant B which is five times 
more soluble than variant A. 
Despite the availability of large amounts of pure protein since the first isolation 
of Blg in the 1930's and subsequent numerous studies to which it was subjected, the 
function of the protein is still unknown although there is a whole array of evidence that 
suggests a role in the transport of some essential metabolite for the new -born. Of 
particular interest are its resistance to acidic conditions and gastric digestion (McAlpine, 
1991), the discovery that Big enhances the retinol uptake in the jejunum and ileum of 
suckling rats (Said,etal., 1989), the detection of a specific receptor in the neonate calf 
(Papiz, et al., 1986) and its capacity to bind small hydrophobic ligands. 
The protein is known to bind a wide variety of compounds. All are small 
molecules with low aqueous solubility, some with high biological relevance, see 
TABLE 1.2. Binding studies have been undertaken using a variety of techniques and 
attempts have been made to characterize the site, in terms of residues and environment 
involved in the interaction with the ligand. Fluorescence of the protein or of the ligands 
(Dufour, et al., 1990; Fugate and Song, 1980), site -direct mutagenesis (Cho, et al., 
1993) and X -ray crystallography ( Papiz, et al., 1986. Monaco, et al., 1987) were the 
most promising approaches but disappointingly have not been able to pinpoint the site 
or sites of binding and so the relevance of the pocket, in contrast to other members of 
the lipocalin family, is still a matter of discussion. The protein shows conformational 
and aggregation changes that are pH dependent (Rambling, et al., 1992). They are of 
interest mainly because the protein can resist acidic conditions without denaturation, 
allowing it to pass through the stomach upon ingestion. The bovine protein is a 
monomer below pH 3.5, then in the range 3.7 to 6.5 it exists in equilibrium between 
monomer, dimer and octamer. Above pH 6.5, the predominant forms are the dimer and 
monomer. These changes are coincident with conformational changes detected by 
circular dichroism and optical rotatory dispersion in particular the transitions occurring 
between pH 4 and 6, and pH 6.5 and 7.8 - often called the Tanford transition. Above 
pH 8.5 irreversible denaturation is initiated. 
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TABLE 1.2 Blg ligands 
Ligand Numb. /monomer Associationa constant Ref. 
(M -1) 
Retinol 1 5x107 (1) 
Stereate 1 1.7x105 (2) 
Palmitate 1 6.8x105 (2) 
Laurate 1 0.5x105 (2) 
Oleate 1 0.4x10-5 (2) 
Heptane 1 0.5x105 (3) 
Butane 1 1.7x103 (4) 
(5.8x102) 
Pentane 1 7.1x103 (4) 
(6.2x103) 
Iodobutane 1 2.8x103 (4) 
SDS 1 3.1x105 (5) 
2,6 -MANSb 1 3.4x105 (6) 
Methyl orange 1 0.2x104 (5) 
n- Octylbenzene p- sulphonate 1.5 6.3x104 (5) 
p- Nitrophenol 1 1.9x104 (7) 
p- Nitrophenylacetate 1 3.1x104 (7) 
p- Nitropheny1- 13- glucuronide 1 1.6x104 (7) 
p- nirophenyl sulphate 1 2.0x103 (7) 
p- Nitrophenyl pyridoxal phosphate 1 3.1x103 (7) 
2- Heptanone 1 0.2x103 (5) 
2- Octanone 1 0.5x103 (5) 
2- Nonanone 1 2.4x103 (5) 
Toluene 4.5x103 (8) 
(5.9x101) 
Trifluorotoluene 4.2x102 (8) 
(3.1x101) 
Hexafluorobenzene 1.6x103 (8) 
Protoporphyrin IX 1 4x107 (9) 
Hemin 1 0.4x107 (9) 
Ellipticine 0.5 7x105 (10) 
a- Figures in parentheses represent the association constant for the binding of a second ligand at a 
second site. b- N- methyl -2- anilino -6- naphthalene sulphonate. (1) Fugate and Song (1980);(2) Spector 
and Fletcher, (1970);(3) Mohammadzadah -K., et al., (1969);(4) Wishnia and Pinder, (1966);(5) O'Neill 
and Kinsella, (1987);(6) Lovrien and Anderson, (1969);(7) Farrel, et al., (1987);(8) Robillard and 
Wishnia, (1972a,b);(9) Dufour, et al., (1990);(10) Dodin, et al., (1990) 
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The crystallographic studies of Blg have been on going for more than thirty years and 
much of the initial work was performed by D. Green and coworkers. It culminated in 
the publication of the low resolution structures of four different crystal forms reported 
in Green, et al., (1979). The work revealed the low content of a -helix and the presence 
of a molecular dyad, both facts in agreement with other studies. At 6 A however it did 
not allow much insight into the detailed structure of the molecule. 
The extension of the resolution to 2.8 A in the so- called crystal form Y (space 
group B2212) was achieved a few years ago and is described in Papiz, et al., (1986). It 
was shown then that the overall folding consisted of the previously described (in 
section 1.1) calyx shape and the close resemblance to the Rbp structure was noted. The 
point is clearly made that the structure suffers from a few problems like the lack of 
definition of the density of one external loop, as well as poor density for the N- and C- 
termini and one of the disulphide bridge (Cys66 -160). The existence of a molecular 
dyad is reaffirmed and the structure shows that the contact surface is established by 
one of the ß -sheet strands. No density identifying a ligand molecule was found in the 
pocket but a model for the binding of retinol based on the Rbp binding site was 
discussed. This model places the retinol in a deeper position inside the calyx than is 
found in Rbp. 
Some of these findings were contested by work on the Z crystal form (space 
group P3221) (Monaco, et al., 1987) in particular in the assignment of density for a 
retinol molecule not in the putative binding pocket but on the surface of the protein. The 
molecule was found to interact with hydrophobic residues in the proximity of Lys141 
with which, and in agreement with biochemical studies (Horwitz and Heller, 1974), it 
is postulated it will form a Schiff -base interaction. The crystal packing revealed no 
close interaction between single protein molecules, as found in the Y form, and it was 
considered that the monomer had been "selected" during crystallization. This is 
corroborated by the existence of a monomer -dimer equilibrium under the conditions of 
crystallization but it contradicts the findings described in the low resolution studies 
(Green, et al., 1979). 
1.3 Apolipoprotein D 
The following sections present a comprehensive literature review of 
apolipoprotein D. The fields of apo D and GCDFP -24 have evolved separately but 
these two molecules have since been determined as one protein. This review will 
attempt to integrate the two fields. 
1.3.1 Biochemical characteristics 
Apolipoprotein D (apo D) from human plasma has been biochemically 
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characterized as a glycoprotein, with 18% (in dry weight) content of carbohydrate 
(McConathy and Alaupovic, P., 1976) comprising the following sugars: 1.89% D- 
glucose, 4.42% D- galactose, 2.96% D- mannose, 4.49% D- glucosamine and 4.82% 
neuraminic acid. Two possible glycosylation sites at Asn45 and Asn75 have been 
interpreted from the sequence (Drayna, et al., 1986) and later confirmed from peptide 
sequencing (Balbín, et al., 1990). 
The sequence is 169 amino acids long and a molecular weight of 19302 kDa is 
expected but the associated sugars increase this to -22 kDa (McConathy and Alaupovic, 
1976) and present possible migration problems in many of the normally used systems 
for molecular weight determination (See and Jackwoski, 1990; Balbín, et al., 1990). It 
presents an apparent molecular weight by SDS -PAGE of -30 kDa in the blood form 
(purified from High Density Lipoproteins - HDL) and -24 kDa in the cyst form 
(purified from Gross -Cystic Disease Fluid - GCDF - in human breast). 
Apo D purified from GCDF migrates in a gel filtration column as a 100 kDa 
protein (Balbín, et al., 1990), leading to the assumption that it is possibly present in the 
GCDF as a tetramer. In the lipoprotein system this protein is found associated to apo 
AI and lecithin -cholesterol acyltransferase (LCAT) as demonstrated by the simultaneous 
removal of 96% of apo D, 64% of LCAT and 11% of apo AI from high- density 
lipoproteins particles, with an anti-apo D immunoadsorbent (Albers, et al., 1981). 
However, Hölmquist, (1989) using gel filtration to purify LCAT, found that only 33% 
of this protein is associated with apo D. Also Fielding and Fielding, (1980) suggest the 
existence of two complexes with the following compositions, apo AI : LCAT : apo D 
with molar ratio 1.0 : 0.9 : 1.9 and apo D: apo AI : apo All (1.0 : 3.8 : 2.2). Blanco - 
Vaca, et al., (1990; 1992) have found evidence for disulphide interchange with other 
apolipoproteins and suggest that the covalently associated heterodimer apo D : apo All 
accounts for 67% of the apo D in the plasma, while other minor heterodimers are 
formed with apo B100 in VLDL (very-low density lipoproteins) and LDL (low- density 
lipoproteins). The reasons for this dimerization are not clear. There is evidence as well, 
for the existence of free apo D in the plasma as it was found in human urine at a 
concentration of 1.4 mg/1 (Hölmquist, 1990). This is a higher value than any described 
for other apolipoproteins which are tightly associated to lipidic particles. 
The protein is capable, as well, of establishing interactions with lipids. In 
particular in the plasma, by disruption of the HDL a lipoprotein sub -particle, the Lp -D, 
is formed that consists of 65 -75% protein and the rest lipids (McConathy and 
Alaupovic, 1973; 1976; 1986). 
1.3.2 Genetic characteristics 
The screening of a human cDNA liver library has allowed the determination of 
the whole gene sequence, translated to 169 amino -acids for the mature apo D plus a 20- 
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residue amino terminal secretion peptide signal (Drayna, et al., 1986). This work 
confirmed that the N - terminus is chemically blocked (McConathy and Alaupovic, 
1976) by cyclization of the glutamic acid. 
The sequencing of several clones indicated a possible polymorphism at position 
110, Leu for Phe (Drayna, et al., 1986). Polymorphism was also detected in the blood 
apo D by isoelectric focusing (IEF) gel where several bands were revealed between pH 
4.2 -4.9 (Kamboh, et al., 1989). The number of bands is reduced by digestion of the 
protein with neuraminidase proving that some of the polymorphism is due to differing 
carbohydrate content and in particular of neuraminic acid. It was also demonstrated 
(Kamboh, et al., 1989) that the IEF pattern was different for some individuals of 
African ancestry and that this different phenotype was due to the existence of two 
alleles for the protein, APOD *1 and APOD *2. The frequency of APOD *2 in Nigerian 
blacks is 2.2% and in U.S. blacks 1.3 %. This allele was not detected in U.S. whites, 
Dogrib Indians, Mayan Indians, Aleuts, Kodiak Island Eskimos and St. Lawrence 
Island Eskimos. 
The apo D human gene is divided into at least five exons; three introns are 
found in the protein -coding region and at least one in the 5' untranslated region 
(Drayna, et al., 1987). The intron positions are similar to those of the Rbp (retinol- 
binding protein) gene. The unique gene was localized in human chromosome 3, with 
41% of the signal clustered over the distal long arm. 
The rat amino acid sequence deduced from a cDNA library of sciatic nerve 
showed 73.4% identity to the human gene (Spreyer, et al., 1990), while the sequence 
from rabbit testis cDNA library is 80% identical to the human (Provost, et al., 1990). 
1.3.3 General distribution 
In the work described by Drayna, et al., (1986), the human tissue distribution 
of apo D mRNA was examined. The mRNA was detected in the pancreas, adrenal 
gland, kidney, small intestine, placenta, spleen and fetal brain, all of which presented a 
higher signal of expression than the liver. It was not detected in white blood cells or in 
monocytes (cell lines U937 and HL60). 
The protein has been immuno -localized in the supranuclear area of enterocytes 
(human intestine cells) and in the perinuclear area of hepatocytes (human liver) 
(Bouma, et aí.,1988). The protein was not detected in the colon (Mazoujian and 
Haagensen, Jr., 1990). 
Apo D has been detected by immunoreaction in HDL (Provost, et al., 1990) of 
rabbit, pig, dog, cow, goat, sheep, Cynomolgus and Rhesus monkey; it was not 
detected in guinea pig, cat or rat HDL. In rabbit the apo D mRNA was present in, from 
highest to lowest level of expression, spleen, adrenal gland, lung, brain, testis, kidney, 
heart, small intestine, bone marrow, thymus, pancreas, skeletal muscle, liver and 
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lymph node. The level of expression in the spleen is 59 -fold higher than in the liver. 
In the Rhesus monkey (Smith, et al., 1990), apo D mRNA was detected in cells 
of mesenchymal origin, which were identified as fibroblasts and interstitial cells, and in 
most of the peripherial tissues examined like spleen, testes, liver, pancreas, skeletal 
muscle, kidney, jejunum, pituitary, peripherial nerve and brain. 
1.3.3.1 Distribution in the nervous system 
Apo D was detected (Boyles, et al., 1990) in rat sciatic nerve extracts as well as 
in rat spinal cord and rat dorsal root ganglia but the detection system used could not 
detect apo D in rat plasma due to very low levels. In particular, apo D was detected by 
immuno- cytochemistry in spinal cord fibrous astrocytes, oligodendrocytes and 
protoplasmic astrocytes, though in smaller quantities in the last two cell types. A signal 
was also detected in giant motor neurons of the ventral horn and in the neuropil of the 
dorsal horn. In the dorsal root ganglia and sciatic nerve, apo D was detected in cells 
thought to be neurolemmal or fibroblasts. 
Electron microscopy was used to observe the apo D- containing cells in the rat 
neural tissue (Boyles, et al., 1990). It was found in the endoplasmic reticulum (part of 
the secretory apparatus) of both spinal cord astrocytes and oligodendrocytes and of the 
neurolemmal or fibroblasts of the dorsal root ganglia and sciatic nerve. The protein was 
detected too on the cell surface of neurolemmal cells and associated with the matrix of 
the nerve. In neurons of both spinal cord and dorsal root ganglia it was observed in 
small, membrane -bounded compartments and never in the secretory apparatus. The 
macrophages of the sciatic nerve contained apo D only in lysosomal structures and 
infoldings or projections of the cell surface. All of this suggests that apo D is a 
secretory product of astrocytes, oligodendrocytes and neurolemmal or fibroblastic cells 
while being taken up by macrophages and specific neurons. 
Spreyer, et al., (1990), working with regenerating rat sciatic nerve, identified 
the endoneural fibroblast as the major type cell expressing apo D mRNA; no mRNA 
was found in macrophages or Schwann cells. 
In Rhesus monkey (Smith, et aí.,1990) synthesis was detected in cells of the 
peripherial nerve and brain, like neuroglial cells, cells in the subarachnoid space of the 
surface of the brain as well as perivascular cells and scattered neurons in the brain . 
1.3.3.2 Localization in tumour cells 
Apo D is in general found at higher concentrations in the cytosol of well 
differentiated breast tumour than in aggressive poorly differentiated ones (Silva, et al., 
1982). 
Using polyclonal antibodies and the immunoperoxidase technique (Mazoujian 
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and Haagensen, Jr., 1990) apo D was localized in sweat gland tumours of apocrine 
differentiation. It was found as well in metaplastic epocrine epithelium of the breast and 
in the fluid contained within the cysts though normal breast epithelium did not stain 
except for a few sporadic cells. Normal adrenal cortex and corpus luteum, peripherial 
nerves, pituitary and renal tubules demonstrated immunoreactivity. Colon, oesophagus, 
lung, pancreas, parathyroid glands, stomach and thyroid revealed no staining. 
The same study showed that 13 out of 25 cases of breast carcinoma, as well as 
endometrial (6 out of 8), ovarian (4 out 10), prostatic (5 out of 8) adenocarcinomas and 
leiomyosarcoma (1 out 1) stained positively for apo D. Some staining was found for 
carcinomas from the colon, kidney, liver, lung, pancreas and stomach. It was 
concluded that apo D is localized in steroid -responsive tissues. 
In the particular case of sweat glands (Mazoujian, 1990), immunocytochemistry 
experiments revealed the presence of apo D in normal apocrine glands and ducts but not 
in eccrine ones. In the sweat gland tumours studied, many stained for apo D. No 
detection was demonstrated in tumours of eccrine differentiation. It was concluded that 
apo D is useful for the identification of apocrine differentiation and demonstration of 
functional activity on this subset of sweat gland tumours. 
Several cancer lines excrete apo D. The LNCaP prostate cell line (Simard,et al., 
1991) and the human breast ZR -75 -1, MCF -7 (Simard, et al., 1990) and T47D 
(Haagensen, et al., 1992) are ideal models for the study of the physiological function of 
apo D and of the regulation of its expression. 
Though not constituted of tumour cells, cysts are considered to be the 
consequence of aberration in the environment of the particular tissue leading to 
hypersecretion (Dogliotti, et al., 1990). Of the proteins found in the fluid of cysts from 
the human breast gross -cystic disease apo D is the major component (Balbín, et al., 
1990) 
1.3.3.3 Apo D in the lipoprotein system 
The protein was first detected in plasma as a distinct apolipoprotein by 
McConathy and Alaupovic, (1973). That study concluded that in terms of amino acid 
composition and immunological criteria, the protein is different from other 
apolipoproteins. 
Apo D (McConathy and Alaupovic, 1986) is present as a minor component in 
the plasma (5% of the proteins) of normolipidemic subjects, at concentrations ranging 
from 60 -100 mg/1 of plasma. It is mainly (60 - 65 %) localized in the HDL (high density 
lipoproteins) with the following relative distributions; 43% in the HDL3 subparticle 
and 21% in the HDL2 subparticle (Curry, et al., 1977) with trace amounts in the VLDL 
(very low density lipoproteins) and LDL (low density lipoproteins), and the remainder 
(36 %) in the VHDL (very high density lipoproteins) - which can be considered to be a 
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lipoprotein -free fraction. It was already mentioned above, that by the break -up of the 
HDL3 a sub -particle is formed designated as Lp -D. It consists of 65 -75% protein, 
while the remainder is composed by 8.2% triglycerides, 18.1% cholesterol, 27.7% 
cholesterol ester and 46.5% phospholipid of which 26.4% is lysolecithin, 33.3% 
sphingomyelin and 40.1% lecithin. These are unusually high relative values for the first 
two phospholipids and low for the last when compared with other lipoproteic particles 
(McConathy and Alaupovic, 1986 and 1976). 
Baboon plasma contains apo D which has been partially characterized with 
respect to the amino acid and carbohydrate (Bojanovski, et al., 1980). Specifically it 
differs from the human form in that it posesses relatively more basic amino acids and 
more marnose in its carbohydrate composition. 
1.3.4 Functional role 
The function of apo D is far from clear. The discovery of circumstances in vivo 
where a particular protein is present, especially conditions where either specific or high 
expression occur, or where a defined pathology is concurrent with biochemical 
alterations in the behaviour of a protein (genetic alterations or unbalanced regulation), 
are of immense use in the determination of the functional role. At the moment, four 
main manifestations of protein occurrence can be delineated and studied: the association 
of apo D with other apolipoproteins and lipids in the plasma, the overproduction of 
protein in injured periphereal nerves of rat, the excretion of the protein by some tumour 
cells and finally the production of apo D in cysts. These four situations will be outlined 
separately and the common points among them summarized. 
1.3.4.1 Plasma 
The plasma lipoprotein system is a very dynamic one that fulfils the task of 
transporting triacylglycerols and cholesterol through the organism (Erkelens, 1989). It 
is composed of macromolecular structures designated as lipoprotein particles and these 
have been categorized according to their separation by ultracentrifugation in increasing 
density as chylomicrons, very-low- density- lipoproteins (VLDL), intermediate- density- 
lipoproteins (IDL), low -density- lipoproteins (LDL) and high- density- lipoproteins 
(HDL) (Chapman, 1986). Each displays distinct physical properties, see TABLE 1.3, 
and is composed of protein and lipids, cholesteryl -esters, triglycerides, phospholipids 
and cholesterol in the proportions described in TABLE 1.4. 
The lipoprotein particle is basically a bilayer system: a "sack" composed of 
phospholipids, cholesterol and protein, ready to receive neutral lipids and consequently 
to swell. The apolipoproteins stabilize the structure and size of particular lipoproteins 
(Erkelens, 1989), see TABLE 1.5, but some have further functions. For example, apo 
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B48 enables chylomicrons to move through the cellular membrane and apo B 100, does 
the same for the VLDL. Some act as ligands to receptors and therefore "guide" the 
lipoproteins to catabolic sites, like apo B100 that interacts with apo B/E receptor, and 
TABLE 1.3 Physical characteristics of lipoproteins (Gotto,Jr., etal., 
1986) 
Lipoprotein Particle size (nm) Density (g/ml) Molecular weight 
(Da) 
Chylomicrons 75 -1200 0.93 -4x10g 
VLDL 30 -80 0.93 -1.006 1-8x107 
IDL 25 -35 1.006 -1.019 5-lxl07 
LDL 18 -25 1.019 -1.063 2.3x106 
HDL2 9 -12 1.063 -1.125 3.6x 105 
HDL3 5 -9 1.125 -1.210 1.8x105 
TABLE 1.4 Composition of lipoproteins (Gotto,Jr., eral., 1986) 







Chylomicrons 35 63 2 95 5 
VLDL 43 55 2 76 24 
IDL 38 60 2 78 22 
LDL 42 58 0.2 19 81 
HDL2 22 75 2 18 82 
HDL3 23 72 5 16 84 
apo E with the apo E and apo B/E receptors. Others are cofactors for the enzymes 
involved in lipid transport such as apo AI for lecithin -cholesterol acyltransferase 
(LCAT) or apo CH for lipoprotein lipase, or even as inhibitors like apo CIII in the 
catabolic pathway of the VLDL and chylomicrons. A number of enzymes (Erkelens, 
1989) are associated with, or act upon, the system, such as LCAT (which esterifies 
cholesterol), lipoprotein lipase (which hydrolyses triacylglycerols from chylomicrons 
and VLDL and is attached to the luminal side of endothelial cells), the hepatic lipases 
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(which probably hydrolyse triacylglycerols from IDL and interconvert HDL 
subparticles - HDL2 and HDL3) and there are as well some transfer proteins like 
cholesteryl -ester transfer protein which are involved in the exchange or transfer of 
neutral lipids. Essential to the whole process are the already -mentioned receptors that 
exist on the surface of cells of tissues like the liver, involved in the metabolism of 
lipids. 
TABLE 1.5 Protein composition of the lipoproteins (Gotto,Jr., et al., 
1986) 
HDL LDL IDL 
(mol %) 
VLDL Molecular weight 
(Da) 
Apo AI 100 28016 
Apo MI 100 17414 
Apo ATV 44465 
Apo B48 264000 
and 90 8 2 
Apo B100 550000 
Apo CI 97 1 2 6630 
Apo CII 60 10 30 8900 
Apo CIII 60 10 10 20 8800 
Apo D 100 22000 
Apo E 50 10 20 20 34145 
The close association of apo D, in the HDL3, with apolipoprotein AI (apo AI) 
and especially with LCAT (Albers, et al., 1981; Fielding and Fielding, 1980) which 
catalyzes the formation of cholesteryl- esters and lysophosphatidyl choline from 
cholesterol and phospholipids, led to the proposition of the involvement of apo D in the 
esterification of cholesterol either as an LCAT activator (Kostner, 1974) or as a transfer 
protein of cholesteryl -ester (Chajek and Fielding, 1978). However, these two possible 
roles were proved not to be real. The involvement of apo D was verified not to be of a 
regulatory kind, as it is for apo M, because very little change in the activity of LCAT 
was noted in the presence of apo D (Steyrer and Kostner, 1988), and the authors 
postulated instead, a stabilization effect of apo D on LCAT. Furthermore, the separation 
of apo D from a protein with cholesteryl -ester transferring properties (Morton and 
Zilversmit, 1981) and the verification that the removal of most of the apo D from 
plasma had no effect on the transferring activity (Albers, et al., 1981) eliminated the 
idea of a role in the direct transport of cholesterol, in the lipoprotein system. The fact 
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remains however, that a physiological complex exists suggesting that the roles of these 
three proteins, apo AI, apo D and LCAT are connected. 
Several studies have been undertaken to find factors and circumstances that can 
be correlated to abnormal concentrations of apo D in the plasma. Thus, Albers, et al., 
(1981), have found that the levels of apo D are slightly higher in men than in women 
both for normolipidemic and hyperlipidemic adults. This was confirmed by Haffner, 
et al., (1985) for a random population, though no such correlation had been found by 
Curry, et al., (1977). Hypertriglyceridemics showed lower levels of apo D (Albers, et 
al., 1981) while hypercholesterolemics and dysbetalipoproteinemics presented normal 
concentrations (all these clinical conditions are associated to genetic disorders or 
disorders like daibetes, hypothyroidism, anorexia, etc. See TABLE 1 in Gotto,Jr., et 
al., 1986). The same study presented evidence for half the normal apo D levels in 
subjects with familial LCAT deficiency (having little or no LCAT in the plasma). Curry, 
et al., (1977) also found that the phenotype designated as hyperchylomicronemia 
showed half the normal levels of apo D. 
Two alleles have been detected (Kamboh, et al., 1989) in the human population 
(see section 1.3.2) and an attempt was made to find changes associated with the the 
presence of the very rare allele APOD *2. Though noting that due to the small 
population examined the results are not statistically relevant, it was concluded that no 
significant change in the lipid or lipoprotein levels could be found to be associated with 
the presence of APOD *2. 
A thorough collection of data reported by Haffner, et al., (1985) examined the 
correlation of factors like smoking, intake of alcohol, age, gender and adiposity with 
apo D, apo AI, apo AH levels and other components of the lipoproteins. It was 
observed that apo D was positively correlated to the cholesterol content in the 
subparticle HDL3 (HDL3C), apo AI and apo AII, while LCAT had a moderate positive 
correlation with HDL3C and a negative correlation with HDL2C. It was found as well 
that age was positively correlated with apo D in women while no other factor was 
correlated to age. The triglycerides in the VLDL were correlated to HDLC, especially 
HDL2C, and with LCAT; the same pattern was seen for the body mass index (BMI). 
Alcohol was positively correlated to HDLC as well as to apo AI and apo AII, both in 
men and women, while correlated to apo D only in men. Negative correlations were 
observed for males between smoking and apo AI, D, AH, and in both genders for 
smoking and HDL3C and LCAT. 
1.3.4.2 Neural tissue 
The regeneration of peripheral nerves (Boyles, et al., 1990; Spreyer, et al., 
1990) demands an influx of "raw materials" for the re- establishment of the tissue. 
Schwann cells distal to the injury site, and macrophages, are involved in cleaning the 
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destroyed cells and in the recuperation of lipids, such as cholesterol, from the cell 
membrane. In addition, locally produced lipids and lipids entering from the plasma are 
used for the regeneration. 
Lipoproteins seem to have a role in the transpon of the lipids during denervation 
and regeneration (Boyles, 1989) as large amounts of cholesterol -rich lipoproteins with 
apo E and apo AI were identified in regenerating at sciatic nerve. In the same work the 
receptor for apo E was found to be present in regenerating axons. While apo E was 
shown to be produced by both locally resident macrophages and endothelial cells, apo 
AI entered the nerve from the plasma as a component of plasma lipoproteins when the 
blood/nerve barrier is destroyed during injury. 
Later, apo D and apo AIV were identified also; they accumulate in the 
regenerating peripheral nerve (Boyles, et al., 1990), but while apo AIV seemed not to 
be produced locally as concluded by absence of signal in metabolic labelling 
experiments with [35S]methionine, apo D did incorporate the label. A fraction of apo D, 
13 -15 %, was found in the lipoprotein -free fraction indicating that some of the protein is 
in the free form. 
These proteins (apo's AI, MV, D, E) and albumin are seen (Boyles, et al., 
1990) to increase from the first day after injury over several weeks while the 
regeneration occurs, FIG. 1.3. Apo AI and AIV increased for 2 -3 days before 
decreasing briefly and then peaking at 3 weeks at 26 -fold and 14 -fold respectively of 
the basal concentration. The concentration decreases to around 3 -fold above normal by 
6 weeks after injury. Apo D and apo E showed a fast increase and their concentrations 
peaked at 500 -fold and 250 -fold respectively at 3 -4 weeks after injury, then the 
concentrations decrease and at 6 weeks the levels are still 200-fold and 150 -fold 
respectively of the normal. The increase coincides with the period of axon growth (1 -2 
weeks after injury) and active myelination (2 -8 weeks after injury). 
Apo E was demonstrated (Handelmann, et al., 1992) to have a double direct 
effect in vitro, on the growth of the rabbit dorsal root ganglion neurons, when 
complexed as a lipoprotein it stimulates neurite growth by increasing the uptake of 
cholesterol (an essential component of membranes) in the form of ß -VLDL. When in its 
free -form it decreases branching while promoting extension of the cells. 
Another study (Spreyer, et al., 1990) found an increase in apo D mRNA in 
endoneural fibroblasts present in regenerating rat sciatic nerve. The increase was noted 
from the second day after injury, peaking at to 40 -fold by the sixth day and then slowly 
decreasing to 5 -fold after 12 weeks. It is noted that the increase cannot only be 
accounted for by the 4- to 8 -fold increase in the number of fibroblasts. The protein was 
found in the lipoprotein fraction of the medium used to culture the crushed sciatic 
nerves. 
Despite this involvement in the neural tissue, patients with apolipoprotein 
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deficiencies, like familial hypercholesterolemia where there is a diminished expression 
of normal functional low density lipoprotein receptors (in particular receptors for apo E) 
or with lower levels of apo E, suffer no neurological problems (Boyles, et al., 1990). 
FIG. 1.3 Variation of the concentration of albumin, apo's AI, 
AIV, D and E in regenerating rat sciatic nerve. (Boyles, et al., 1990) 
The points were generated by densitometry of immunoblots of reduced SDS- 
PAGE. The concentrations are relative to the level in normal nerve. Graph A 
shows the changes for albumin (circles), apo AIV (open squares) and AI 
(filled squares). Graph B shows variations of apo D (filled triangles) and apo E 
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Gross -cystic- disease (GCD) is the most common mammary pathology of the 
human breast tissue occurring in 10% of the population of premenopausal women. The 
peak age for full development of the disease is around 40 -44 years (Haagensen, 1971). 
The disease is characterized by the spontaneous formation of cysts in the mammary 
gland (Molina, et al., 1990). These structures are filled with abundant fluid and lined 
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by a single layer of epithelium or connective tissue (Haagensen, Jr., et al., 1979). 
Though the cysts are not considered to be premalignant lesions (Dogliotti, et 
al., 1990), several studies have examined the correlation of GCD to carcinoma 
(Haagensen, 1971; see references in Balbín, et al., 1990) and have found that there is 
an increase in the risk of developing breast cancer in women exhibiting GCD. 
The fluid has been analysed extensively and it has been possible to categorize 
the cyst into two main groups. The components reported to be present in the cysts were 
hormones (Dogliotti, et al., 1990; Bradlow, et al.,1981), electrolytes (Dogliotti, et al., 
1990) and proteins (Dogliotti, et al., 1990; Balbín, et al., 1990; Haagensen, Jr., et al., 
1979). Another approach to categorize cysts has been to examine the morphology of the 
lining epithelium cells (Dogliotti, et al., 1990). 
The determination of the concentration of monovalent cations, Na + and K +, and 
their charge counterpart Cl -, allows an immediate separation of cysts in two groups. 
Type I presents high K +/Na+ ratios, low concentration of Cl- and low pH, while for 
type II these factors are present as low K +/Na +, and higher Cl- concentration and pH. It 
is noticeable that the type I presents electrolyte characteristics of an intracellular 
compartment, while type II is typical of an extracellular medium. 
The array of hormones present in the cyst fluid is very large, and some present 
in extremely unusual concentrations (like androsterone, dehydroisoandrosterone and 
other 17- ketosteroids) which can be 4 to 110 times higher than in the plasma ( Bradlow, 
et al., 1981). These concentrations are not typical of other cyst fluids. The report by 
Dogliotti, et al., (1990), states that both free -triiodothyronine and free- thyroxine had 
higher concentrations in the cyst than in the plasma. This report states too, that 
significantly higher concentrations of dehydroisoandrosterone are present in cysts of 
type I compared to in type II. 
The fluid contains four major protein components, GCDFP -70 (gross- cystic- 
disease -fluid -protein) identified as albumin (Haagensen, Jr., et al., 1979; Balbín, et al., 
1991), GCDFP -44 identified as Zn -a2- glycoprotein (Haagensen, Jr., et al., 1979), 
GCDFP -24 that accounts for over half the total protein in the fluid and has been 
identified as apo D (Balbín, et al., 1990) and GCDFP -15. Some other proteins are 
present, though in much lower concentrations, like a- amylase, epidermal growth factor 
(Dogliotti, et al., 1990), pepsin C (Sánchez, et al., 1992) and many others (Dogliotti, 
et al., 1990). Balbín, et al., (1991) have demonstrated that the distinction into the two 
cyst types can be done by determination of albumin content, as this protein is more 
concentrated in type II cysts than in type I. Interestingly, two reports have identified 
enzymatic activity associated with apo D from cyst fluid; Kesner, et al., (1990) 
discusses that there is associated proteolytic activity and Banerjee, et al., (1990) show 
evidence for associated esterase activity. 
Dogliotti, et al., (1990) discuss the correlation between the cyst type and the 
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morphology of the epithelium lining the cysts and find that epithelia of type I cysts have 
higher probability of being constituted by apocrine cells. 
The knowledge about breast cysts is still not advanced enough to understand the 
mechanism of formation and the relevance of these different characteristics. However, 
some hypotheses have been presented, such as Balbín, et al., (1991) who have 
proposed that type I cysts are the initial stage of development characterized by activity 
of the apocrine epithelium explaining the intracellular charateristics of the fluid. It 
follows that type II would be a later stage of development when the epithelium has been 
flattened and become more permeable. 
Of utmost interest was the discovery of a progesterone binding protein existing 
in the breast cyst fluid with different properties from other known steroid binding 
proteins (Pearlman, et al., 1973). This protein was later designated as GCDFP -24 
(Haagensen, Jr., et al., 1979) and then shown to be apo D (Balbín, et al., 1990). 
Much work has been done on the binding properties of apo D (as GCDFP -24), in 
particular the work by Lea, (1988) and Dilley, et al., (1990) who have measured the 
affinities for several ligands, see TABLE 1.6. These studies have concentrated upon the 
metabolites of cholesterol as these are so common in breast cyst fluid. 
1.3.4.4 Tumour cells 
The finding of high concentrations of apo D in the cyst fluid and later the 
discovery, as discussed in section 1.3.3.2, that the protein is present in several cases of 
breast carcinoma has raised the possibility of its use as a biochemical marker for breast 
carcinoma. 
Soreide, et al., (1987; 1991a; 1991b) have looked at the validity of using apo D 
as a biological marker for providing diagnostic information. It was concluded that there 
is significant negative correlation between the presence of apo D and the advance of the 
tumour towards more aggressive stages, and between the concentration of apo D and 
the presence of malignant tissue: However it was pointed out that the apo D as a marker 
of tumour differentiation, is only useful as part of a group of tumor parameters. 
In section 1.3.3.2 it was pointed out that apo D was secreted by several cancer 
cell lines. Work done with breast cancer cell lines ZR -15, MCF -7 (Simard, et al., 1990; 
Labrie, et al.,1990), and T47D (Haagensen, et al., 1992) and the prostate cancer cell 
line LNCaP (Simard, et al., 1991) have demonstrated that there is an inverse relation 
between apo D secretion and cell growth, modulated by steroid hormones. As an 
example, dihydrotestosterone when added in increasing concentrations to the LNCaP 
cell line only induces growth between 10 -11 and 10 -9 M, while the amount of apo D 
expressed in that range is diminished. Above concentrations of 10 "9 M, the level of apo 
D is raised sharply by 3.2 -fold. Very similar effects are seen with the other proteic 
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TABLE 1.6 Apo D ligands 
Liganda Association constant (M-1) Ref. 
Cnolesterol 0 (1) 
Progesterone 1.3x106 (1) 
1.0x106 (2) 
R-5020 5.5x105 (1) 
Org 2058 1.3x105 (1) 
R 1881 8x104 (1) 
Dehydrotestosterone 1.8x105 (1) 
Androstenedione 0 (1) 
Dehydroisoandrosterone 1 x105 (1) 
Tamoxifen 4.5x105 (1) 
Estriol 0 (1) 
Estradiol 3x104 (1) 
<2.0x105 (2) 
Dehydroisoandrosterone-sulphate 5x104 (1) 
Estrone sulphate 1 x104 (1) 
Pregnenolone 1.3x106 (2) 
513-pregnan-3-o1-20-one 9.1x105 (2) 
5a-pregnan-3,20-dione 8.3x105 (2) 
50-pregnan-3,20-dione 8.0x105 (2) 
Promegestone 4.2x105 (2) 
Megestrol acetate 2.2x 105 (2) 
Medroxyprogesterone acetate 2.2x105 (2) 
1.3x105 (1) 
17a-hydroxy-4-pregnene-3,20-dione <2.0x105 (2) 
17a-hydroxy-5-pregnene-3-one-20-ol <2.0x105 (2) 
20a-hydroxy-4-pregnene-3-one <2.0x105 (2) 
Deoxycorticosterone <2.0x105 (2) 
5x104 (1) 
Estrone <2.0x105 (2) 
7x104 (1) 
Cortisol <2.0x105 (2) 
Testosterone <2.0x105 (2) 
1x105 (1) 
4-androstene-3,17-dione <2.0x105 (2) 
a- for all the ligands there are four binding sites per tetramer of protein. (1) Lea, (1988);(2) Dilley, et 
al., (1990) 
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components of the gross- cystic- disease, GCDFP -44 and GCDFP -15 (Haagensen, et 
al., 1992) in T47D breast cancer cell line. The expression of these proteins and in 
particular of apo D is closely controled by steroid hormones, and it seems to be 
connected to the growth of the cells that excrete them. 
It is also noted that a report (Albers, et al., 1984) on the effects of the anabolic 
steroid stanozolol on the proteins of the lipoprotein system LCAT, apo B, Lp(a) 
(Lipoprotein (a)) and in particular apo D, finds that there is a decrease in the in vivo 
concentrations of all the proteins except for apo B. 
As a note, expression of apo D can be detected in normal human diploid 
fibroblast cultures as well (Provost, etal., 1991).The expression was dependent on the 
growth state of the culture and it was concluded that it is probably a growth arrest 
consequence. 
The importance of apo D for the modulation of growth is a relevant factor raised 
by these experiments but that has not yet, to our knowledge, been explained. 
Nevertheless the relevance of apo D as a biochemical marker of cell development 
(growth/expansion) in general and tumour cells in particular is, once again, emphasized 
by these findings. 
1.3.4.5 Lipocalin member 
The determination of the sequence (Drayna, et al., 1986 ) and the recognition of 
apo D as a member of the lipocalin family has revealed the probable role of the protein 
in binding small hydrophobic molecules. 
A three- dimensional model of apo D based on the structure of insecticyanin and 
bilin- binding protein (Bbp) ( Peitsch and Boguski, 1990) has led to the prediction that 
apo D binds the same sort of ligands as insecticyanin and Bbp. In fact the ligand- 
binding experiments described in this article indicate that apo D does bind bilirubin. 
Most interesting was the fact that the affinity for cholesterol was shown to be extremely 
low. This is supported by analysing the modelled "binding pocket" where there seems 
to be enough space for two molecules of cholesterol and insufficient for cholesteryl 
esters due to their elongated form. It is proposed as well that the binding of the protein 
to the HDL is favoured by the hydrophobic loop at the entrance to the binding cavity. 
1.3.4.6 Summary 
In the previous sections the properties and characteristics of apo D have been 
described. They can be summarized in the following way: 
a) in the blood - involvement of apo D with the lipoprotein system, which 
has the function of transporting lipids 
b) in the neural system - involved in the regeneration process 
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parallelism with apo E 
c) in breast cysts - binding of some steroids in wich the cysts are particular 
rich 
no binding of cholesterol 
d) in tumor cells - probable biological marker 
steroids regulate its expression 
involvement in growth modulation ?? 
e) as a lipocalin member - a small hydrophobic molecule carrier 
So it is possible to conclude that apo D is probably involved in the control of or 
is at least part of growth/regeneration processes. It probably fulfils this role by either 
removing unecessary or inhibiting metabolites or by bringing metabolites essential for 
these processes. 
1.4 Thesis rationale 
The work described in this thesis involves the examination of different 
structural aspects of apo D and Blg. 
The structure of Blg presents many problems, as mentioned by Papiz, et al., 
(1986), and in particular there were several aspects of the trigonal crystal form, B1gZ, 
that did not seem to agree with previous work (see section 1.2). It was our purpose to 
obtain a better X -ray structure and at the same time to try to obtain proof of the 
importance of the "pocket" for the binding of the ligands. 
For apo D the questions were of a more general nature with the aim of finding 
promising leads based on the intention of bringing the different known aspects of the 
protein, as GCDFP -24 and as apo D, to some sort of unity. The questions asked were 
of the sort: how is it that a globular protein is involved with and binds to lipoproteins? 
what ligands does apo D bind when associated to HDL and are they relevant in any of 
the different situations where apó D is present? what is the three- dimensional structure 
of apo D and what are the structural characteristics common to other lipocalins? 
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2. Materials and Methods 
This chapter will describe first, the methods applied to apo D: purification, 
antibody techniques and general biochemical techniques, deglycosylation procedures, 
CD studies, aggregation experiments, studies of the cysteine residues, lipid interaction 
experiments, ligand binding studies and crystallization attempts. Followed by the 
methods used with Blg: crystallization conditions, heavy atom soaking, 
crystallographic data collection and programmes used. 
2.1 HDL preparation 
The rationale of the HDL preparation is based on the different densities of the 
various plasma components and on the use of ultra- centrifugation flotation for their 
separation. The procedure described (Dr. H.S. Simpson - personal communication) is 
similar in principle to others reported in the literature (McConathy and Alaupovic, 1973; 
Kostner and Alaupovic, 1972). 
Whole, out -dated blood (around 30 days after collection), obtained from the 
Scottish National Blood Transfusion Service, Royal Infirmary, Edinburgh was 
centrifuged at 3000 rpm (Beckman rotor JA -14), 10 °C for lh with the following 
additives; 0.01% EDTA , 0.5 g/1 ascorbic acid, 1 mM PMSF and 0.01% thimerosal. 
The supernatant (plasma), which usually presented a red -brown colour from freeze - 
thawing haemolysis was removed and the pellet discarded. The density of the plasma, 
after adding PMSF to 100 p.M and ascorbic acid to 0.5 g/l, was assumed to be 1.006 
g/ml and adjusted to 1.063 g/ml by adding 0.0834 g of solid KBr per millilitre. 
In centrifugation tubes of 60 ml volume, 50 ml of the prepared plasma were 
overlayed with 1.003 g/ml of KBr solution to a total volumi of 60 ml. The tubes were 
spun for 22 h at 45000 rpm (Beckman rotor 45Tí) at 4 °C. This resulted in a separation 
into three fractions; the yellow tóp layer contained all the low density plasma 
components (< =1.003 g/ml) except for the VLDL which formed a white skin on the 
wall of the tube. The bottom layer presented a gradient of colour from yellow to red, 
containing all the components denser than 1.003 g/ml, of which HDL are part. 
The top layer was removed with care, using a thin Pasteur pipette, positioned 
against the wall of the tube at the liquid -air interface, drawing up the liquid without 
disturbing the layers. The white skin was subsequently removed from the wall with 
white tissue paper.The bottom layer was homogenized by gentle mixing with a wide - 
bore plastic pipette without disturbing the pellet of cell membrane fragments usually 
found at the bottom of the tube. 
The additives PMSF and ascorbic acid were added to the bottom solution in 
concentrations of 100 .tM and 0.5 g/1 respectively and the pH was adjusted to >7 with 
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NaOH, to avoid precipitation. 
The density was then adjusted by the following procedure: 
a) The solution was weighed and the density determined. 
b) The following formula was used to determine the amount of solid 
KBr added to attain a final density of 1.23 g/ml. 
m=Vo(do-d)/1-dv 
m - amount of KBr to be added (g) 
Vo - total initial volume of the solution (ml) 
do - initial density (g/ml) 
d - final desired density (g/ml) 
v - specific volume of the salt (for KBr =0.312 ml/g) 
c) It was usually necessary to rectify the density further. This was done by adding small 
amounts of solid KBr until it was possible to have this solution overlayed by a 1.225 
g/ml KBr solution. 
The above setup was centrifuged, using the same conditions as before, 
inducing the HDL to float to the top of the tube. This layer was collected with a thin 
Pasteur pipette as described above for the low density components. 
Ascorbic acid was added to 0.5 g/1 and the pH was adjusted to >7 with 
NaOH. The solution was diluted to a volume of -35 ml with a 1.225 g/ml KBr solution 
and the density adjusted to 1.23 g/ml as described before. After overlaying with a 
1.225 g/ml KBr solution, the sample was spun for 16h at 30000 rpm (Beckman rotor 
45Tí), 4 °C. This last step has the purpose of further cleaning the HDL. 
2.2.1 Apo D purification by hydroxylapatite chromatography from plasma 
The procedures described are derived from the method presented by 
McConathy and Alaupovic, (1973). The method exploits the capacity of 
hydroxylapatite to retain any proteic component of the HDL other than apolipoprotein D 
(apo D). The modifications are basically a scale -up of the procedure and the removal of 
any steps that could provoke the denaturation of the protein. This was not a major 
concern of the original method as it had been conceived to characterize the protein 
biochemically - amino acid analysis, carbohydrate analysis, immune cross- reactions 
(McConathy and Alaupovic, 1973 and 1976) - while the structural characterization by 
X -ray crystallography requires larger quantities of native -state protein. 
The HDL, isolated as described above, was dialysed extensively against 1 mM 
potassium hydrogen phosphate (K2HPO4), pH 8, 0.5 g/1 ascorbic acid, 100 µM 
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PMSF, 0.01% thimerosal. The dialysate was concentrated approximately 5 fold on an 
Amicon concentrator using a YM10 ultrafiltration membrane (Amicon) and loaded into 
a 3.0x60 cm column containing hydroxylapatite (BioRad HTP) which had been 
extensively equilibrated with 1 mM K2HPO4, pH 8. An amount of 100 -200 mg of total 
concentrated protein solution, evaluated by the Lowry method modified for the 
presence of lipids (section 2.6), were routinely loaded into the column at a flow rate of 
40 ml/h. This procedure was performed at 4 °C. 
A non -bound fraction containing apo D was eluted with the equilibration buffer. 
The elution buffer was then substituted by 1 M K2HPO4, pH 8 and a second peak 
emerged which contained all the other components of HDL. 
2.2.2 Apo D purification by hydroxylapatite chromatography from GCDF 
The procedure for isolation of apo D from gross -cystic disease fluid is similar to 
that for the plasma (section 2.2.1), except that the raw fluid after dialysis against 1 mM 
K2HPO4, pH 8 is spun at 45000 rpm (Beckman rotor 50Tí), 4 °C for 2 h before being 
loaded into 2.6x70 cm hydroxylapatite column and eluted at a flow rate of 40 ml/h. 
2.3 Apo D purification from GCDF by gel filtration 
The procedure followed was as described by Balbín, et al., (1990). 
Several batches of GCDF were spun for lh at 30000 rpm (Beckman rotor 
50Tí), 4 °C to pellet cell debris. The supernatant was subsequently concentrated 5 -fold 
with a Centricon -10 system (Amicon), at 4 °C. Between 0.5 and 0.8 ml of the 
concentrate were loaded into a preparative gel filtration column (Beckman 
TSK300SWG 21.5x300 mm, precolumn Beckman Spherogel 7.5x75 mm), attached to 
a HPLC system (Waters), equilibrated and eluted at 0.2 ml/min with 0.1 M ammonium 
acetate, pH 6. The runs were performed at room temperature and the 1 ml fractions 
collected were analysed by SDS -PAGE (section 2.4). 
2.4 SDS-PAGE 
The gel electrophoresis was performed according to the method of Laemmli 
(Laemmli, 1970), usually at a concentration of 12.5% acrylamide. The mini -gel system 
from BioRad was routinely used. 
The gels were routinely stained with coomassie blue. 
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2.5 Methods for evaluating the protein concentration 
For evaluating the concentration of apo D in solutions of pure protein, the 
absorption at 280 nm was determined. Both the theoretical molar absorption coefficient 
of 32320 M-lcm-1, calculated according to (Gill & von Hippel, 1989), and the molar 
mass of 19400 g (the carbohydrate components ignored) were used. 
For Blg the values used were a molar absortion coefficient at 280 nm of 
17600 M -1cm-1 (Dufour and Haertlé, 1990), and a molar mass of 18000 g. 
For the determination of protein content in the HDL or protein concentration in 
the presence of lipid, a modification of the Lowry method was used. The modifications 
from the standard method (Peterson, 1979) require the presence of 1% SDS in the 
solution A, the incubation time after adding the Folin -Ciocalteau reagent is of 45 min 
not of 30 min, and the measurement of the absorption is done at 660 nm not at 750 nm. 
A standard curve was prepared with bovine serum albumin or with apo D, when 
required. 
2.6 Delipidation of the HDL 
The delipidation of the HDL (Osborne,Jr., 1986) was performed by dropwise 
addition of 1 ml of methanol followed by 2 ml of diethylether to 250 µl of lipoprotein 
solution while vortexing. The mixture was allowed to stand in ice for 10 min. This was 
followed by centrifugation for 4 min at 1000 rpm in a bench -top centrifuge to remove 
the supernatant. Diethylether (3 ml) was added while vortexing the slurry, followed by 
a new centrifugation period and discarding the supernatant. The procedure was repeated 
twice after which the remaining organic solvent was removed under a stream of 
nitrogen. 
2.7 Polyclonal antibody preparation 
The protein was prepared (McConathy and Alaupovic, 1986) by extensive 
delipidation of HDL, as described in section 2.6, followed by resolubilization with 8 M 
urea in 1 mM K2HPO4, pH 8. The solution was then diluted to 2 M urea in the same 
buffer and loaded directly onto the hydroxylapatite column using the conditions 
described in 2.2.1. 
A 5 mg sample of apo D obtained in this way was further purified by several 
electrophoresis runs on 12.5% SDS -PAGE. The gels (17x14 cm) were stained with 
regular Coomassie stainer for 20 min and destained for 20 min so as to detect the 
transversal band containing apo D. This band was cut and reduced to smaller pieces 
before being frozen at -20 °C. 
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After several gels had been run and the apo D bands cut and pooled, the protein 
was electroeluted from the gels. The electroelution was achieved by placing the gel 
pieces in small wells with one open end and the other (in the direction of the elution) 
closed with dialysis tubing, filling the well and the two tanks with electrophoresis 
buffer and applying 125V for 5 hours. 
The prepared apo D was dialysed against water and 1001.4 (in 300 µl) were 
mixed with 200 µl of of sodium phosphate buffer (10 mM sodium phosphate, 9 g/1 
NaC1, pH 7.4) and 500 Ill of Freund's adjuvant. This mixture was injected 
intracutaneously in the back quarters of a rabbit (not used previously for antibody 
raising). Before injection some blood was removed and used to produce pre- immune 
serum. A boost of 5014 was administered 10 days later and then every 15 days for 
two months or until the amount of anti-apo D serum collected was considered to be 
enough. The animal was not sacrified. 
2.8 Western blots 
The electrophoresis gels were blotted in a semi -dry system (LKB semi dry 
blotting system) into nitrocellulose. Six pieces of 3MM paper and one piece of 
nitrocellulose were cut to the same size as the gel to be blotted. Two of the pieces of 
paper were soaked in anode buffer 1 (0.3 M Tris.HC1 (pH 10.4), 20% (v /v) methanol, 
0.1% SDS) and placed, one on top of the other, on the anode plate. A piece of paper 
soaked in anode buffer 2 (25 mM Tris.HC1 (pH 10.4), 20% (v /v) methanol, 0.1% 
(w /v) SDS) was placed on top of these, followed by the nitrocellulose which had been 
soaked in water and then the gel which had been soaked in cathode buffer (25 mM 
Tris.HC1 (pH 9.4), 20% (v /v) methanol, 0.1% (w/v) SDS, 40mM 6- amino -n- hexanoic 
acid). The remaining 3 pieces of paper were soaked in cathode buffer and layered on 
the top of the gel. The cathode plate was placed on top of the stack and transfer was 
achieved by applying a current of 0.8 mA per cm2 gel area. 
Depending on the procedure to be used for the development of the Western blot, 
two different methods, described in the following sections, were applied for the 
reaction with the antibodies. 
TBS buffer (1.211 g/1 Tris, 9 g/1 NaCl, pH 7.4) was routinely used for the 
western blots. 
2.8.1 Development with 4- chloro -l- naphthol 
The membrane was blocked with TBS plus 0.5% Tween -20 for 2 h at room 
temperature or overnight at 4 °C. Incubation with the anti-serum was done at a dilution 
of 1 /100 in TBS for 2 h of gentle agitation at room temperature or overnight at 4 °C. The 
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membrane was washed for three periods of 15 min with TBS at room temperature. 
Incubation with goat anti- rabbit second antibody coupled to horseradish 
peroxidase (BioRad) was performed at room temperature with gentle agitation for 1 h. 
This was followed by three washings of 20 min each. The development was done by 
incubating the membrane with 5 ml of 3 mg/ml 4- chloro- 1- naphthol in methanol, 25 ml 
of TBS and 8 pl of 30% hydrogen peroxide for a few minutes, the reaction was 
stopped with water when it was judged appropriate. 
2.8.2 Development with the ECL system (Amersham) 
The ECL development system (Amersham) was used when permanent records 
of the western blots were required. 
The blocking of the membrane was done by incubation with TBS plus 0.5% 
Tween -20 and 5% dried skimmed milk (Marvel) for 2 h at room temperature. The 
incubation with the anti-serum was done at a 1 /1000 dilution in TBS, 0.5% Tween -20, 
5% Marvel at room temperature for 1 h. This was followed by washing once with 
TBS, 0.5% Tween -20 for 30 min plus three periods of 5 min. The membrane was then 
incubated for 20 min with a dilution of 1 /5000 of the goat anti- rabbit second antibody, 
coupled to horse -radish peroxidase (BioRad) in TBS, 0.5% Tween -20, 5% Marvel. 
The final washes were done with one period of 20 min and 3 periods of 5 min with 
TBS, 0.5% Tween. The development was performed according to the manufacturers 
instructions. 
2.9 Deglycosylation of apo D 
The attempts to remove sugars from apo D were split in two branches, the 
removal of neuraminic acid, which is easily available to enzymes, and the total removal 
of the sugar components, which is not allways attained without denaturation ofthe 
protein. 
2.9.1 Digestion of sialic acid 
The digestion of the sialic acid present on apo D was done with Vibrio cholerae 
neuraminidase, acylneuraminyl hydrolase (EC 3.2.1.18), (Boehringer) as described in 
(Walsh, et al., 1990). 
An amount of 0.5 mg of apo D in 20 µl of water was diluted to 40 µl with 
buffer containing 100 mM sodium acetate, 14 mM calcium chloride, 0.04% sodium 
azide, 0.2 p.M TPCK (tosyl -L- phenylalanine chloromethylketone), pH 5.5. 
Approximately 0.8 mU of enzyme were added to the solution and incubated at 37 °C, 
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for 24 h. After 18 h a fresh aliquot of enzyme was added. 
2.9.1.1 Evaluating the sialic acid digestion - Warren's assay 
Warren's assay was used to monitor the extent of sialic acid digestion. This 
method, as described by Chaplin, (1986) detects free sialic acid with a sensitivity of 3- 
300 µM. 
The protein was dialysed to eliminate any existing free sialic acid. The protein 
concentration was determined by aborption at 280 nm and the required amount for the 
assay was chemically desialated by prior incubation in 0.05 M sulphuric acid at 100 °C 
for 1 h, freeze -dried and then resuspended in 80 p.l of water. 
The composition of the necessary reagents is as follows; 
Cyclohexanone (BDH) 
Reagent A - 4.278 g of sodium metaperiodate (BDH) were dissolved in 4 ml of 
water. Orthophosphoric acid (BDH) (58 ml) was added and the solution made up to 
100 ml with water. 
Reagent B - 10 g of sodium arsenite (Sigma) and 7.1 g of sodium sulphate 
(BDH) were dissolved in 0.1 M sulphuric acid (BDH), to a final volume of 100 ml. 
Reagent C - Thiobarbituric acid (Aldrich) (1.2 g) and sodium sulphate (BDH) 
(14.2 g) were dissolved in water to a final volume of 200 ml. This solution is stable for 
a few weeks only. 
To 80 p.1 of protein solution, 40 p.1 of reagent A were added and mixed well. 
The mixture was left at room temperature for 20 min followed by the addition of 400 µl 
of reagent B while vortexing. After incubating another 5 min at room temperature, 1.2 
ml of reagent C were added and vortexed. The vial was capped and put into a boiling 
bath for 15 min. The solution was rapidly cooled to room temperature and the 
chromophore was extracted with lml of cyclohexanone with vigourous shaking. The 
layers were separated by centrifugation and the absorbance of the top layer was 
measured at 549 nm. The extinction coefficient of sialic acid (in the assay conditions) is 
57000 M-lcm -t. In the blank, water replaces the protein solution. 
2.9.1.2 Extraction of neuraminidase 
Neuraminidase was eliminated from the protein solution by the use of affinity 
chromatography according to the following protocol (Cuatrecasas and Illiano, 1971). 
N- (p- aminophenyl) oxamic acid matrix (Sigma) (2 ml) was equilibrated with 
0.05 M sodium acetate, 0.2 mM EDTA, 2 mM calcium chloride, pH 5.5. The protein 
mixture was applied to the column in the digestion buffer (section 2.9.1.1). 
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Neuraminidase was retained in the column and the rest of the protein components were 
eluted with the equilibration buffer. Neuraminidase was removed from the column with 
0.1 M sodium hydrogen carbonate, pH 9.1. 
2.9.2 Deglycosylation with endo F / GPase F 
The enzyme cocktail contains endo -ß -N- acetylglucosaminidase F (EC 3.2.1.96) 
and peptide N- glycohydrolase F (EC 3.2.2.18) from Flavobacterium 
meningosepticum (Sigma). The different procedures attempted were based on the 
method described in Biochemica Information, Boehringer Mannheim. 
Apo D (25 µg) in 50 µl of 0.25 M sodium acetate, 20 mM EDTA, pH 6.5 was 
incubated with 0.10 U of enzyme for 24 h at 37 °C. Various additives such as 5 mg/ml 
n- octylglucoside, 10 -20 mM mercaptoethanol, 1 -10 mg/ml SDS, 5 -6 M guanidinium 
chloride, 5 mg/ml CHAPS were included in the buffer, either before or during the 
reaction in order to optimize deglycosylation conditions. 
The extent of deglycosylation was evaluated by SDS -PAGE. 
2.9.3 Chemical deglycosylation 
The method used is that described in Beeley, (1985); Edge, et al., (1981) and is 
recommended for removal of SeriThr- linked sugar units and all but the sugar linked 
directly to the protein in Asn -liked chains. 
Warning: The reagent trifluoromethane sulphonic acid (TFMS) is an extremely 
corrosive volatile acid and should be handled with care and kept in ice all times during 
handling (storage at -20 °C in a vial with teflon -lined cap). 
Anisole (Sigma) (1m1) was mixed with 2 ml of TFMS (Sigma) in a 5 ml 
Reactivial (Pierce) and cooled to 0 °C. Thoroughly dried protein (5 -10 mg), was 
dissolved in 1 ml of the above mixture in the reactivial and nitrogen was bubbled 
through for 30 seconds at 0 °C. The mixture was then incubated for at least 1 h at 
different temperatures. The protein was recovered by the dropwise addition of 2 
volumes of diethylether (precooled to -40 °C), followed by 3 ml of ice -cold 50% 
(vol/vol) water / pyridine. The precipitate formed was redissolved by vortexing and the 
ether phase was later discarded.The extraction with ether was repeated 3 -4 times. The 
aqueous phase was dialysed against 2 mM pyridine / acetic acid, pH -5.5 overnight. 
The protein precipitated during dialysis probably due to the fact that the pH used 
is close to the pI of apo D. To redissolve the protein, a subsequent dialysis against 10 
mM potassium phosphate, pH 7.3 followed. The samples were analysed by SDS - 
PAGE. 
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2.10 Circular dichroism experiments 
The circular dichroism experiments were kindly done at the Scottish CD facility, 
Stirling University, by S. Kelly in the laboratory of Dr. N. Price. A Jasco J -6000 
spectropolarimeter was used and all the experiments were done at 21 °C. The buffers 
used (all at a 10 mM concentration) were the following: cacodylate, pH 5.5; sodium 
acetate, pH 4.5; sodium phosphate, pH 6.5 and pH 7.5; potassium hydrogen 
phosphate, pH 7.0 and Tris, pH 8.5. All experiments were corrected for protein 
concentration (evaluated by absorbance or modified Lowry (section 2.5) at an optimum 
value of 0.3 mg/ml for apo D) and path length. The CONTIN procedure (Provencher 
and Glöckner, 1981) was applied to the far UV spectra to evaluate the secondary 
structure content. 
2.11 Apo D - apo AI aggregation experiments 
Apo AI (Sigma) was resuspended to 0.5 mg/m1 in 0.2 M Tris, pH 8.4, 1 mM 
PMSF, 0.01mM TPCK, 1% ethanol and stored at 4 °C. 
The required aliquot of apo AI was diluted to 0.2 mg/ml with each of the 
following three buffers; 0.2 M Tris, pH 7.4, and 0.1 M citric acid / sodium hydrogen 
phosphate at pH 7.5 and 5.5. The same procedure was used to prepare samples of apo 
D. The solution of apo D and apo AI were combined at a ratio of 1:1 (v:v). The pH 7.4 
sample was incubated for a couple of hours at room temperature while pH 7.5 and pH 
5.5 solutions were incubated at 4 °C. The latter mixtures were incubated in the presence 
of 3 M guanidinium chloride (GnC1) for 4 h and then dialysed against decreasing 
concentrations of GnC1 to 0 M in 0.5 M decrements for 4 h each. The samples were 
analysed in the final incubation buffer by gel filtration as described in 2.12. 
2.12 Gel filtration experiments 
Analytical gel filtration was used to analyse the mobility of apo D under 
different conditions. For most cases a G3000 SWXL (7.8x300 mm) with SWXL guard 
column was used, attached to a Gilson FPLC system. For the apo D / lipid vesicle 
association experiments, described in section 2.11, a G4000 SWXL columnn (7.8x300 
mm) was used. The absorption at 280 nm was registered. 
2.13.1 Ellman's assay for thiols 
This assay measures the release of a chromophore nitrothiobenzoate (NTB) 
upon the reaction of a thiol with 5,5- dithiobis -2- nitrobenzoic acid (DTNB) (Sigma). 
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The protein was dissolved in 0.1 M potassium phosphate, 1 mM EDTA, pH 7.3 
with or without 6 M guanidinium chloride (GnC1) at a minimum free thiol concentration 
of 21.1M (Creighton, 1989). After zeroing the system, 50 µl of 3 mM DTNB (0.1 M 
potassium phosphate, pH 7.3) were added to 1 ml of sample and blank. Absorption 
measurements were made at 412 nm. The molar extinction coefficient of NTB is 
13700 M-lcm-1 in 6 M GnC1 and 14150 M-lcm-1 in its absence. 
2.13.2 Disulphide analysis 
The photometric determination of the number of free thiols and disulphide 
bonds present in apo D was achieved by the method described by Thannhauser, et al., 
(1984; 1987). 
The reagent 2- nitro- 5- thiosulphobenzoate (NTSB), was prepared by dissolving 
100 mg of Ellman's reagent, 5,5- dithiobis- 2- nitrobenzoic acid (Sigma), in 10 ml of 1 M 
sodium sulphite. The pH was adjusted to 7.5. This bright red solution was warmed to 
38 °C and oxygen bubbled through, till the colour changed to pale yellow. The solution 
is stable for 1 year at -20 °C. 
The assay was performed by adding at least 8 nmol of protein to 3 ml of 1:100 
dilution of NTSB stock solution in 50 mM glycine, 100 mM sodium sulphite, 3 mM 
EDTA, with or without 2 M guanidinium thiocyanate, and the pH was adjusted to 9.5. 
The reaction mixture was incubated for 25 min in the dark. After which the absorbance 
at 412 nm was recorded. The molar extinction coefficient of the chromophore in the 
presence of guanidinium thiocyanate is 13900 M-lcm-1 and in its absence it was 
considered to be 14150 M- lcm-1. The stoichiometry of the reaction is such that one 
mole of chromophore is produced per mole of disulphide bond or mole of free thiol. 
2.14 Protein / Lipid interaction studies 
The lipid vesicles (with and without protein) were prepared by a slight 
modification of the procedure described in Sizer, et al., 1987. 
Typically, 3.8 mg (5.2 x 10 -6 mol) of dipalmitoyl phosphatidylcholine (DPPC) 
(Sigma) were dissolved in 380 µl of chloroform. A stock solution of cholesterol 
(Sigma) was prepared at 10 mg/ml in chloroform. The protein solution was obtained by 
dissolving 2.6 x 10 -8 mol of apo D in 400 µl of 17 mM n- octylglucoside (Sigma), 10 
mM sodium hydrogen phosphate, 0.1% sodium azide, 1 mM ascorbic acid, pH 7.5. 
The lipid vesicles were prepared by mixing the DPPC and cholesterol solution 
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to a final molar ratio of 150:7.5 before evaporating the chloroform in a glass vial under 
a nitrogen stream. This was followed by freeze -drying for 1 h. The film formed was 
resuspended in 34 mM n- octylglucoside, 10 mM sodium hydrogen phosphate, 0.1% 
sodium azide, 1 mM ascorbic acid, pH 7.5. Usually some aggregates remained. This 
preparation was sonicated for 10 short bursts in an ice -bath while the protein -detergent 
solution was sonicated for five short bursts under the same conditions (ice bath and 
glass vial for rapid cooling). It was necessary to centrifuge the solutions after 
sonication to eliminate the froth which sonication typically produced. In experiments 
where protein was going to be incorporated, the sonicated suspensions were mixed 
together at a molar ratio of 1:200 (protein:DPPC) and 5 bursts of sonication in an ice 
bath were applied. 
The samples, lipid vesicles with or without protein, were dialysed against 10 
mM sodium hydrogen phosphate, 0.1% sodium azide, 1 mM ascorbic acid for 48 h 
(two to three changes of 51 volumes of buffer). The vesicles were isolated by FPLC 
gel filtration as described in section 2.12. 
2.15 Apo D/Triton X114 temperature- induced phase partitioning 
Apo D and Blg, both at the concentrations of 100 µg/ml and 10.tg/ml 
concentration were incubated separately at 4 °C for 15 min in 50 mM KH2PO4, pH 7.0, 
1% v/v Triton X114 (Sánchez- Ferrer, et al., 1990). '5 and 15 .tl aliquots from the 100 
and 10.tg/ml protein solutions respectively, were removed at the end of the incubation 
and kept at 4 °C. The temperature was then raised up to 30 °C for 30 min at the end of 
which the samples were centrifuged for 10 min at 11000 g (bench -top centrifuge). 
Again aliquots (5 and 15 µl) were removed from the supernatant. The different aliquots 
and a small amount of the pellet were run in a 12.5% SDS -PAGE. 
2.16 Electron microscopy 
The buffer of the lipid vesicles (with or without protein) was changed to the 
following volatile buffer: 0.125 M ammonium acetate, 2.6 mM ammonium carbonate, 
0.26 mM EDTA, pH 7.4. A 5 pl drop of 2 -10x diluted vesicle preparation was laid on 
the microscope grid, previously coated with collodion and carbon. The adsorption was 
allowed to occur for 1 min and then the liquid was removed with filter paper. Staining 
was done by incubating a 10 .tl drop of 2% PTA (phosphotungstic acid), pH 7.4 on the 
grid for 30 seconds. The grids were observed with a Phillips CM12 transmission 
electron microscope with the kind assistance of Mrs.S. Bury. 
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2.17 Fluorescence ligand -binding studies. 
The ligand- binding experiments were performed in a Perkin -Elmer 
Luminescence Spectrometer L -50 at 25±0.1 °C, controlled by a temperature controler 
Grant LTD6 at the laboratory of Dr.D. Dryden, University of Edinburgh. All the 
experiments were done in 50 mM potassium dihydrogen phosphate, pH 7.0 and the 
ethanol used for dissolving the ligands was of chromatographic grade (Rathburn). The 
slits were set at 5nm bandwidth, the sample was excited at 280 nm and the emission 
was recorded at 340 nm (the maximum wavelength of emission for the protein under 
these conditions). 
To correct for the inner filter effect (Birdsall, et al., 1983), the titration of N- 
acetyl-tryptophanamide (Sigma) with ligands and ethanol was measured under the same 
conditions as the protein. Specifically, it is important that the absorbance at the 
excitation wavelength will be the same as that of the protein. 
The protein (in a weakly buffered stock solution) was diluted to a total volume 
of 1 ml with the buffer described above to attain a concentration of 2.0 x 10 -6 M. This 
was centrifuged for 10 minutes in a Eppendorf centrifuge an absorbance spectrum was 
recorded between 240 nm and 350 nm on 950 p.1 of the solution. The protein 
concentration was determined by subtracting the baseline absorbance measured between 
300 and 350 nm (where no absorbance due to the protein is detected) from the 
maximum absorbance at 280 nm and using the molar extinction coefficient indicated in 
section 2.6. An aliquot of 900 µl of this solution was then put into the quartz 
fluorimeter cuvette and 100 µ1 of buffer were added. The solution was allowed to 
equilibrate at the experimental temperature. 
Ligands were added to lml of protein solution, at a concentration of 100 µM in 
ethanol, using a 10 µl Hamilton syringe. The ligand was equilibrated with the protein in 
2 µl additions up to 12 µl and then in 41.11 additions up to a final added volume of 40 
µl. The solution was mixed thoroughly after each addition with a 200 µl automatic 
pipette. The readings were normally stable after the mixing and at least 3 fluorescence 
values were registered; more if the reading was considered noisy. At least two assays 
per ligand were carried out and when the ligand appeared to bind, three were registered. 
A base line for the effect of the ethanol on the fluorescence of apo D was 
produced by titrating the protein with ethanol, and the emission spectra were recorded 
at different stages of the titration. 
In each assay the values were averaged and rounded to the nearest unit. The 
fluorescence difference between the initial and each point was calculated and corrected 
for concentration, so that all the measurements were extrapolated to a protein 
concentration of 2.0 x 10 -6 M. The corrected values were averaged between assays for 
the same ligand and finally subtracted from the ethanol baseline (corrected and averaged 
37 
as per the ligand titrations). These values were then corrected if the N- acetyl- 
tryptophanamide titrations showed significant inner filter effect. 
The ligands used were the following: progesterone (4- pregene- 3,20 -dione), 
cholesterol (5- cholesten- 313-ol) , prostaglandin E1 (( i ia,13E,15S)- 11,15 -dihydroxy -9- 
oxoprosta -13 -enoic acid), prostaglandin Fla ((5Z,9a,11a,13E,15S)-9,11,15- 
trihydroxyprosta- 5,15 -dienoic acid), prostaglandin D2 ((5Z,9a,13E,15S) -9, 15- 
dihydroxy -11- oxoprosta- 5,13 -Bien -1 -oic acid), arachidonic acid (eicosa- 
5Z,8Z,11Z,14Z- tetraenoic acid), palmitic acid (hexadecanoic acid), DPPC (L -a- 
dipalmitoyl phosphatidyl choline) all from Sigma. 
12 -Hete (12- hydroxy-[S- (E,Z,Z,Z)]- 5,8,10,14- eicosatetraenoic acid), 5,15 - 
diHete ( 5, 15- dihydroxy- [S- [R *,R *- (E,E,Z,Z)]]- 6,8,11,13 -eicosatetraenoic acid, 
leukotriene D4 ((5S,6R,7E,9E,11Z,14Z) -5- hydroxy -6 -(S- cystainylglycinyl) 
eicosatetraenoic acid), linoleic acid( octadeca- 9Z,8Z,11Z,14Z- tetraenoic acid), oleic acid 
(octadeca -9Z -enoic acid) from Cascade Biochem, Reading. 
EP092 (( +5)- endo -(6'- carboxyhex- 2'Z- enyl)- f 1- [(N- phenylthiocarbamoyl) 
hydrazono] -ethyl} bicyclo [2.2.1] heptane was provided by Drs Wilson, Dawson and 
Jones from the Department of Pharmacology, University of Edinburgh. 
Other ligands, in particular cholesteryl esters, which we wished to test could not be 
used because of their very low solubility in ethanol, DMSO or DMF. 
The analysis of the binding parameters was kindly done by Dr.G. Atkins, 
University of Edinburgh. 
2.18 Crystallization conditions for apo D 
It was known from the beginning that the crystallization of apo D would not be 
without problems since its heterogeneity was well described in the literature. In 
particular, the high level of glycosylation (see section 2.9) induces observable 
heterogeneous behaviour in SDS -PAGE (diffuse band) and isoelectrofocusing (high 
number of bands) (Kamboh, et al., 1989). It was shown as well, that the removal of 
the neuraminic acid would reduce that heterogeneity (Kamboh, et al., 1989), though 
not totally. Despite all this, it was decided to try to crystallize the native protein isolated 
from gross -cystic disease fluid and later the neuraminic acid -free protein. 
Two approaches were used, the "sparse matrix" described by Jancarik and Kim, 
(1991) and the "incomplete factorial experiment" described by Carter,Jr. and Carter, 
(1979); Carter,Jr., etal., (1988); Betts, etal., (1989). 
The "sparse matrix " precipitant solutions were prepared as described in the 
article but two more solutions were added. These had numbers 51- and 52- in sequence 
with the reported ones. 
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51- 0.1 M cacodylate, 50 mM cadmium acetate, pH 6.5 
52- 1 mM cadmium acetate, 0.1 M cacodylate, 30% PEG 6000, pH 6.5 
These two solutions were prepared because some of the members of the 
superfamily have been crystallized (high quality crystals) in the presence of cadmium or 
even with cadmium as precipitant (Newcomer, et al., 1984; Böcskei, et al., 1991). 
The "incomplete factorial experiment" procedure is well described in the 
literature referenced above. 
2.19 Crystallization conditions for BIgZ 
The conditions used were based on the ones described by Aschaffenburg, et 
al., (1965); Bolognesi, et al., (1979); Monaco,et al., (1987). 
Dialysis crystallization - pH 7.8 - the protein (Sigma) was dissolved in 0.2 M 
phosphate buffer (sodium phosphate /potassium phosphate 1:1 (mol:mol)), pH 7.8 at 30 
mg/ml. It was put into a 50 p1 dialysis button (Cambridge Repetition Engineers) and 
dialysed at 20 °C against 20 ml of 0.2 M phosphate buffer, 1.5 M ammonium sulphate, 
pH 7.4. The buttons were checked regularly and every 3 -4 days the concentration of 
ammonium sulphate was increased by 0.2 M and the pH readjusted. This continued up 
to the concentration of 1.9 M ammonium sulphate when the increases were reduced to 
0.1 M at a time, up to around 2.1 M when crystals would start to appear. 
Dialysis crystallization - pH 8.5 - the protein (Sigma) was dissolved in 0.1 M 
Tris, pH 8.5 at 30 mg/ml. The button (50 p.1) was dialysed against 0.1 M Tris, 1 M 
sodium citrate, 0.20 M, pH 8.5 at 20 °C. The concentration of ammonium sulphate was 
increased by 0.2 M and pH was controlled. At around a concentration of 0.27 M 
crystals would start to appear. 
Sitting drop - pH 7.8 - To 50 µl of a solution of Blg (30 mg/ml) in 0.2 M 
phosphate buffer (sodium phosphate /potassium phosphate 1:1 (mol:mol)) pH 7.8, 10 
p.1 of ammonium sulphate 2.17 M, 0.2 M phosphate buffer, pH 7.8 and 15 p.1 of 0.2 M 
phosphate buffer pH 7.8, were added. This mixture was equilibrated against 2.17 M 
ammonium sulphate, 0.2 M phosphate, pH 7.8. The crystals would take typically 
around a week to show up and 2 -2.5 weeks to attain maximum size (0.3 -1 mm on the 
long diagonal of the faces). The crystals would not last more than a month if left in 
these conditions, but they could be stabilized for two months if changed to 0.2 M 
phosphate buffer, 3 M ammonium sulphate , pH 7.8. 
Note: the sitting drop technique was routinely used for the growth of B1gZ crystals 
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2.20 B1gZ co- crystallization experiments 
The co-crystallization experiments were done both with the sitting -drop 
(Charles Supper Company) and dialysis button (Cambridge Repetition Engineers) 
conditions described above. Typically 3 mg of Blg were incubated with the ligand (1- 
10x the molar quantity of the protein - if it was an aqueous immiscible liquid, up to 1 
ml of the ligand would be added to the incubation mixture while if it was an insoluble 
solid then an amount as much as 1000x the molar quantity of protein would be 
equilibrated with the incubation mixture) in lml of 0.2 M phosphate buffer (pH 7.8) at 
4 °C for 24 h in a slow rotating wheel. The mixture would then be concentrated to 30 
mg/ml with a Centricon -10 microconcentrator (Amicon), after the immiscible or 
insoluble ligands, if present, had been separated. 
In the initial sitting drop trials, the concentration of ammonium sulphate in the 
well solution would range from 12% to 60% saturation. The drop would be constituted 
from 1 volume of protein plus ligand and 1 volume of well solution. 
The number of known Blg ligands is quite large, as described in section 1.2. 
For the co- crystallization experiments only a few were used, with the only criteria of 
being reasonably stable. Attempts were made with other molecules that are not known 
ligands but similar to known ones. The list is the following: heptane, 2- nonanone, 
iodobutane, palmitate, hemin, iodonitrobenzene, iodophenol, p- nitrophenol, ascorbic 
acid, n- octylglucoside. 
2.21 Heavy atom Blg 
All the heavy atom soaking experiments were performed with the heavy atom 
dissolved in 3 M ammonium sulphate, 0.2 M phosphate buffer (see section 2.19), pH 
7.8 in Linbro plates (normally used for Elisas). There was a wealth of experiments 
done by Dr.D.W. Green and collaborators and it was possible to repeat or explore 
further the conditions used as we had access to their data. 
The quality of the soak was evaluated by the traditional techniques (Blundell 
and Johnson, 1976) of observing the aspect of the crystal and in most cases by 
precession photograph. 
Only the conditions for heavy atom soaks where a three -dimensional reflection 
set was collected and used for the determination of the structure phases are described: 
MMA (monomercuric acetic acid) - 2 mM for 2 weeks (longer than that leads to 
an obvious deterioration of the crystals) 
HgI2.KI 1:10 (mol:mol) previously dissolved in water and then mixed together 
in the final buffer - 50 µM overnight 
K2Pt(NO2)4 - 3 mM for 4 days 
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2.22 Data collection and processing 
The three- dimensional data sets were collected at the University of Glasgow 
(Chemistry Department) and Oxford (Laboratory of Molecular Biophysics) with the 
kind assistance of Dr.A. Freer, Prof.N. Isaacs and Dr.D. Stuart. In both places, a 
Xentronics area detector mounted on a rotating anode was used. 
The B1gZ crystals present rhombohedral morphology with the c* -axis along the 
long diagonal, so they were mounted with this diagonal down the Lindemann tube 
(though due to their shape, the diagonal is never colinear with the Lindemann tube axis) 
which allows for a minimum of 60° rotation needed to obtain a complete data set. When 
the collection of Bijvoet pairs was a specific requirement of the data collection, then the 
crystals were mounted with the long diagonal perpendicular to the tube axis. This 
permits the collection of the Bijvoet pairs as close in time as possible or, best of all in 
the same frame; in this orientation a rotation of 180° is needed for the collection of a 
complete set of reflections with reasonable redundancy. The data collection was always 
done at room temperature. 
The data were processed with the packages Xengen or XDS (Kabsch, 1988a; 
1988b) 
Some data were collected at the Chemistry Department, Edinburgh University 
using a Siemens -S toe AED2 four -circle diffractometer installed on a sealed tube 
generator, fitted with a graphite monochromator. This system was used in the later 
stages of the project to evaluate the quality of the three -dimensional reflection sets from 
heavy atom soaking experiments. 
2.23 Precession photography 
To evaluate the quality of the crystals after heavy atom soaking or obtained from 
co- crystallization experiments, precession photography was performed with a Huber 
precession camera mounted either on a sealed tube or rotating anode generator, as 
available. The photographs were taken at room temperature, routinely for 24 -36h with a 
10° precession angle. 
2.24 Programs used 
Most of the crystallographic handling of the data was done with the CCP4 (LCF 
version) package (SERC, Daresbury Laboratory) installed in a microVax 3100. The 
molecular replacement, part of the crystallographic refinement and analysis of the 
models was performed with the the X -PLOR package (Brünger, A.T., 1992) installed 
in a ES V10. The display of the molecular models and electron- density maps was done 
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with O (Jones, et al., 1991) also on an ES V 10 workstation. The final model was also 
analysed with DSSP (Kabsch and Sander, 1983) and PROFILE (Lüthy, et al., 1992). 
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Chapter 3 Crystallographic work with Blg 
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3. Crystallographic work with Blg 
This chapter will deal with the crystallographic work in three general parts. The 
first (including sections 3.1 to 3.2) reports the data collection and analysis, the second 
(sections 3.3 to 3.7) describes the heavy atom phasing and model building. The final 
part (section 3.8) reports the molecular replacement work. 
3.1 Data quality 
In this section several aspects of data processing will be discussed in light of the 
procedures used and results achieved at different stages of the work. 
3.1.1 Indexing problems 
The processing of the data was done in space group P3221, and there are 
aspects of this space group that deserve detailed attention, in particular, the possibility 
of processing reflections in two indexing systems. Both these systems are acceptable 
within the symmetry restrictions of the space group but the same one has to be used at 
all times. 
The indexing problem arises from the symmetry of reciprocal space, which is 
described by Laue group P3m1. This Laue group generates an hexagonal system where 
the hexagonal relationship arises from an improper three -fold rotation axis. This means 
that if a right handed axis system is to be defined in two sequential 60° of data or 
hexagonal cells, there are four ways to do so ( 1 to 4, as shown in FIG. 3.1), and these 
four cells are not equivalent. For example, if two batches corresponding to sequential 
portions of data, were being compared and one had been indexed with cell 1 and the 
other with cell 4, then equivalent reflections (related by a two -fold in this example) 
would be indexed with same hkil indices and they would be directly comparable. 
However if the indexings used were 1 and 3, then reflections with the same indices 
would not be equivalent and they should not be merged. 
This "misindexing" is easily noticeable for batches of the same data set as the 
merging scale factors will be quite different from the internal scaling factors and the 
merging residual will be quite poor: for example the BIgZ native data was originally 
collected in two batches, each with internal residuals of around 6 %. In spite of the fact 
that no changes in the diffraction pattern were observed from one batch to the other, the 
merging residual was 14 %. This problem was solved by choosing a different 
orientation matrix for the second batch; the final indexing, related to the first by 180 °, 
gave a merging residual of 6.3 %. Further, when comparing different data sets, the 
isomorphous residual will be extremely high for the different indexing systems. For 
example the MMA derivative data set processed in an inconsistent indexing system to 
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FIG. 3.1 Four possible axial systems for Laue group P3m1 
Each axis sytem is defined by a number, 1 to 4. Represented with different 
filling patterns are two different reflections and their symmetry equivalents. In 
the same indexing system, the two different reflections have the same h and k 










the native data, had an isomorphous residual of 40% when compared to the latter, while 
in the same indexing system this value dropped to 25 %. 
In the cases described, the data were reprocessed in order to change the 
indexing. However, this is not necessary since the relationship between two equivalent 
reflections in different indexing systems can be described in the following way; the 
reflection that in cell 3, Fig. 3.2, is indexed as hkil corresponds in cell 1 to -k -i -hl or 
by the application of the inversion centre, the three -fold and two -fold symmetry 
operations, to khil. Thus equivalent reflections are indexed as hki in one system and 
khi in the other, which means that a simple change of h for k will convert one cell into 
the other. The same result is achieved by reasoning that, as the problem with the 
indexing is the application of an hexagonal system where there is no six -fold, it should 
be possible to convert from one cell to another non -equivalent, by the application of that 
same six -fold. This means that hkil becomes -h -k -il with the six -fold proper rotation 
and then, when reduced to the initial wedge of reciprocal space by applying the 
inversion center and finally the two -fold, results in khil , as above. 
Having found this relationship between non -equivalent cells it is possible by 
choosing two reflections that are obviously distinct (one very strong and the other very 
weak) and related by the six -fold transformation (hki and kid), to distinguish different 
indexings. For example, in B1gZ data sets the reflections 1,0,10 and 0,1,10 have very 
marked intensity differences and are related by the six -fold rotation, as is verifiable by 
applying the sequence of transformations described above. Thus in one indexing 
system 1,0,10 is much more intense than 0,1,10 while in the other indexing system the 
reverse is observed. 
The reflection sets were always checked for the intensities ratio of the pairs 
1,0,10 / 0,1,10 and 1,0,23 / 0,1,23 which, in the CCP4 package correspond to 1,0,10 
/ 1,0, -10 and 1,0,23 / 1,0, -23 (just a different symmetry equivalent). The ratio for 
these pairs in the indexing system used, was »1 for the first and «1 for the second. 
If a change of indexing was required, the data set would be put through a small 
program to swap h for k and reduce the data to the necessary unique section. 
3.1.2 Internal data quality 
Despite the fact that a dozen data sets have been collected from various different 
crystals, only the native, the three derivatives used for phasing and the co- 
crystallization with ascorbic acid will be analysed. 
A series of internal statistics considered to be indicators of the precision of data, 
are presented in TABLES 3.1 to 3.4. Specifically, completeness (observed percentage 
of total number of reflections), average redundancy (average number of observations 
per unique reflection), percentage of unique reflections with intensity over sigma of 
intensity higher than 2 or 3 (both for intensities and for anomalous differences) 
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FIG. 3.2 Schematic representation of reciprocal space for Laue 
group P3m1. 
Viewed down the three -fold axis. Two possible indexing systems are 
represented, 1 and 3 (see FIG. 3.1 and text). Circles represent one reflection 
and its symmetry equivalents. The reflections have been labeled with the 




TABLE 3.1 Native and "ascorbic" data quality 
(processed by XENGEN) 
Cell dim. a =54.0 
Native residual = 6.3% 
Cell 
'`Ascorbic "residual = 4.3% 
A,b =54.0 A,c =112.7 A dim. a =54.3 A,b =54.3 A,c =113.3 A 
Res.bins (A) red. complet. % >_2 I red. complet. % >_2 
00 -5.1 2.8 96% 97% 4.4 99% 97% 
5.1-4.0 2.7 91% 96% 1.9 99% 97% 
4.0-3.5 2.9 83% 88% 1.9 97% 95% 
3.5-3.2 2.8 81% 81% 2.0 95% 88% 
3.2-3.0 2.6 73% 69% 1.9 90% 81% 
3.0-2.8 1.7 32% 56% 1.2 37% 63% 
Cell dim.- cell dimensions, only the cell axes lengths are indicated. The angles were 90 °, 90 °, 120 °. 
Res.bins- Resolution bins; red.- redundancy (number of observed reflections /unique number of 
reflections collected); complet.- completeness (unique number of reflections collected/number of 
possible reflectionsx100); %?2- percentage of reflections collected with signal equal or higher than 
2xsigma 
TABLE 3.2 MMA and Platinum derivative data quality 
(processed by XDS) 
Cell dim. a =54.3 
MMA residual = 6.3% 
Cell 
Platinum residual = 8.5% 
A,b =54.3 A,c =113.3 A dim. a =54.1 A,b =54.1 A,c =112.9 A 
Res.bins (A) red. complet. % >3 red. complet. % >3 
00 -6.3 3.2 84% 92% I 1.8 97% 89% 
6.3-4.5 2.1 90% 81% I 1.7 99% 76% 
4.5-3.7 1.8 84% 61% I 1.5 87% 53% 
3.7-3.2 1.1 25% 31% I 1.2 71% 34% 
Cell dim.- cell dimensions, only the cell axes lengths are indicated. The angles were 90 °, 90 °, 120 °. 
Res.bins- Resolution bins; red.- redundancy (number of observed reflections /unique number of 
reflections collected); complet.- completeness (unique number of reflections collected /number of 
possible reflectionsx100); % >3- percentage of reflections collected with signal higher than 3xsigma 
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TABLE 3.3 HgI data quality (collected by diffractometer) 
Cell dimensions a =54.2 A, b =54.2 A, c =113.1 A, a =90 °, ( 90 °, y =120° 
All data collected from 43 A to 6.0 A 
Redundancy = 1 
606 reflections 
% >2 = 76% 
Redundancy- number of observed reflections/unique number of reflections collected; %>2- percentage of 
reflections collected with signal higher than 3xsigma 
TABLE 3.4 MMA anomalous data quality 
Res.bins complet. % >2 
00 -6.6 58% 40% 
6.6-4.5 65% 18% 
4.5-3.7 70% 6.2% 
3.7-3.2 56% 4.0% 
Res.bins- Resolution bins; complet.- completeness (number of unique reflections collected with 
anomalous signal/number of unique reflections collectedx100); %>2- percentage of reflections with 
anomalous signal higher than 2xsigma 
resolution and the symmetry residual (defined as [EE(II(h,i)- I(h)I)/E(I(h))]x100 where 
I(h,i) is the scaled ith observation of reflection h and I(h) is the merged final intensity of 
that reflection), were analysed as function of resolution. 
During the work with B1gZ several characteristics of this crystal form became 
apparent. One was the clear drop in intensity of the diffraction pattern at the higher 
angles and the almost absence of diffraction beyond the 3 A resolution, as can be 
observed from the tables for the native and ascorbic acid co-crystals. 
Another intrinsic problem in the crystal quality was the disorder observed. This 
is manifested by the wide shape of the diffraction spots and in the "stains" on 
photographs taken at the synchrotron source at Daresbury (FIG. 3.3), an effect 
attributed to thermal diffusion scattering. 
The strategy for collection of good data by the rotation method depends on the 
variation of as many factors as possible (Evans, 1993). In effect this can be translated 
as the need for observation of each reflection and its symmetry equivalents as many 
times as possible during the collection process. Unfortunately, the data sets used for the 
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FIG. 3.3 Rotation photograph of BIgZ data collected in the SRS 
An example of a 2.5° rotation photograph of B1gZ crystal, collected from station 
7.2 at the SRS, Daresbury laboratory. 
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structure determination of B1gZ do not contain great amount of redundancy; the native 
data set has the best value for the average redundancy. 
Both the MMA and the platinum derivatives exhibit a reduction in the resolution 
of diffraction and a general drop in the intensity of reflections. The deterioration of the 
derivative crystals may be explained by the low reactivity of the protein (under the 
crystallization conditions) with the heavy atom compounds and the need for long 
soaking times (see conditions in section 2.21). Despite the apparent low quality of the 
anomalous differences, since beyond the resolution of 4.5 A only around 5% of the 
reflections have an amplitude higher than 26 associated, they were essential for the 
phasing. 
The data set collected on the diffractometer suffers from the required increase in 
time for the collection of reflections and it was only possible to observe diffraction to 6 
A resolution. 
The native data set has been recollected at Daresbury SRS station 9.5 using a 
MAR image plate detector. Once processed, it is the intention to use these data for 
refinement of the structure as it will be a higher resolution, high redundancy data set. 
3.2 Analysis of relative characteristics between data sets 
Data sets from different crystals need to be put on the same scale for the 
extraction of structural and crystallographic information. This section will describe 
statistical aspects of the different comparisons done during the course of this work. 
3.2.1 Scaling of data sets 
The correct scaling of two data sets is of extreme importance. The production of 
phases involves comparison of native and heavy atom derivative structure factor 
amplitudes during the Patterson, synthesis and phase triangle construction. As this 
comparison is done on an "one -to -one" amplitude basis, the importance of removing all 
the differences that are not due to changes in the crystal structure is clear. Blow, et al., 
(1988) demonstrate that a change of 20% in the scaling factor affects the value for the 
phase calculated from a single derivative, by 180 °. 
The scaling and relative analysis of the different data sets was done initially with 
the program ANSC (CCP4 package), which calculated and applied an overall relative 
scaling and temperature factor to the derivative data set. Subsequently, it was 
considered that due to the rapid deterioration of the heavy atom derivatives during data 
collection and consequent introduction of systematic errors associated with low 
redundancy of those data sets, it would be advantageous to scale these reflection sets by 
local scaling as well. In reality, for the particular case of the HgI data set, which was 
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obtained from the diffractometer and thus collected and processed with a different 
strategy from the native data, it was considered advisable to apply a "finer" scaling 
procedure to try to account for the different systematic errors introduced. The local 
scaling procedure determines scaling factors by minimizing the differences between 
each data set, on a restricted number of neighbours around each particular reflection, 
and not the overall differences or the differences in resolution bins. If the number of 
reflections used for the scaling calculation is very small then any difference, including 
real differences, may be removed. The program used is called LOCAL and the number 
of reflections used in each zone was 25. The procedure was repeated until the residual 
stabilized. 
The application and effect of the scaling was checked with plots of the scaling 
factors in resolution bins and in bins of Miller indices to monitor any systematic 
unaccounted behaviour. Nothing unusual was detected. 
3.2.2 Analysis after scaling 
ANSC performs an analysis of the differences between two data sets by 
determining the mean isomorphous difference and the mean fractional isomorphous 
difference as function of resolution. These analyses can give an estimate of the 
changes, and in particular of the non -isomorphous changes, which occur on adding the 
heavy atom compound to the crystal. The results after the the two scaling steps are 
presented in FIG. 3.4 and FIG. 3.5. 
The overall mean isomorphous difference for MMA was 27 %, for HgI 16 %, 
for the platinum 21% and for the ascorbic data 26 %. Both the MMA and platinum 
derivatives exhibit a peak at around 6 A on the mean fractional isomorphous difference 
plot. This is characteristic of heavy atom substitution as it represents the substitution of 
the first solvent shell by a stronger scatterer. Better isomorphism is expected from the 
MMA than from the platinum derivative because the mean isomorphous difference 
decays more rapidly with resolution for the former and the mean fractional 
isomorphous difference does not increase as much. It should be pointed out that for a 
totally isomorphous derivative the mean isomorphous difference would drop with 
resolution due to the decrease in the scattering of the heavy atom at higher angles and to 
the increase in noise in the weaker high resolution reflections. The mean fractional 
difference should be stable with increasing resolution, indicating that the changes only 
result from the introduction of a very electron -dense atom and not from increased 
disorder at smaller resolution spacings. 
The data for these two derivatives were truncated at 3.5 A because the two 
indicators presented evidence of non -isomorphism beyond that. A cut -off of 30% for 
the mean fractional difference was introduced, and resulted in the removal of 
amplitudes beyond 3.5 A for both derivative data sets. This in line with the 40% 
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FIG. 3.4 Mean isomorphous difference plot over resolution bins 
for the derivatives and "ascorbic" data sets 
Mean isomorphous difference is defined as <IF- Fnatl >, where F and Fnat are 
the amplitudes of derivative and native data respectively. Ascorbic data ( ), 
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FIG. 3.5 Mean fractional isomorphous difference plot over 
resolution bins for the derivatives and "ascorbic" data sets 
Mean fractional isomorphous difference or Rsym is defined as E(IF- 
FnatI)/E(Fnat) where F and Fnat are the derivative and native amplitudes, 
respectively. Ascorbic data ( ), HgI data (- -), MMA data ( ), 
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theoretical change resulting from the totally isomorphous introduction of a mercury 
atom in a 24 kDa protein described by Blundell and Johnson, (1976). 
The analysis of the low resolution derivative HgI does not reveal much except 
that modification of the protein is apparent. 
The plots for ascorbic acid show that changes have occurred. A mean fractional 
isomorphous difference of 26% was unexpected for an experiment where the only 
anticipated modification was the binding of the ligand. However the changes are 
probably isomorphous since the mean diffference plot drops with resolution and the 
mean fractional plot increases slowly with resolution. This means that the ligand is 
bound to the molecule without provoking radical distortions. 
3.3 Heavy atom positioning 
The strategy for the determination of the heavy atom positions is usually based 
on solving one derivative, estimating protein phases from this derivative and then using 
these phases for difference Fourier syntheses to determine the positions of heavy atoms 
in other derivatives. The first step is usually achieved by Patterson synthesis of the 
differences between the structure factor amplitudes of the heavy atom derivative and 
native crystal. The Patterson synthesis can be described (Woolfson, 1970) as the 
convolution of the electron density with itself. In other words it is the three- dimensional 
map that results from the multiplication of the electron density with itself after 
translation by a defined vector, integrated over the whole unit cell. If the original 
electron density represents the heavy atoms only, then the resulting Patterson will be 
zero except at the translated vector coordinates where two equivalent heavy atom 
positions have been matched. Some of these vector positions are defined by the 
translation vectors between symmetry equivalent positions of the particular space group 
and a sub -group will be positioned in well determined parts of the Patterson space, the 
Harker sections. The Harker sections are defined as the planes or lines where the 
difference vectors between equivalent positions that have one or more constant 
coordinates will be positioned. Thus because the mathematical relation between the 
Patterson space and the real space coordinates is known for this section of space, it is 
possible to determine the position of the heavy atom in the unit cell. 
The difference between the derivative and native structure factors amplitudes is 
a rough approximation to the heavy atom structure factors, in fact the Patterson 
synthesis with these terms will have contributions from the protein -protein and protein - 
heavy atom vectors (Blundell and Johnson, 1976). These extra contributions will be 
minor as long as there are enough terms and the heavy atom structure factors are small. 
Difference Patterson syntheses were produced for the isomorphous differences 
of the three derivatives atoms and in the case of MMA, an anomalous difference 
Patterson was prepared too. The Harker sections w =1/3 of these maps are shown in 
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FIG. 3.6 to FIG. 3.9. The MMA isomorphous Patterson showed only the peaks due to 
the heavy atom site; the anomalous Patterson, although noisier, presented the same 
peaks as the isomorphous map demonstrating that the anomalous data would contribute 
to phasing. It is clear from the sections that the MMA and the HgI derivatives have been 
substituted in the same position. The platinum derivative produced a noisy map with a 
small peak confirming that it was weaker and probably more non -isomorphous than the 
other derivatives, as already expected from the ANSC analysis (see section 3.2.2). 
However, because the major peak position in the platinum derivative was different from 
any of the other derivative sites it would have an important contribution for the 
determination of phases. 
3.3.1 Solution of the MMA Patterson function 
The MMA derivative was automatically solved with the SHELX -86 package. 
This program determines atomic coordinates explaining all the Harker vectors present in 
a Patterson synthesis (Sheldrick, 1991). It produced one solution at the fractional 
coordinates x= 0.855, y= 0.482, z= 0.238, equivalent to x =0.37, y =0.52, z= 0.095. 
The heavy atom parameters for MMA were refined with the program REFINE 
using FHLE refinement. FHLE refinement (Blundell and Johnson, 1976) minimizes 
the difference between the absolute values of the calculated heavy atom structure factor 
(a function of the heavy atom parameters) and the observed heavy atom structure factor. 
The latter is estimated from the structure factor amplitudes observed for the native and 
derivative crystals (Dodson, 1976): 
for centric reflections FH= IF 'pH ± Fpl 
for acentric reflections FH2- F'pH2 + Fp2 t 2FPF'pH [1- 1 /2(koano/2Fp)2]1 /2 
where Fp is the native structure factor amplitude, F' pH= Ke13 s * *2FpH, FpH is the 
derivative structure factor amplitude, B and K are the overall temperature and scaling 
factors and s= 2sineû , FH the heavy atom structure factor contribution, nano is the 
anomalous difference and k is the ratio between isomorphous and the anomalous heavy 
atom contributions. These expressions can both be split into two estimates, the FIRE 
(heavy atom lower estimate) and FHUE (heavy atom upper estimate) and for most 
reflections the lower estimate is the more correct. 
The expression for the acentric reflections can be further simplified (Dodson, 
1976) to: 
F2HLE= o2iso + (koano/2)2 (1) 
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3.6 Harker section w -1/3 of MMA isomorphous Patterson 
Only half of the section was calculated and the levels were contoured at one 
sigma intervals above the average. 
FIG. 3.7 Harker section w =1/3 of MMA anomalous Patterson 
Only half of the section was calculated and the levels were contoured at one 
sigma intervals above the average. 
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FIG. 3.8 Harker section w =1/3 of platinum derivative Patterson 
Only half of the section was calculated and the levels were contoured at one 
sigma intervals above the average. 
FIG. 3.9 Harker section w =1/3 of HgI Patterson 
Only half of the section wac calculated and the levels were contoured at one 
sigma intervals above the average. 
58 
where oiso is the isomorphous difference. 
This procedure is ideal for refinement of the heavy atom parameters of a single 
derivative (Blundell and Johnson, 1976) because the parameters are independent of the 
minimized function. The procedure works very securely with iust centric reflections 
while with acentric the quality of the parameters depends on the accurate measurement 
of the anomalous differences. The relative FPH to Fp temperature and scale factors are 
not very well refined nor are occupancy and atomic temperature factor parameters. 
The refinement of the MMA positional parameters with isomorphous and 
anomalous data also permitted the distinction of the "coherent pairs" for the heavy atom 
hand (Stout, 1979). The need for this "choice" can be understood from the fact there 
are two possible solutions for the MMA difference Patterson, the previously mentioned 
solution and its inverse at x= -0.37, y= -0.52, z=- 0.095. In addition, because with this 
space group there is a choice between the enantiomorphs P3221 or P3121, four 
possible pairs for the combination of the space group and heavy atom position hands 
result. At the heavy atom refinement stage, it is only possible to distinguish the 
"coherent pairs ". This means that from the four pairs only two, one for each space 
group enantiomorph will satisfy the data collected. The rationale is the following: the 
absolute heavy atom contribution to the diffraction pattern protein crystal is the same 
either when positioned at x,y,z or -x, -y, -z. The direction, however, of the heavy atom 
vector changes totally, since the phase changes from positive to negative. The net result 
is that the phase triangle formed by the derivative, native and heavy atom structure 
factors is different for each position: a difference that is noticeable in the phase and 
absolute value of the derivative structure factor. However for most reflections the heavy 
atom contribution is very small when compared to the protein contribution which, with 
the added uncertainties resulting from the errors present on the observed terms, makes 
the two triangles quite similar. In other words, the derivative structure factor for one 
and the other cases are indistinguishable, especially when only the absolute value is 
considered. The question arises whether distinction between the two heavy atom 
positions is possible with a selection of well measured native and derivative reflections 
with large differences. Neverthless, with the anomalous contribution present (which 
has a fixed direction relative to the heavy atom isomorphous vector) the difference on 
the triangle constructions increases allowing the distinction of the two positions. 
FHLE refinement compares the triangle constructions and this is apparent from 
expression (1), where both nano and oiso can be expressed respectively by the 
projections of the anomalous and isomorphous components on directions perpendicular 
and parallel to the derivative structure factor respectively (Blundell and Johnson, 1976). 
The estimated absolute value for the heavy atom contribution is also dependent on the 
angle difference between the derivative structure factor and the heavy atom 
isomorphous structure factor, which is different for each triangle construction. The 
59 
triangles will be the same for the pair composed by one hand of the space group and the 
positive coordinates of the heavy atom and the other pair composed by the other space 
group hand and the negative coordinates because the coordinate transformation between 
enantiomorphic space groups is related by an inversion centre too. Thus, for each space 
group there is one position that gives better agreement between the calculated and the 
observed heavy atom amplitude. For the wrong pair, the values of heavy atom 
occupancy and temperature factor and consequently the amplitude of the calculated 
heavy atom contribution can never account satisfactorly for the differences in the 
triangle construction. 
For the MMA case the results after six cycles of refinement were the following: 
Space Group x y z R g con 
1 P3221 0.37 0.52 0.095 55% 0.29 0.39 
2 P3221 0.63 0.48 0.91 75% 0.12 0.10 
3 P3121 0.37 0.52 0.095 67% -0.09 0.05 
4 P3121 0.63 0.48 0.91 59% 0.30 0.33 
where R= E(FHobs-Neale/Nobs), g is the gradient of ( <FH c2 >)1/2 against IFHobsl 
and con is a correlation factor between FHobs and FHcalc, the observed and calculated 
heavy atom amplitudes respectively. Both g and con are equal to unity for the perfect 
case. 
It is clear from the results that pairs 1 and 4 present the best statistics and were 
therefore considered as the real arrangement. 
These positions are equivalent to those estimated for mercurial compounds used 
in previous work (Green, et al., 1979; Monaco, et al., 1987), where the chosen 
enantiomorph was P3221. It must be noted that, Green, et al., (1979) have used a non - 
conventional setting, with the crystallographic dyad that defines the origin coincident 
with the b axis, which is different from the one described in the International Tables, 
vol.A, (1983) for P3221. In the work conducted by Monaco, etal., (1987) the 
mercurial compound position coordinates are the same as described in (Green, et al., 
1979), which seems to indicate that the same non -conventional setting was used. The 
diagrams (Monaco, et al., 1987) however, show the molecular packing in the 
conventional setting. This inconsistency is confusing as it could indicate that the heavy 
atom positions were determined with respect to a particular origin but the density was 
calculated with respect to another. 
The parameters of the MMA derivative in P3221 after FHLE refinement were: 
fractional coordinates x,y,z: 0.379(2) 0.518(2) 0.094(1) 
atomic temperature factor: 28.4 
occupancy: 7.1(3) 
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3.3.2 Difference maps for the determination of the position of the other heavy atoms 
Phases were determined from the MMA derivative with the program PHASE in 
the space group used by Green, et al., (1979), P3221. These phases were used to 
produce difference Fourier maps between all the derivatives and the native. 
Observation of these maps allowed determination of the heavy atom 
coordinates. In the MMA case, it was also possible to check the peak shape of the 
already- determined position, so as to verify that no distortion indicative of a multiple 
site was present. No minor sites appeared in the MMA difference map. For the other 
derivatives, the positions of the major substitutions could be easily determined from the 
respective difference maps. The positions for the platinum derivative were x1 =0.46, 
y1 =0.2, z1 =0.026 and x2 =0.34, y2 =0.72, z2 =0.07, while for the HgI the most 
prominent position was x =0.37, y =0.52, z =0.09. This is the same position as that for 
the MMA derivative, while the top platinum position is very similar to the top solution 
described for the same compound in Green, et al., (1979). 
3.3.3 Choice of space group enantiomorph 
The procedure described in Blundell and Johnson, (1976) was used to 
determine the exact enantiomorph. This procedure requires the existence of two heavy 
atom derivatives data sets, of which one will have measured anomalous differences. 
All the calculations must done in one of the possible space groups. Two sets of phases 
are calculated from a single derivative with anomalous measurements, the phases will 
include isomorphous and anomalous contributions; one set is prepared with the 
anomalous contribution unchanged and the other set with the signal of the anomalous 
differences inverted. With these phase sets, two difference Fourier syntheses are 
calculated for the the second derivative. The highest peaks in both maps indicate the 
heavy atom position of the second derivative site. The height will not be the same for 
these common peaks; if the higher peak is present in the map calculated from the phases 
with unchanged anomalous contribution then the enantiomorph chosen to prepare the 
maps is the correct one, if the higher peak is found in the map calculated with the 
inverted anomalous signal then the correct enantiomorph is the opposite of the one used 
for all these calculations. 
The procedure was attempted with the phases calculated from the MMA 
derivative for both the platinum and HgI difference maps, in P3221. The HgI difference 
maps showed no difference between each other, probably because the site of this 
derivative is common to MMA and so the image of the heavy atom used to produce the 
phases is present in the map. 
For the platinum case, the map calculated with an unchanged anomalous signal 
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presented the highest peak at x =0.46, y =0.20, y =0.026 with a height of 1.59 units and 
an r.m.s. deviation of 0.15, while the inverted anomalous signal map had its highest 
peak placed in the same position with a value of 1.17 units and the same r.m.s. 
deviation. Sections of these two maps are shown on FIG. 3.10, and it is clear that the 
map with unchanged anomalous signal has the highest peak. This means that the correct 
enantiomorph is P3221, also confirmed by molecular replacement (see section 3.8.4) 
and is in line with the choice described in the literature (Green, et al., 1979; Monaco, 
et al., 1987). 
3.3.4 Heavy atom refinement and phase calculation 
The positions of all the heavy atoms, defined in section 3.3.2, were refined 
with the phase refinement program, MLPHARE. This sort of refinement improves the 
heavy atom parameters by minimizing the difference between the absolute values of the 
observed and the calculated derivative structure factors (Blundell and Johnson, 1976). 
The calculated derivative structure factor amplitude is determined from the following 
expression: 
FPxcalc=I FPcalc + Fxcalc I 
Fpcalc and Fxcalc are the vectors for the calculated protein and heavy atom 
contributions. This means that the difference between the phases of the protein and 
heavy atom vector has to be calculated in each cycle of refinement and that the method 
works correctly when several derivatives with different sites are refined together or 
when one derivative is being refined against outside phases, but not when the 
parameters of a single derivative (Dodson, 1976) or multiple derivatives with common 
sites are being refined. The procedure seems to detect incorrect positions, indicated by 
an occupancy close to zero, as long as there are well estimated positions being refined 
at the same time (Blundell and Johnson, 1976) and to be able to refine correctly the 
relative scale factors and temperature factors between the native and the derivative 
(Dodson, 1976). 
The procedure was applied for all the positions described above, from which 
the minor site of the platinum derivative was rejected. Subsequently, phases were 
calculated and difference maps for all derivatives were inspected. Some possible extra 
sites were put into a few cycles of refinement but rejected. 
The final positions and statistics are presented in TABLE 3.5. It is apparent that 
MMA is the derivative that is contributing the most to the phase calculation. This is 
demonstrated by the phasing power for both the isomorphous and anomalous 
contributions which are above 1 over all resolution ranges. The platinum derivative is 
the weaker one since it has the highest Rcullis and lowest phasing power, even at low 
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FIG. 3.10 Sections of platinum derivative difference map for the 
determination of the space group enantiomorph 
Top: phases calculated with isomorphous plus positive anomalous contribution 
Bottom: phases calculated with isomorphous plus negative anomalous 
contribution 
Peaks were contoured at one sigma intervals above the average. 
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resolution. The HgI with a phasing power just over 1, is contributing reasonably to the 
lower resolution ranges. 
The phases for B1gZ were calculated with MLPHARE for the resolution range 
200 to 3.5 A and the figure of merit for the final phases is plotted in resolution ranges 
in FIG. 3.11. This statistical parameter evaluates the sharpness of the phase probability 
distribution and can be approximated as the cosine of the error in phase angle for the 
reflection. The real quality of the phases can only be judged from the electron- density 
map but it was expected that with an average figure of merit value of 0.46 the map 
would be of poor quality since the average error in the phases was approximately 62 °. 
All the derivatives were used to the full, meaning that the derivatives were used even in 
ranges where the phasing power was less than one. Specifically, the platinum was kept 
because by being substituted in a site not common to any of the other derivatives it 
would contribute for the overall accuracy of the phases. 
3.4 Phase refinement and extension by solvent flattening 
The examination of the multiple isomorphous relacement map permitted the 
molecular envelope to be distinguished and the recognition of one a -helix and a number 
of f3-strands, as reported in the previous crystallographic models (Papiz, et al., 1986; 
Monaco, et al., 1987). One of the f3-sheet planes was much better defined than the 
other; in the "good" part of the density the disulphide bond Cys106 -119 was visible 
among four reasonably defined strands while the other disulphide bond, Cys66 -160 
was placed among weak and broken density, FIG. 3.12. 
The a -helix was easily recognised due to its tubular appearence although 
structural details like the direction and even the handedness were of ambiguous 
interpretation. Chain tracing of this map would be extremely difficult, since a lack of 
continuous density affects the whole molecule but especially the loop regions. Since the 
clarity of the information contained in the electron -density map is so dependent on the 
quality of the phases it is essential to refine them in an attempt to improve the density. 
The refinement of phases by a density modification procedure is a well 
established crystallographic step (Podjarny, et al., 1987; Tulinsky, 1985); there are 
several methods but they all have the same "mechanical" basis. Briefly, the electron - 
density has several properties such as positivity (electron- density maps are always 
positive except in the presence of series termination errors), uniformity of solvent 
regions (the density corresponding to the solvent regions is generally flat), continuity of 
the biopolymer chain (at medium resolution biopolymers are represented by 
continuously connected density), in some cases local symmetry (non -crystallographic 
symmetry relates density within the molecular envelope) and others. If these 
characteristics are well understood then they can be explored for density improvement 
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TABLE 3.5 Refined heavy atom parameters and phasing statistics 
MMA derivative 
x=0.372 y=0.516 z=0.094 occ.=9.7 bfac.=30. 
ano.occ.=6.0 
Res.bins 17.8 11.2 8.2 6.4 5.3 4.5 3.9 3.5 total 
Phas.pow. 
Acentric 0.5 1.6 1.8 2.2 2.1 1.4 1.3 1.2 1.5 
Centric 0.5 1.2 1.4 1.7 1.4 0.9 1.0 0.8 1.2 
Anomalous 2.6 0.9 0.8 0.9 0.9 1.0 1.0 1.0 1.1 
Rcullis 0.72 0.49 0.50 0.40 0.57 0.73 0.75 0.85 0.58 
Platinum derivative 
x=0.467 y=0.206 z=0.026 occ.=3.9 bfac.=30. 
Res.bins 17.8 11.2 8.2 6.4 5.3 4.5 3.9 3.5 total 
Phas.pow. 
Acentric 0.4 0.8 0.8 0.9 1.0 0.6 0.6 0.6 0.7 
Centric 0.2 0.6 0.7 0.7 0.8 0.5 0.5 0.6 0.6 
Rcullis 0.93 0.68 0.65 0.62 0.76 0.89 1.06 0.96 0.78 
HgI derivative 
x=0.375 y=0.529 z=0.093 occ.=4.0 bfac.=30. 
Res.bins 17.8 11.2 8.2 6.4 5.3 4.5 3.9 3.5 total 
Phas.pow. 
Acentric 0.7 0.8 LO 1.2 1.0 0.0 0.0 0.0 1.1 
Centric 0.4 0.6 0.8 0.9 0.8 0.0 0.0 0.0 0.8 
Rcullis 0.88 0.69 0.70 0.70 0.92 0.0 0.0 0.0 0.73 
occ.- occupancy; ano.occ.- anomalous occupancy; bfac.- heavy atom temperature factor, Res.bins- 
Resolution bins in A; Phas.pow.- Phasing power (<FHcalc > / <IFPHobs- FPHcalcl>; Rcullis- Cullis 
Rfactor (< IFPHobs- FPHcalcl > / <IFPHobs- FPobsl> for centric reflections only; FHcalc- heavy atom 
calculated structure factor amplitude; FPHobs- derivative observed structure factor amplitude; FPHcalc- 
derivative calculated structure factor amplitude; FPobs- native observed structure factor amplitude 
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FIG. 3.11 Plot of figure 
Fom - represents the average 
1 







of merit over resolution bins 
of figure of merit for each resolution bin. 
Figure of merit 
1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 11 9 7 5 3 
Resolution (A) 
19 17 15 
by constraining the overall density to a model of the chosen property. The method is 
more powerful the larger the change it induces and the larger the number of map grid 
points it affects (Podjarny, et al., 1987). The general algorithm involves the calculation 
of an initial map with the highest quality phases possible, modification of the map, back 
transformation of the modified map and combination of the resulting information, 
calculated phases and in some cases calculated amplitudes, with the experimental data. 
A new map is calculated with the modified terms and the procedure is repeated until 
convergence is achieved. 
Map quality is also related to the number of terms present in the Fourier 
transform, thus an increase in this number either at the same resolution as before or at a 
higher resolution will result in a more well -defined molecular picture. The density 
modification methods alter the initial density and introduce extra information of a 
general nature. During the back Fourier transform of the modified density, extra terms 
are calculated permiting the extension of phase information (Tulinsky, 1985). The 
errors in the procedure are filtered out as long as there is experimental information that 
can be incorporated into the extended terms. 
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FIG. 3.12 Two pictures of different parts of the density produced 
with the MIR phases 
Top: view of the MIR density around Cys106 -119 
Bottom: view of the MIR density around Cys66 -160 
Final model is shown. 
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3.4.1 Phase refinement 
The improvement of the density was performed by the application of solvent 
uniformity because it does not demand any interpretation of the existing density. The 
following lines will describe the method and the results obtained. 
The procedure applied is designated as solvent flattening and is in fact a 
conjunction of two of the properties described above. The particular algorithm used 
(Wang, 1985; Leslie, 1988), flattens the solvent and applies a positivity constraint in 
the molecular region. 
The different stages are the following, with the programs used at each stage 
enclose within brackets. The map was calculated with as many terms as possible 
( FFTKW). All the negative density present in this map was set to zero (TRUNCMAP), 
after which the map was back transformed (SFC) and all the structure factors at the 
resolution range used were calculated. The structure factors were multiplied by a 
weighting function (HKLWEIGHT) that corresponds in real space to the substitution of 
the value of the density at a particular grid point by a weighted average of the density 
within a given radius. This reciprocal space weighting is, in fact, only applied to the 
low resolution structure factors, at spacings larger than 5 A (Leslie, 1988), or in other 
words, applied to the reflections that contain more information about the solvent. With 
the new structure factors, it was possible to determine the molecular boundaries 
because the electron density generated (FFTKW) was a "blurred" original map and 
defined a molecular mask. Thus with knowledge of the crystal solvent content, the 
solvent part of the cell is easily defined (ENVELOPE). To the density, a constant term 
is added (FLATMAP) that substitutes the missing F000 term. This added constant 
satisfies the requisite that the ratio of the average solvent density to the average protein 
density should be some defined value. After this addition, the density in the solvent 
regions is set to the average solvent density and the negative parts in the protein 
envelope are attenuated. The map thus modified is back transformed (SFC) and after 
scaling (SCALENEW), the calculated phases are combined (COMBINE) with the 
experimental ones. The procedure is repeated using the refined phases and the same 
envelope until no further modification is observed. A new envelope is created whenever 
it is considered that the existing one is not constraining the density anymore. 
The essential parameter in this procedure is the solvent content, because it 
determines the number of the grid points affected by the modification. From Matthews, 
(1968) formula the solvent content for B1gZ was determined to be 42 %, however for 
the application of the solvent flattening it was decided to use a conservative value of 
32 %, since it was observed that higher values removed the density corresponding to 
loops and other solvent exposed parts of the molecule. Another parameter observed to 
have some effect on the continuity of the density was the averaging radius for the 
determination of the "blurred" map or mask, with a smaller radius the mask was 
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detailed but loss of connectivity was observed in the weaker density present on the 
main -chain p- strands. The "improved" maps were determined using the combined 
phases and the observed amplitudes. 
The evolution of the improvements was followed by observing the electron - 
density maps and by determining the residual between calculated and experimental 
amplitudes, the overall (and high resolution) average figures of merit and residual. The 
results are plotted in FIG. 3.13. During phase refinement only two envelopes were 
determined because the evolution from the first to the second mask was minor. 
Convergence was attained reasonably quickly as demonstrated by the values plotted. 
The map produced at the 4th cycle presented more connectivity than the original one but 
the differences between the fourth and the sixth maps were minute. 
3.4.2 Phase extension 
The extension of the phases by solvent flattening from 3.5 to 3.0 A was 
attempted for two reasons. First, it has been reported that the refinement of the original 
phases continues as new terms are introduced (Zhang and Main, 1988) and second the 
determination of phases to at least 3.0 A for f3-sheet proteins can be important since 
beyond this resolution the "lateral fusion" of the strands disappears and the chain 
tracing is facilitated. 
It has also been reported that the success of the extension is dependent on the 
completeness of the reflection set (Frederick, et al., 1984; McClarin, et al., 1986) and 
because the native data set was considered to be incomplete at 3 A, data collected on a 
weak derivative was used instead. This derivative data set was >90% complete to 3.2 A 
resolution and 82.5% complete in the range 3.2 to 3.0 A and it had a mean 
isomorphous fractional difference with the native of 13 %. It was not used for phase 
calculation because the unique heavy atom site present had very low occupancy. 
The extension was done-in the following way: substitution of the native 
amplitudes for the derivative ones while keeping the original and refined (see section 
3.4.1) native phases, refinement of the phases at 3.5 A to accommodate any difference 
between data sets, calculation of all the phases for reflections with amplitude present 
but no experimental phase, refinement of the new phases, extension and refinement of 
phases to 3.0 A in three steps, 3.5 to 3.3 A, 3.3 to 3.15 A and 3.15 to 3.0 A. The 
extension was done for one to two reciprocal space units at a time which meant that 
300 -400 reflections were added in each step. The evolution of the extension can be 
followed from the figure of merit and residual plotted on FIG. 3.14. 
The map after this treatment showed major improvements, it was now possible 
to recognize the hand of the helix hand (right handed) (FIG. 3.15), and the [3-sheets 
from the "bad side " (see section 3.4) of the molecule started to appear (FIG. 3.16). It 
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FIG. 3.13 Plot of phase refinement evolution 
Fom is the average figure of merit, represented by (-- -) for all the data and 
( - ) for the resolution range 3.5 -4 Á. Rfactor is the residual between the 
calculated and observed amplitudes, represented by ( ). The black triangle 
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has to be recognized that there were still regions of difficult interpretation and that the 
assignment of residues to the density in some parts of the map was difficult. However, 
because most of the main -chain could be followed, it was decided to initiate the 
building of the molecular model. 
3.5 Model building 
The strategy for model building was based on the need to improve the map 
further. For that, another method of map improvement, already mentioned in section 
3.4 was applied. This method (Rice, et al., 1988), constrains the density to a 
biopolymer continuity by introducing information from partial models, the constraint 
being the more effective the more atoms are included into the partial model. The "tricky 
step" with this procedure is the need for interpretation of the density to produce the 
partial model. This model information is added to the map by combination of the 
original phases with the partial model phases, and a new map is created from which a 
better model can be extracted. 
With B1gZ, the building of partial models was done with a conservative attitude, 
because from the beginning of the crystallographic work it was known that the wrong 
positioning of residues in the density, or wrong threading, was probably the major 
problem with the B1gY model. The model was built into the electron- density as a 
polyalanine backbone. However, in the areas where side -chain density existed, 
chemical reasoning together with the sequence alignment allowed the majority of 
residues to be identified. The assignment of sequence was started from residue Cys 121 
and disulphide bridge Cys106 -119, since these chemical groups could be easily 
recognized (the heavy atom site marked the free cysteine and, nearby, the density for 
the disulphide, connected the two clearly defined a- strands) and therefore could be used 
as "anchors" for the start of the threading. 
Essential for the building was the partially refined structure of Mup (kindly 
provided by Prof.A.C.T. North) superimposed with the density. To achieve this, the 
molecular replacement solution (see section 3.8) for Mup was used. This molecule was 
expected to be similar to Blg, from sequence alignment (Adams, 1992) and in fact, was 
seen, from the superimposition of the model into the density, to have many common 
three -dimensional features. Adding to these reasons was the fact that Mup, as an 
example of a well -built protein molecule, served as a teaching aid. 
Model building proceeded through two partial model stages. The first model 
built consisted of 118 residues and 816 atoms, distributed in three segments: 
first segment - 
second segment - 
residue 21 to 48, all alanines 
residue 67 to 107, where 67 to 89 were alanines and 90 
to 107 the Blg residues 
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FIG. 3.14 Plot of phase extension evolution 
Fom is the average figure of merit, represented by ( ). Rfactor is the 
residual between calculated and observed amplitudes, represented by ( - - -). 
The triangles mark the cycles where new envelopes or phases were extended. 
Cycle 6 - new envelope and phases extended to 3.5 A, cycle 9 - extension to 
3.3 A, cycle 12 - new envelope, cycle 16 extension to 3.15 A, cycle 18 - new 
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third segment - residue 117 to 157, where 117 to 140 were Big residues 
and the remaining alanines 
The second and third segments were connected by the disulphide bond Cysl06 -119, 
forming the major segment. 
The second model consisted of 131 residues and 1182 atoms distributed in four 
segments: 
first segment - residue 16 to 49, built according to the sequence 
second segment - residue 52 to 60, built as alanines 
third segment - residues 67 to 75, built according to the sequence 
fourth segment - residues 79 to 158, where 79 -84 were built according to 
the sequence, 85 -89 as alanines, 90 -142 following the 
sequence, 143 as alanine 
FIG. 3.15 a -helix density after solvent flattening 
The density is in blue and the final model is in yellow. 
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FIG. 3.16 Density of the strands on the "bad" side of the 
molecule after solvent flattening 
The density is in blue and the final model is in yellow. 
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fifth segment - residues 145 to 159, where 145 and 146 were present as 
alanines, 147 -155 were built according to the sequence 
and 156 -159 as alanines 
Each partial model was refined by a molecular dynamics procedure (X -PLOR) 
to improve the stereochemistry and fit to the X -ray data. The dynamics procedure 
consists of a search of the protein's conformation by simulating the effect of heating and 
slow cooling on the dynamics (direction and velocity) of each atom. The atoms should 
escape false local minima and following a gradient of energy, function by the 
stereochemical restrictions and agreements with the experimental data, attain an energy 
minima. 
To remove any excessive influence of incorrect parts of the model on the 
combined phases, a temperature factor refinement was performed in X -PLOR after the 
74 
annealing procedure. The reason for applying this procedure is based on the concept 
that wrongly placed atoms would have higher temperature factors to account for the 
disagreement with the density. This results in weighting each residue's contribution to 
the partial phases and consequently to the combined phases. 
The phases and calculated amplitudes were produced by SFC and scaled to the 
experimental data with SCALENEW. The phases were finally combined, with the MIR 
phases and with the solvent flattened phases, using the program COMBINE (all these 
programs, SFC, SCALENEW and COMBINE, are part of the CCP4 package). 
It was found convenient when rebuilding the model to not only refer to both the 
MIR and solvent flattened combined with model information but also to the 2Fobs 
Fcalc and Fobs Foac maps( where Fobs are the observed amplitude, Fogs the 
calculated amplitudes from the partial model and the phases obtained from the models) 
and the original maps, MIR and solvent flattened. 
The evolution and details of the dynamics procedure are described in TABLE 
3.6. The residual dropped between models, as expected from introducing more atoms 
into the models. In both models it was necessary to restrict the movement of the 
terminae of some of the fragments to avoid "flying" and subsequent steric clashes with 
other parts of the molecules, which would trigger the program to stop. During the 
minimization and dynamics procedure, the ionic side -chains were kept neutral, to avoid 
drastic movements of parts of the molecule due to ionic interactions. The maximum 
temperature of the slowcooling protocol was set at a low value for the first model (2000 
K) and then increased to 3000 K for the second model, this way increasing the 
possiblity of releasing the from energy 
The evolution of the model and in particular its agreement with experimental 
data is probably better evaluated from the parameters measured during the phase 
combination procedure, especially through the comparison of observed and calculated 
phases since the latter are independent of the refinement done in the previous steps. In 
TABLE 3.7, the parameters relative to the comparison between the two partial models 
and the experimental data, amplitudes and phases (MIR and solvent flattened) are 
displayed. The changes were greater for the MIR data than for the solvent flattened data 
as expected, since the solvent flattening procedure refined the phase information. From 
the relative lack of closure and the phase change, it can be concluded that the influence 
of adding the model information is felt more strongly in the higher resolution ranges. 
Finally, it seems clear that the second model is an improvement over the first, because 
the overall relative lack of closure decreases from the first to the second model 
indicating that the building has evolved correctly. 
3.6 Final model 
The final model consisted of 158 residues and 1516 atoms, the first three 
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TABLE 3.6 Dynamics procedure details 
Model 1 (constrained residues 21, 48, 67) 
Refinement step Details Resolution R- factor 
1- Weight calculation Wa = 45388 
2- Minimization 160 cycles of minimization 
3- Slow cooling Max.Temp.= 2000 K 
no. of steps = 50 
timestep = 0.0005 ps 
4- Minimization 120 cycles of minimization 
5- B- factor refinement 15 steps of refinement 
side -chain/main -chain 
8-3 A 50.8% 
8-3 A 37.3% 





Model 2 (constrained 52, 60, 67, 75) 
Refinement step Details Resolution R- factor 
1- Weight calculation Wa = 54044 8 -3 A 48.9% 
2- Minimization 160 cycles of minimization 8 -3 A 34.1% 
3- Slow cooling Max.Temp.= 3000 K 8 -3 A 29.0% 
no. of steps = 50 
timestep = 0.0005 ps 
4- Minimization 120 cycles of minimization 8 -3 A 28.1% 
5- B- factor refinement 15 steps of refinement 8 -3 A 26.1% 
side -chain /main -chain 
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TABLE 3.7 Evolution of map improvement by partial model phase 
combination 
MIR + model 1 combination to 3.5 A 
res.bins(A) r.lack clos. no.refl. old fm new fm abs.ph.ch. 
50 -7.8 0.8160 250 0.689 0.797 11.90 
7.8 -5.5 0.6112 445 0.577 0.780 23.80 
5.5 -4.5 0.4552 536 0.420 0.744 37.66 
4.5 -3.9 0.4850 606 0.322 0.718 47.96 
3.9 -3.5 0.5373 660 0.194 0.680 62.37 
total 0.5882 2497 0.391 0.733 41.64 
Solvent flattened + model 1 combination to 3.0 A 
res.bins(A) r.lack clos. no.refl. old fm new fm abs.ph.ch. 
50 -6.7 0.7698 395 0.856 0.867 8.37 
6.7 -4.7 0.5478 682 0.807 0.822 16.35 
4.7 -3.9 0.4540 806 0.768 0.796 21.71 
3.9 -3.4 0.5529 891 0.761 0.780 23.40 
3.4 -3.0 0.6634 842 0.740 0.747 26.15 
total 0.5922 3616 0.777 0.793 20.69 
MIR + model 2 combination to 3.5 A 
res.bins(A) r.lack clos. no.refl. old fm new fm abs.ph.ch. 
50 -7.8 0.7986 250 0.689 0.805 10.41 
7.8 -5.5 0.4559 445 0.577 0.818 29.74 
5.5 -4.5 0.3556 536 0.420 0.771 39.82 
4.5 -3.9 0.3692 6Ó6 0.322 0.758 55.48 
3.9 -3.5 0.4642 660 0.194 0.720 59.31 
total 0.5017 2497 0.391 0.766 44.03 
res.bins- resolution bins; r.lack clos.- relative lack of closure (relative lack of closure between calculated 
and observed structure factors); no.refl.- number of reflections in each bin; old fm- old average figure of 
merit (figure of merit before combination); new fm- new average figure of merit (figure of merit after 
combination); abs.ph.ch.- absolute phase change from observed to combined phase. 
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TABLE 3.7 Continuation 
Solvent flattened + model 2 combination to 3,0 A 
res.bins(A) r.lack clos. no.refl. old fm new fm abs.ph.ch. 
50 -6.7 0.7267 395 0.856 0.863 8.94 
6.7 -4.7 0.4223 682 0.807 0.827 22.13 
4.7 -3.9 0.3536 806 0.768 0.798 28.74 
3.9 -3.4 0.4898 891 0.761 0.791 26.15 
3.4 -3.0 0.5882 842 0.740 0.754 30.61 
total 0.5094 3616 0.777 0.799 25.13 
res.bins- resolution bins; r.lack clos.- relative lack of closure (relative lack of closure between calculated 
and observed structure factors); no.refl.- number of reflections in each bin; old fm- old average figure of 
merit (figure of merit before combination); new fm- new average figure of merit (figure of merit after 
combination); abs.ph.ch.- absolute phase change from observed to combined phase. 
residues at the N- terminus and the last residue (C- terminus) had little or no density and 
therefore were not included. No stretches of alanines were left. This model was totally 
rebuilt from the second model. The rebuilding was done from Cys 121 towards the C- 
terminus and towards the centre of the molecule at Cys66. Then, building was restarted 
from Trp19 towards the N- terminus and forward, towards Cys66. The two fragments 
formed in this way, met and closed at the loop between the third and fourth strands 
following the density from the MIR +2nd model combined map (FIG. 3.17), with no 
need for extra adjustments on the positions of residues previously positioned. This 
strategy was used because the density was weaker on the second and especially on the 
third I3-strand. The model was then refined as before, with the results shown in TABLE 
3.8. The residual attained is quite satisfactory for this resolution range, especially if 
compared with the value obtained for the B1gY model, positioned by molecular 
replacement (see section 3.8), after the same dynamics procedure. The final residual 
was 26.2% for 162 residues and 1548 atoms compared with 22.9% of the BlgZ model. 
Bearing in mind that the model is far from refined, several analyses were 
performed. A geometry analysis using X -PLOR, which evaluates the deviation from 
ideal values for bond lengths, bond angles and dihedral angles, indicated that some 
regions of the molecule contained very poor geometry (FIG. 3.18). The program 
calculated the ratio between the empirical energy (function of bond lengths, bond angles 
and dihedral angles) and the value of the root mean square deviation for each residue. 
This value indicates the stretches of model with worst stereochemistry and a well 
refined structure typically presents values of 0 -3 for this ratio. The residues that present 
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FIG. 3.17 Density for loop between the third and fourth strands 
Density in blue and model in yellow. 
problems are: 
A1a26 - At the end of the first 13-strand, for the moment this was built with an 
unusual bond angle formed by the N, Ca and C atoms. 
Pro50 - Positioned in the loop between the second and third n-strand, the high 
energy value is due to unusual dihedral angle in the ring, N- Ca -C -Cy. 
Asp53 - Positioned after the loop between the second and third 13-strand. It has 
an unusual bond angle, C- Ca -Cß. The stretch from Thr49 to Asp53 has been difficult 
to model. The density for the main -chain was present but the exact position of the side - 
chains and therefore the overall aspect of the loop was not well determined. 
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Lys60 - Positioned at the end of the third p- strand, it presents two unusual 
dihedral angles, Ca-C13-Cy-CS, and Cp- Cy- CS -CE. Density was only visible in maps 
produced with combined phases. 
Pro79 - Positioned in the loop between the fourth and fifth p- strand. Bad 
bond angle, C(79)- N(80)- Ca(80). The main -chain density for this loop was clearly 
seen but without much detail resulting in a difficult building of the residues. 
Glu108 to Leul 17 - All of these residues are positioned in a loop (between the 
seventh and eighth f3-strands) for which not much density exists, it was just possible to 
guess the main -chain from the MIR map. 
Thr125, Pro126 and Glu127 - Loop between eighth p -strand and a -helix. 
Density present but it was difficult to build. 
Glu134, Lys135 and Phe136 - In the middle of the a- helix. It was badly built. 
The problem is simple to correct. 
TABLE 3.8 
Final model 
Final model refinement 
Details Resolution R- factor Refinement step 
1- Weight calculation Wa = 65935 8 -3 A 44.2% 
2- Minimization 100 cycles of minimization 8-3 A 32.0% 
3- Slow cooling Max.Temp.= 4000 K 
no. of steps = 50 
timestep = 0.0005 ps 
8-3 A 23.9% 




















































































































































































































































































Pro144, Met145 and His146 - Positioned in the loop between the a -helix and 
the last 0-strand. Not much density was present. 
Asn152 - Positioned at the beginning of a loop (end of the last 0-strand). It has 
two short bond distances, Ca -Cß and Cß -Cy . 
From the analysis of these "bad points ", manual intervention should improve 
the geometry of most of these residues. The hardest spots are certainly the two loops 
(G1u 108 -Leu 117) and (Pro144-His146) because the density is non -existent or very 
weak. 
Crystal packing contacts shorter than 4 A for non -hydrogen atoms were 
analysed using X -PLOR. The majority result from the dimer interaction but because 
changes will occur with refinement no analysis will be performed. 
3.6.1 Comparison of the final B1gZ model with B1gY and Rbp 
The comparison of the model obtained for B1gZ with the existing B1gY model 
was done in order to evaluate the relevance of the changes introduced during this work. 
No comparison to the model available for the published structure of B1gZ (Monaco, et 
al., 1987) was done, the reasons being: 
- the model contained information from BlgY 
- as demonstrated by the molecular replacement work done in parallel and 
described in section 3.8, the published B1gZ model seems to have little similarity with 
the structure here described. 
The models of BlgZ and B1gY were compared by determining the root mean 
square difference (rmsd) between the coordinates of the same residues. The results are 
plotted in FIG. 3.19. For non -refined, medium resolution structures like these two it 
seems reasonable to only comment about residues where the main -chain rmsd is above 
2.5 A. The regions this way selected are, in general, the ones where changes in 
sequence threading where applied or where main -chain density for BlgZ did not agree 
with the existing B1gY model. The discussion below will deal with the whole model 
and will mention the analysis results from DSSP, a program by Kabsch and Sander, 
(1983). The residue numbering is from the BlgZ model, unless otherwise stated. 
Thr4 - Asp28 - No major changes. 
Ile29 - Gly64 - The fragment from Ile29 to Gly64 presents the largest changes between 

















































































































































-1i- strands and three loops. The discrepancy was a result of the shortening of the loop 
between the third and fourth [3-strands and the extension of the loop between the first 
and second [3-strands. Because for the shortened loop the density was weak, building 
was done according to the strategy described above, from Trp 19 (a conserved residue) 
towards the centre of the molecule at Cys66. This produced threading shifts, the extra 
long loop, the unambiguous linking with fragment at Cys66 (FIG. 3.17) and 
consequent shortening of a loop. In more detail: 
11e29 - Leu32 - This fragment forms an a- helical turn in B1gZ (FIG. 3.20), 
while in B1gY it is similar but was only recognized as a turn by DSSP. 
Asp33 - Va141 - This stretch (FIG.3.20) makes connection to the second strand. 
It is much longer in B1gZ than in BlgY and because of that the residue just before the 
strand is G1n35 in BlgY and Va141 in B1gZ. 
Interestingly, the same sort of structure, helix plus extended loop, is present in the Mup 
structure, and this accounts for the close sequence alignment between the two 
molecules described by Adams, (1992) that was not seen in the B1gY structure for this 
region. 
Tyr42 - Thr49 - It was identified as 13-sheet in BlgZ and is totally 
superimposable by a similar stretch in BlgY (Ser36 - Glu44). This means that a 
threading shift of five residues is present betweeen the two models. 
Asp53 - Lys60 - This secor.? [ strand, as defined by DSSP, is superimposed 
with the B1gY fragment Thr49 - I1e55. The same threading shift as above is present. 
These shifts result in different side -chains being present in the pocket of the molecule. 
For B1gY the following residues, belonging to this part of the sequence, have their 
side -chain into the pocket: 
Pro38, Va141, Va143, G1u51 and Asp53. 
In B1gZ they were substitued by: 
Va143, Leu46, Pro48, Leu54, 11e56 and Leu58. 
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FIG. 3.20 Tube representation of new model and BIgY main -chain 
atoms between I1e29 and Arg40. 
B1gZ new model in red, B1gY in yellow. The N- terminus of both fragments is 
towards the left of the picture. 
It is clearly seen that in B1gY there are two charged residues present in the hydrophobic 
environment, while in B1gZ no such feature is observed. This results in an increase of 
the hydrophobicity of the pocket of B1gZ and confers some credibility to the changes 
between models. 
Thr49 - G1y52 - Forms the small loop betwen the third and fourth strands 
which is equivalent to a slightly different shaped loop in B1gY (G1u45 - Pro48). 
Trp61 - G1u65 - This loop (FIG. 3.21) is much smaller in BlgZ than in B1gY, 
where it is eleven residues long (I1e56 - G1u65). Part of this BIgY loop there are three 
solvent exposed residues I1e56, Leu57 and Leu58 which are not present in the same 
situation in BlgZ. In B1gZ, Trp61 is present in a small cleft closer to the "bulk" of the 
molecule, while in BIgY, it is quite exposed to the solvent. This change correlates with 
some spectroscopic data which suggest that the two tryptophans have similar 
environments (Mills, 1976). At the end of this loop the models are back in frame with 
each other. 
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- G1u65 - Lys75 - In this stretch that includes a p- strand, Cys66 forms a disulphide 
bridge with Cys160 in both B1gZ and B1gY. The residues A1a67 -Lys69 follow different 
paths such that in B1gZ it is Lys69 rather then Lys70 which has access to the binding 
pocket. This residue is important because a lysine has been implicated in an interaction 
with retinol (Horwitz and Heller, 1974). Cho, et al., (1993) tried to establish the 
importance of the pocket and in particular of Lys70 for the binding of that ligand, by 
site -directed mutagenesis. However, their results were not conclusive and could be 
explained by having concentrated their efforts in the wrong residue. This stretch in 
B1gZ is out of frame with B1gY from Lys69 up to Lys75. 
Thr76 - Asp85 - Similar loop and I3-strand. 
A1a86 - G1u89 - Loop without much density in B1gZ. 
Asn90 - G1u108 - Includes two 13-strands and one loop that suffered just small 
adjustments. 
Asn109 - Leu117 - Loop that has changed place. In B1gZ there was just density enough 
to guess the main- chain. 
Va1118 - Glu127 -13 -strand and loop, that includes one of the residues involved in the 
well defined disulphide bridge Cys 106 -119 and the thiol of Cys 121.Only small 
adjustments were observed. 
Va1128 - Asp129 - Connection to a -helix. It was to decided make the connection in a 
slightly different way from B1gY. Not much density. 
Asp130 - A1a142 - This stretch forms the long a- helix. There were no changes 
introduced except the addition of an extra turn to the end of the helix. This extra turn 
resulted from the inclusion of residues Leu140, Lys141 as part of the a- helix. 
Leu143 - His146 - The loop is different in BlgZ from B1gY. 
Ile147 - Phe151 - This is the last I3-strand, it establishes the interaction with the other 
molecule in the dimer. The residues involved in the interaction have changed due to the 
two residue thread change towards the C- terminus. 
86 
FIG. 3.21 Loop Trp61 -GIu65 in the final model 
Tubular representation of main -chain atoms of BIgZ final model (red) -Trp61 to 
G1u65 - and B1gY (yellow) - I1e56 to Glu 65. 
Asn152 - His161 - It includes a new loop in B1gZ, with a helical turn between Pro153 
and Leu156. Cys160 forms the disulphide bridge Cys66 -160 in both models. 
The structures of B1gY, Rbp and B1gZ model were run through the program 
PROFILE, which evaluates and scores each residue according to its environment 
(Lüthy, et al., 1992). The Rbp structure was analysed as a control of a refined 
lipocalin. The environments are evaluated in terms of the area of the residue that is 
buried, fraction of side -chain area covered by polar atoms and local secondary 
structure. The total score for the whole sequence is a function of the how consistent the 
sequence and fold are with each other, meaning that wrongly traced structures will 
score lower. The total score for BIgY was 27.14, for B1gZ final model 55.37 and for 
Rbp 48.09. By averaging the scores of 21 sequential residues and attributing this value 
to the central residue of that stretch it is possible to detect wrong parts of the structure. 
This was done for BlgY, B1gZ and Rbp and the result is presented in FIG. 3.22. For 
correct structures this value is usually between 0.2 and 0.5 and never close to zero or 







































































































































































































































































































stretches where the values are close to zero and even negative, from Ser30 to I1e71 plus 
the smaller stretch from Lys77 to Va181 and the stretch from A1a143 to the C- terminus. 
On the other hand, the BIgZ model presented values above 0.2 for all the sequence. 
These results mean that the three -dimensional profile of the B1gY model is not 
consistent with its sequence or in other words that B1gY has not been correctly built. 
Also interesting is the fact the parts where the larger differences between the two 
models, B1gY and B1gZ, are found are the stretches where B1gY scores badly. This 
observation gives more weight to the changes introduced and demonstrates the value of 
this program to detect problems with structural models. 
The changes observed between the two models (BIgY and BIgZ) can not be 
attributed to conformational or crystal packing differences except maybe for the 
positioning of loops involving residues 86 to 89 and 109 to 117. The other changes 
were most probably due to mis- interpretation of density for the B1gY model. The 
calculated profiles for B1gZ and B1gY confirmed that the trigonal model is a better 
structure and gave credit to the hope that the alterations will be confirmed by the full 
refinement of the BIgZ model and re- building of B1gY. 
The final model for B1gZ can be described with the same cartoon representation 
used for B1gY by Papiz, et al., (1986), showing the residues that form the different 
secondary structure elements (FIG. 3.23). A thorough analysis of the new model and a 
full interpretation of biochemical data based on the many modifications has not yet been 
done at this stage since some details are likely to change during refinement. 
3.7 Preliminary analysis of the "ascorbic acid" data 
As already discussed in section 3.2.2, the co- crystal of Blg and ascorbic acid 
resulted in a data set with a high mean fractional isomorphous difference (26 %) from 
the native data. It was then argued, that despite this unexpected value it seemed that the 
structures in the two crystals were isomorphous. To verify what happened during co- 
crystallization, a difference map between the "ascorbic acid" and the native data was 
produced with the phases from the final BIgZ model. 
The map shows positive density at a 3a level above the average only in the 
centre of the pocket and close to the Cys121. The density by the cysteine is round 
shaped indicating that during co-crystallization an heavy atom compound was present 
and reacted with the free -thiol. The presence of this peak explains the high mean 
fractional isomorphous difference. 
The density observed in the centre of the pocket (FIG. 3.24) seems to belong to 
a long flat molecule, maybe a two or three ringed- structure with a smaller "detached" 
group positioned towards the opening of the pocket. Attempts to fit the ascorbic acid 
molecule to the density revealed that the density corresponds to a much larger molecule 
90 
FIG. 3.23 Cartoon of BIgY (Papiz, et al., 1986) and BIgZ 
secondary structure elements 
Squares represent the 13- strands, circles represent a- helix. The numbering 
indicates the residués that constitute each secondary structure element. The 
definition of the elements in Blgz was done with DSSP. 
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FIG. 3.24 Density found inside the pocket of Blg crystallized in 
the presence of ascorbic acid 
In green, tubular represenation of B1gZ final model main -chain atoms. In blue 
the density found inside the pocket from a difference map between the ascorbic 
and the native data sets. 
Top: view of density in between strands. 
Bottom: view into the pocket. 
than vitamin C. It seems improbable, as well, that this polar molecule will bind into the 
pocket especially since it became much more apolar due to the alterations on the 
threading discussed above. It seems more probable that, since the particular batch of 
protein was used only for this experiment, an apolar solvent used during the 
purification of the protein remained bound to the protein or that a contaminant with 
affinity for Blg was present in the co- crystallization experiment. 
Despite the difficulties in determining the true nature of the ligand, the structural 
role of the pocket in Blg has now been established without doubt. As discussed in 
section 1.2, the fact that the protein binds small hydrophobic molecules has been long 
known but the location and environment of the binding site was never totally 
understood and contradictory results were leading to the idea that the pocket was not 
biologically functional in Blg. The finding of density has re- stated the importance of the 
pocket and the possibility of crystallographic analysis of the interactions between 
ligands and the protein. 
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Addendum 
The calculation of difference maps for the p- nitrophenol (pnp) and palmitic acid 
co- crystals revealed density inside the pocket. Surprisingly, that density presented the 
same shape and was positioned in the same region of the pocket as the density observed 
for the ascorbic acid co- crystallization. Changes in the resolution range did not result in 
any alteration of the common charateristics of the three difference maps. It was verified 
that the information was not present as a "ghost" in the phases used since no 
comparable density could be observed in a difference map calculated for a weak 
derivative (mean fractional isomorphous difference of 13 %). It should be noted as well, 
that the mean fractional isomorphous difference for both the palmitic acid and pnp 
against the native was quite high, 26 and 30% respectively. It was concluded that 
changes have occurred either in the overall packing or in the protein conformation or 
both, which cannot be considered isomorphous. Therefore the basic principle for the 
use of the difference map is not valid and the density observed is a result of the overall 
alterations. For the full understanding of the modifications in the co-crystals, including 
the positioning of the ligand it will be necessary to refine the positioning of the whole 
molecule first and then refine the position of residues in the protein. For the moment it 
can only be concluded that modifications occur in the crystals upon co-crystallization 
and that the nature of molecular interactions of ligands to the binding pocket is still 
unknown. 
3.8 Molecular replacement 
In parallel to the structure solution by isomorphous replacement, molecular 
replacement was also undertaken to obtain approximate phases from B1gY (bovine beta - 
lactoglobulin - crystal form B2212) and Mup (major urinary protein) models (see 
section 1.1). Mup was chosen since it was demonstrated to be one of the lipocalin 
family members most closely related to Blg (Ali, 1989; Adams, 1992). The model was 
kindly provided by A.C.T. North and had been refined to -27% at 2.4 A with X- 
PLOR. 
The molecular replacement strategy consisted of both an "automatic" and a 
"manual" approach. The "automatic" molecular replacement was carried out mainly 
with the package X -PLOR using the independently determined BlgY model and the 
Mup model and is described in sections 3.8.1 and 3.8.2. The "manual" procedure was 
devised because it was foreseen that some difficulties would be encountered when 
looking for a solution using a traditional molecular replacement procedure with non- 
fully refined models (Tickle, 1992; Dauter, 1992) of proteins mainly constituted by E3- 
sheet (Blundell and Tickle, 1985). The "manual" approach involved the use of the 
derivative heavy atom constellations in each of B1gY and B1gZ crystal forms as a basis 
for the determination of the rotation and translation parameters and will be discussed in 
more detail in section 3.8.5. 
3.8.1 X -PLOR rotation function 
For a predominantly f3-sheet protein, Blundell and Tickle, (1985) recommended 
that a complete data set to roughly 3 A be used. As the native data set were incomplete 
to this resolution, missing reflections were supplemented (see TABLE 3.9) from a data 
set of a very weak derivative (Riso 13 %), shown subsequently by difference Fouriers 1 
to be genuinely isomorphous with the native except for the presence of an heavy atom 
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with low occupancy. 
The procedure is a real space Patterson search (Huber, 1985). In other words 
the Patterson function of the model, placed in a cell with P1 symmetry, and including 
around 70 -80% of the model (Blow, 1985), is rotated over the Patterson map calculated 
from the measured intensities. The rotation is performed over a particular range of 
Eulerian angles defined by the asymmetric unit of rotation space and a correlation 
function between the maps is calculated at intervals. The origin peak is removed from 
the maps and only a set number of the strongest features is used. The correlation 
function calculated is the product function of the two maps. 
Most of the recommended default values presented in the X -PLOR manual were 
used. To summarize, the top 6000 peaks in the rotation map were selected, the 
threshold of the peak height was set to 0.0, a 2.5° grid interval was used for the search. 
Data with spacings in the range 8 A to 4 A were used, where the low resolution limit 
was chosen to 
TABLE 3.9 Completeness of the native data and supplemented 
data sets 
Bins of resolution (A) native % complete supplemented % complete 
6.4 95.4 96.0 
5.0 98.5 99.1 
4.3 97.8 98.5 
3.8 96.0 97.8 
3.5 95.2 96.5 
3.2 90.4 93.9 
3.0 83.0 87.1 
remove the solvent and associated salt features from the Patterson maps (Blow, 1985), 
while the high resolution limit was the maximum (see above) allowed by the restrictive 
computer memory available. 
The maps were restricted to a maximum distance of 18 A from the origin, a 
value considered enough to include most of the infra- molecular vectorsbut exclude most 
inter molecular vectors and a minimum distance of 5 A chosen for the prupose of origin 
removal. The Lattman angle range for the search was established (Rao et al., 1980) to 
be 0° to 120° for e -, 0° to 90.0° for 02 and 0° to 720° for O +. 
Prior to the use of Mup as a search model, its coordinates were aligned with 
those of the B1gY model using the LSQ facility of the program O (Jones, et al., 1991). 
This step was intended to facilitate the recognition of real solutions by comparing the 
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results from the two models. 
The results for the rotation functions of both search models, B1gY and Mup 
were never clear since the top positions were not obviously separated from other 
solutions. The ten top positions for the two search models are presented in TABLE 
3.10. It is apparent that the solutions are in the same area of space and it seems 
reasonable to assume that the real solution will be among the top 100. 
TABLE 3.10 Top rotation solutions for Mup and BIgY models 
B1gY angles Rotation correl. 
(Sigma = 0.312) 
Mup angles Rotation correl. 
(Sigma = 0.301) 
314.3, 87.5, 270.7 3.615 143.7, 60.0, 58.70 3.395 
313.2, 85.0, 260.7 3.349 142.6, 60.0, 117.6 3.393 
314.1, 87.5, 281.3 3.349 144.4, 57.5, 87.1 3.305 
313.8, 87.5, 292.0 3.430 314.4, 82.5, 275.6 3.303 
316.2, 85.0, 237.4 3.354 142.9, 57.5, 142.9 3.280 
312.9, 90.0, 251.1 3.335 145.7, 62.5, 35.7 3.262 
313.5, 87.5, 302.1 3.260 146.2, 57.5, 125.3 3.236 
133.5, 90.0, 93.5 3.243 146.9, 60.0, 46.9 3.236 
310.0, 82.5, 213.3 3.226 145.8, 62.5, 105.8 3.212 
133.7, 85.0, 36.2 3.213 142.8, 65.0, 80.4 3.186 
The rotation was immediately followed by PC- refinement (Patterson correlation 
refinement) on all the peaks produced in the previous step. This procedure correlates 
the observed normalized structure factors and the normalized structure factors calculated 
from the rotated model. The latter are a function of the overall orientation parameters 
and of the translation and rotation parameters for selected rigid bodies. Thus the 
procedure allows for the filtering of a subset of orientations and it actually improves 
both the overall orientation parameters and packing relationships of different parts of 
the molecule. The range of resolution used was extended to 10 -3.2 A to try to use all 
the available information in determining the orientation. Because of the structural 
characteristics of the members of the lipocalin family as compact and single- domain 
proteins, no fragmentation of the molecules was 
conceivable and so the refinement was applied only to the overall rotational parameters. 
The results for the two search models are shown in FIG. 3.25. 
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FIG. 3.25 PC- refinement solutions for BIgY and Mup 
Plot of the Patterson correlation value for B1gY and Mup after refinement of the 
rotational parameters. The correlation values were plotted according to the 
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For B1gY, two solutions emerge having the same correlation factor of 0.0856: 
a) 01= 312.1 °, 02= 82.0 °, 03= 268.1° 
b) 01= 132.0 °, 02= 98.0 °, 03= 31.8° 
The two solutions are in fact related by 180° rotation about the y axis of the 
trigonal space group, as determined by the ROTMAN facility in X -PLOR. This means 
that they are crystallographically related though the selection of the rotation asymmetric 
unit and the cluster analysis should have removed equivalent orientations. It is possible 
that after the rotation they presented angular values that were not related under the 
imposed threshold criteria and it was the PC- refinement that induced the convergence. 
The PC- refinement has a wide radius of convergence because the top two 
rotation solutions are quite different (at least 10° difference in 03) and they converge 
into the same final solution after refinement. 
In the case of the Mup model, one of the top solutions was found at 01= 
313.7, 02= 80.0, 03= 272.2, with the same program settings used for Blg. It is 
interesting to note the lack of the second solution, although there was another position 
emerging at 01= 128.2, 02= 87.7, 03= 40.1, but with a much lower score for the 
correlation factor (0.040 compared to 0.053 for the top solution). Note as well that the 
scores for Mup are understandably lower than those obtained for B1gY since the 
sequence identity is reduced. 
3.8.2 Translation solution 
The translation solution for B1gY solved in two stages. Initially a rough solution 
was obtained using the parallelized version (Adams, 1992) of the program BRUTE 
(Fujinaga and Read, 1987) and then it was repeated in X -PLOR but in a reduced 
volume around the BRUTE top position. 
The BRUTE search was done in space group P3221 with a 0.5 A grid spacing 
over half of the unit cell (the translation along z varied between O and 1/2) and 
resolution range 8 -4 A. It was found that the grid was of utmost importance since the 
use of 1 A grid resulted in failure to detect the correct solution. The top positions 
shown in TABLE 3.11, were produced for the search with the orientation solution a). 
The resulting top position was put into X -PLOR with a resolution range 15 -4 A , a grid 
of 0.5 A and the correlation of the square of the normalized structure factors was 
computed between a fractional grid of 0.65 to 1.0 for x , 0.0 to 0.1 for y and 0.10 to 
0.25 for z for orientation a) and 0.0 to 0.15 for x, 0.0 to 0.15 for y an -0.10 to 0.10 
for z in the case of orientation b). The results for the two orientation solutions are 
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TABLE 3.11 Top BRUTE translation positions for BIgY, solution 
a) 
The grid on the sections is orthogonalized with a parallel to translation x and c 
parallel to translation z. z was calculated in 200 sections and x and y in 100 
sections. 
The starting position was -1, -1, -1. 
Position 
(Maximum of section) 
100, 2, 31 
92, 97, 27 
85, 96, 70 
59, 30, 98 
Translation correlation 






51, 29, 41 0.4090 
17, 51, 8 0.4087 
17, 62, 21 0.4054 
93, 98, 40 0.4020 
53, 20, 37 0.4020 
shown in TABLE 3.12. It is evident that the top solutions are very close to each other 
and differ only by fractions of an Angstrom in x and y, while z is constant. This can be 
explained by the way the molecule is oriented in the cell, the c axis collinear with a 
fictitious molecular axis that goes through the pocket, such that slight adjustments in x 
and y compensate for the "breathing" of the ß- strands. 
The packing values, which correspond to the solvent content in the unit cell, 
were very sensitive to the validity of the solution since only the correct one gave values 
close to 42 %, which is consistent with the calculations of Matthews' Vm (Matthews, 
1968). The residual was also diagnostic, although not as evident, only dropping below 
55% for the true solution. 
The Mup rotation solution was submitted to an X -PLOR translation search 
consisting of four scans, each of 1/8 of the asymmetric unit (used because of demand 
on computer time and memory) on a 0.5 A grid. The translation search produced the 
solutions shown in TABLE 3.13. The chosen solution is the first solution in the top 
table. It is not clear that the true solution is present because both the packing (39 %) and 
the residual (54.8 %) are not as good as for Blg. The packing function is clearly higher 
for the chosen solution but the correlation function is worse, an explanation could be 
that the packing function values are relative to the unit cell volume while the correlation 
function is probably scaled internally and so cannot be compared between different 
scans. However, by applying the rotation and translation parameters found for Mup to 
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TABLE 3.12 X -PLOR translation function solutions for BIgY 
orientations 
The results are for the two orientations defined for B1gY. T is the translation 
correlation function value and P the packing function, which is equivalent to the 
solvent content of the unit cell. The positions are defined in Angstroms as 
orthogonal coordinates, with a parallel to x translation and c parallel to z 
translation. 
Orientation solution a) 
Position Td P 
53.037, 0.425, 16.905 0.3929 0.4141 
52.798, 0.425, 16.905 0.3917 0.4132 
52.920, 0.213, 16.905 0.3915 0.4134 
52.681, 0.213, 16.905 0.3877 0.4130 
53.160, 0.213, 16.905 0.3876 0.4130 
52.914, 0.638, 16.905 0.3858 0.4145 
53.276, 0.425, 16.905 0.3836 0.4145 
53.153, 0.638, 16.905 0.3820 0.4146 
52.558, 0.425, 16.905 0.3816 0.4124 
52.804, 0.000, 16.905 0.3795 0.4135 
a- Sigma of translation function =0.050 
Orientation solution b) 
Position Ta P 
0.123, 1.063, 1.753 0.3947 0.4132 
0.245, 1.275, 1.753 0.3944 0.4134 
0.368, 1.063, 1.753 0.3915 0.4130 
0.000, 1.275, 1.753 0.3900 0.4140 
0.491, 1.275, 1.753 0.3892 0.4115 
0.245, 0.850, 1.753 0.3867 0.4131 
0.368, 1.488, 1.753 0.3855 0.4138 
-0.123, 1.063, 1.753 0.3854 0.4132 
0.000, 0.850, 1.753 0.3845 0.4133 
0.123, 1.488, 1.753 0.3830 0.4112 
a- Sigma of translation function =0.063 
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TABLE 3.13 X -PLOR translation solutions for Mup 
The two tables show the five top solutions of two 1/8 of the unit cell 
scans (see text for more details). The real solution is present in the top table. T 
is the translation correlation function value and P the packing function, which is 
equivalent to the solvent content of the unit cell. The positions are defined as 
Angstroms of orthogonal coordinates, with a parallel to x translation and c 
parallel to z translation. 
Search x= 0,75 -1.0, y= 0.0 -1.0, z= 0.0 -0.5 
Position Ta 
26.152, 45.310, 16.100 0.3276 0.3858 
26.032, 45.518, 16.100 0.3268 0.3859 
25.911, 45.310, 16.100 0.3261 0.3853 
25.432, 46.558, 30.691 0.3259 0.3144 
52.312, 0.000, 30.691 0.3259 0.3147 
a- Sigma of translation function =0.049 
Search x= 0.50 -0.75, y= 0.0 -1.0, z= 0.0 -Q.5 
Position Ta P 
26.073, 14.549, 12.075 0.3444 0.2829 
26.314, 14.549, 12.075 0.3436 0.2825 
26.193, 14.341, 12.075 0.3435 0.2823 
25.952, 14.341, 12.075 0.3423 0.2823 
26.194, 14.757, 12.075 0.3404 0.2835 
a- Sigma of translation function =0.048 
BIgY it was possible to verify that the "bad" residual and packing values are only 
caused by the low identity between the two proteins, indicating therefore that the 
molecular replacement has been solved for Mup too. 
3.8.3 Rigid body refinement 
The X -PLOR rigid body refinement routine was used with the entire molecule 
refined as a single rigid body. 
Refinement of the positional and orientation parameters of the top translation 
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solution from BlgY rotation solution b) resulted in a drop of the residual from 51.9% to 
50% with 30 cycles at 15 -6 A and then down to 49.2% with 50 cycles at 15 -3.2 A. The 
2Fobs Fcalc Fourier synthesis created from this model presents very reasonable density 
covering the whole protein. The same happened for solution a). 
For Mup, rigid body refinement reduced the residual from 54.8% to 53.5% 
after 50 cycles at 15 -3.2 A. 
3.8.4 Distinction between the space group enantiomorphs 
The space group choice between P3221 and P3121 can be done at the stage of 
the translation function. When using a real space translation function the search vector 
is applied to the model and to its symmetry equivalents, thus the correlation depends on 
the position of all the molecules in the unit cell. It is then possible to distinguish a left 
from a right handed arrangement of the molecules since the correct arrangement will 
produce a higher correlation and a lower residual. 
This was verified by doing the search in BRUTE with BlgY. The orientation 
matrix for solution a) was used and the search was done in each enantiomorphic space 
group. For P3221 the top solution had a correlation value of 0.4593 and the residual 
was calculated to be 50.4 %, while for P3121 the top solution had a correlation value of 
0.4481 and a residual of 53.1 %. The choice is not as clear as in the case described by 
Baldwin, et al., (1991) where the results with CORELS were 0.64 for the correlation 
factor, 44% for the residual in P3121, while for the other enantiomorph the correlation 
was 0.428 and the residual 48.9 %. However the choice of the enantiomorph P3221 as 
the correct enantiomorph based on the translation function is consistent with the 
isomorphous replacement results (see section 3.3.3). 
3.8.5 "Manual" procedure 
As previously discussed the manual approach was devised to surpass 
difficulties anticipated with a more traditional use of the molecular replacement 
technique. 
The low resolution work described by Green, et al., (1979) presents the idea 
that Blg is dimeric in both the trigonal and orthorhombic space groups. This idea was 
supported by the fact that the arrangement of the common heavy atoms in derivative 
crystals is identical along the crystallographic dyads, as shown in FIG. 3.26, and is 
consistent with the known dimeric form of the protein at neutral pH. 
The "manual "approach involved the use of the coordinates of the three heavy 
atoms common to BlgY (orthorhombic) and BIgZ ( trigonal) derivatives to determine the 
rotation matrix and the translation parameters. The assumption was made that the heavy 
atoms were bound to the same sites in both crystal forms, an assumption supported by 
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FIG. 3.26 Arrangement of BIgY and BIgZ heavy atoms around the 
crystallographic dyad (adapted from Green, et al., 1979) 
The figure represents a projection down the molecular dyad of the positions of 
the heavy atom compounds MMA (circle), HgI4-2 (square) and Pt(NO2)4 
(triangle) in Blg crystal lattices Z (open), Y (open with black dot) and X (filled). 
The dyad is represented by the 1 . 
, 
16, 
their common arrangement around their repective dyad axes, as already described 
above, and by the similar reaction conditions (both pH and salt concentrations are very 
similar for the growth of these two crystal forms). 
The mathematical procedure required the following steps: 
1) Definition of a common reference system. This was achieved by aligning the a and c 
axes of both space groups and defining them as the x and z directions while the y 
direction was defined by a right hand orthogonal system. The base vectors of the 
coordinate system had the modulus of 1 A. 
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2) Definition of the heavy atom positions or symmetry equivalents that correspond to 
one and the same protein molecule in each crystal form and determination of their 
positions relative to the new reference system. The positions of the heavy atoms of 
MMA, HgI4 -2 and Pt(NO2)4 were described for B1gY by Papiz, (1982), and by 
inspecting a plot with all the equivalent positions, three were chosen that appeared to 
have a reasonable arrangement around the 2 -fold axis (the c axis in this case). The 
same was done in B1gZ for positions arranged around the crystallographic dyad at z=0. 
In this crystal form the positions of MMA and Pt (NO2)4 had been determined at a 
resolution of 3.5 A, as described in section 3.3.4, while the position of HgI4 2 was 
obtained from Green, et al., (1979). Thus the vectors determined were: 
for MMA MY= 13.4, 2.6, 21.2 MZ= 6.1, 24.2, 10.5 
for Pt (NO2)4 PY= 7.0, -10.9, 17.6 PZ= -0.9, 22.7, -2.1 
for HgI4- 2 IY= 4.1, -2.5, 19.4 IZ= 6.6, 21.0, 0.223 
where Y and Z define the B1gY and BlgZ crystal forms respectively. 
3) Calculation of the normalized vectors for each heavy atom. It is the direction of these 
vectors that matters for the the orientation matrix, while their modulus is a function of 
the translation. The values calculated were the following: 
mY= 0.53, 0.10, 0.84; pY= 0.32, -0.50, 0.80; i Y= 0.20, -0.12, 0.97 
mZ= 0.22, 0.89, 0.39; pZ= -0.039, 1.00, -0.092; iZ= 0.30, 0.95, 0.010. 
4) Solution of the [Y]R =[Z] equation, where [Y] =[mY, iY, pY]T and [Z] =[mZ, iZ, 
pZ]T are the matrices composed of the vectors defined in 3) which define the 
orientation of the molecule in each crystal form, while R is the rotation matrix that 
transforms one onto the other. The solution requires the calculation of [Y] -1 and the 










5) The differences between the rotated MY, IY, PY vectors and MZ, IZ, PZ define 
the translation vectors. In fact it was decided to use the center of gravity of the rotated 
three positions in Y. This resulted in c o g(rotated) =3.6, 21.1, 2.7 and the distance to 
the center of gravity of the Z crystal form is 
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Ac o g= 0.3, 1.5, 0.2. As the necessary translation was very small, the translation 
vector used was (0.0, 1.5, 0.0). 
6) the rotation was applied to the B1gY model using X -PLOR (in fact X -PLOR required 
the transpose of the matrix shown in 4)) and then the result was translated Finally 60 
steps of rigid body refinement at 15 -6 A dropped the residual from 58% to 50.6% (the 
residual was 52.3% when the range was 15 -4 A). 
The resulting 2Fobs -Fcalc map was not satisfactory since the main chain 
density was frequently interrupted. However, the position of the mercury atom in 
relation to the free cysteine, Cys121, was quite acceptable which indicates that the 
molecule is approximately in the correct position and that the procedure for the 
positioning is self -consistent. 
The orientated molecule was entered into a simulated annealing procedure to 
relieve any twists or alterations in the 13-sheet structure from B1gY to B1gZ. The 
procedure was run in X -PLOR with the settings presented in the manual. The final 
residual value was 30% and the 2Fobs -Fcalc map was perfectly acceptable. The 
changes between the model before and after the simulated annealing can be described as 
"breathing" movements of all the f3-strands. It was clear that no drastic movement of the 
model had occurred. 
As a way of checking the reliability of the model after simulated annealing, the 
"manually" positioned molecule was randomly rotated and put through a 
simulated annealing procedure. The center of gravity was determined with the use of 
the program COGCAL, (personal communication by Dr. P. Taylor), and the molecule 
was rotated around that point by 40° around z and 20° around the new x. After the 
procedure the residual was again 30 %, but the empirical energy values were much 
higher and the molecule was visibly deformed Furthermore the 2Fobs -Fcalc map was 
poor, showing , for example, no density for the disulphide bridge 106 -119. This test 
lent confidence to the "manual" solution and the model produced from it . 
3.8.6 Discussion 
The work done with the molecular replacement techniques, although not used in 
the calculation of density, provided confirmation of the space group enantiomorph and 
of the suspicions that severe problems existed in the structure presented by Monaco, et 
al., (1987). 
The former work at medium resolution in the trigonal space group (Monaco, et 
a1.,1987) concluded that the Blg molecule was not present as a dimer since the 
interactions among molecules related by 2 -fold axes were found to be very distant and 
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no special interactions were observed between pairs of molecules. Some short contacts 
were described, "...the contacts are so tight that interpretation of the electron density 
map is not straightforward." (Monaco, et al., 1987) and it was concluded that the 
protein was in some state of polymeric aggregation. 
The molecular replacement solution obtained during this study shows a clear 
association between two monomers and that this association is related by a 
crystallographic dyad. It also shows that the dimer interactions appear to be generally 
the same in B1gY and BIgZ, being established by the ß- strand closest to the C- terminus. 
In fact the overall packing of the molecules is entirely different from that described by 
Monaco, et al., (1987), and no evidence for any kind of polymeric aggregation other 
than the described dimer formation, is observed. A comparison of the positioning in the 
unit cell of the present structure solution with that of Monaco, et al., (1987) is 
illustrated in FIG. 3.27. 
The comparison of the "manual" and automatic solutions reveals the power of 
the molecular replacement algorithms in X -PLOR, especially in their capacity to refine 
the orientation matrix. Despite the use of information from the heavy atoms and rigid 
body refinement, the "manual" solution only produced an acceptable map after 
simulated annealing. This can be explained by the small misorientation of the "manual" 
solution observed when compared with the automatic one. The "manually" produced 
solution is located in the same position as the "automatic" solution, however a slight but 
obvious difference in orientation is apparent between the two final models. It would be 
expected that rigid body refinement could ease this misorientation; instead there was a 
requirement for application of shifts to the each E3-strand during the simulated annealing 
procedure to bring the resulting model closer to the automatic solution. Based on 
considerations of map quality the "automatic" solution was chosen as the better 
representation. 
The translation function permitted the confirmation of P3221 as the correct 
space group, since both the residual and the correlation values of the top solution are 
favourable to the search performed with this enantiomorph. 
Finally, both the Blg and Mup models produced solutions for the molecular 
replacement procedure. The solution obtained with Mup is not as clear as the ones for 
Blg but it was still possible to recognize the correct from the wrong orientation and 
position parameters. It will be interesting to see if the results for molecular replacement 
are more obvious when the refined models are used. It must be emphasized that both 
the BIgY and Mup molecular replacement solutions were used as helplines in the 
building of the model of B1gZ, as discussed in section 3.5. 
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FIG. 3.27 Position of molecules in two studies of B1gZ crystal 
form 
View of the P3221 unit cell section closest to the origin. The unit cell is 
represented by red lines with the origin and both the x and y axes marked. 
The diagonal between the origin and the far comer on the background is the 
crystallographic dyad. In yellow, a tubular representation of B1gZ new model 
and in blue, the tubular representation of B1gZ from Monaco, et al., (1987). 
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4. Experiments involving apo D 
The following sections will describe the various experiments done with apo D 
in order to gain insight into the biochemistry of this protein. It is important to re -state 
that most of the experiments are only preliminary, nothing more than "opening doors" 
into possibly relevant aspects of apo D. The different purification methods will be 
commented upon, followed by the structural and biological characterizations 
performed. 
4.1 Purification of apo D from plasma 
At the onset of this work the source of apo D was the plasma. The method of 
purification had been established since the detection and initial characterization of the 
protein (McConathy and Alaupovic, 1973). It was only necessary to scaleup the 
method (see section 2.1 and following) to purify larger amounts of protein for 
crystallization trials and general structural characterization. 
A typical chromatography trace is shown on FIG. 4.1. Peak A was eluted with 
FIG. 4.1 Chromatography trace from hydroxylapatite column 
Peak A eluted with 1 mM K2HPO4, pH 8.0 (the loading buffer), peak B was 










the loading buffer (1 mM K2HPO4, pH 8.0), peak B was eluted with 1M K2HPO4, pH 
8.0. The fractions of peak A and B were run in the SDS -PAGE shown on FIG. 4.2, 
peak A fractions contain two broad bands, while peak B fractions contain apo AI and 
all the other components of the HDL (see section 1.3.4.1). Apo D has been identified 
as the major broad band with &molecular weight at 30 kDa in peak A. The identification 
was confirmed (data not shown) by cross -reaction with antibodies against apo D, 
kindly provided by Dr. Kostner from Graz, Austria , and by confirming that the 
sequence (performed by Dr.C. Lopez-06n and Mr.L. -M. Sanchez in Oviedo, Spain) of 
the first five residues was identical to the sequence reported in the literature (Drayna, et 
aí.,1986). The band that migrates at 67 kDa was tentatively identified as one of the 
following: albumin, a contaminant from the plasma, LCAT (lecithin- cholesterol 
acyltransferase (see section 1.3.1), a contaminant from the HDL, or a dimer of apo D. 
The last possibility was shown to be the most probable by a series of facts: 
a) no-cross reaction with antibodies raised against albumin (data not shown) 
b) cross -reaction of the band with antibodies raised against protein electro- 
eluted from the major band (see below) 
c) observation of the same extra high molecular weight, in gels of the protein 
purified from gross- cystic- disease fluid. This higher molecular weight band cross - 
reacted with antibodies raised against the plasma protein. 
The yield of the procedure was 10 -20%, since one liter of plasma, containing 
60 -100 mg of apo D (McConathy and Alaupovic, 1986), produced 10 -20 mg of pure 
apo D. 
4.2 Characterization of the antibodies raised against apo D 
Polyclonal antibodies were produced according to the method described in 
section 2.7. The protein was further purified by SDS -PAGE and electroelution because 
it was thought at the time that the minor band at -67 kDa was a contaminant. The 
electroelution of apo D from the gel bands was a long and difficult process where a lot 
of protein was lost, caused by the excessive density of the gels. 
The production of antibodies was followed by Western blotting and cross - 
reaction was observed at the first bleeding (data not shown). In FIG. 4.3, the result of 
a Western blot of HDL proteins and purified apo D is shown. The blot was incubated 
with immune and pre- immune serum. The SDS -PAGE (FIG. 4.3) of the HDL sample 
shows the numerous proteins that compose that lipoprotein particle. The immune serum 
recognized a band corresponding to apo D, a band corresponding to the dimer of apo D 
and a higher aggregate on the boundary between the stacking and separation gels, in 
both the HDL and purified protein. The pre -immune serum did not show any cross - 
reaction against the same samples. 
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FIG. 4.2 SDS -PAGE of fractions from hydroxylapatite column 
12.5% SDS -PAGE. Fractions of peak A were run in lanes 2 to 6, fractions 
from peak B were run in lanes 10 to 12. Molecular weight markers were run in 
lane 13 and the loaded sample is present in lane 1. All other lanes were loaded 
with fractions between peak A and B. M.W. markers- 94, 67, 43, 30, 20, 14 kDa 
1 2 3 4 5 6 7 8 9 10 11 12 13 
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4.3 Apo D purification from gross- cystic disease fluid (GCDF) 
The sequencing of the major protein (GCDF -24) from gross- cystic -disease fluid 
(GCDF) led to its identification as apo D ( Balbín, et al., 1990). Further, the fluid 
proved to be an excellent source of apo D since concentrations in the range of 
10 -50 mg/ml can be obtained. 
The first attempt to isolate apo D from GCDF was done with the assistance of 
the workers in the laboratory of DEC. López-Otín in Oviedo, Spain, using the method 
described by Balbín, et al., (1990) (section 2.3). Unfortunately, the preparative gel 
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FIG. 4.3 Western blot with antibodies raised against plasma 
apoD 
Left: western blot of purified plasma apo D and HDL, incubated with pre - 
immune serum. Lane 1- apo D purified from plasma, lane 2 - HDL. 
Middle: western blot of purified plasma apo D and HDL, incubated with 
immune serum. Lane 1 - apo D purified from plasma, lane 2 - HDL. 
Right: SDS -PAGE of purified HDL after delipidation. Lanes 2 and 3 - HDL 
samples, 2 and 1 ul respectively. Lanes 1 and 4 - molecular weight markers. 
94, 67, 43, 30, 20, 14 kDa 
1 2 1 2 
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filtration column used was old, not permitting good resolution of the peaks. Therefore 
the resultant apo contaminated. the 
previously used for the purification of apo D from plasma was slightly modified 
(section 2.2.2), and applied to the partially purified material. This resulted in an 
apparent total isolation of apo D from the other proteic components of cyst fluid. From 
this point onwards, apo D was routinely purified from GCDF by the single step 
hydroxylapatite column method. 
The protein from GCDF migrates in SDS -PAGE at a lower molecular weight 
than the plasma protein (FIG. 4.4), which can be possibly explained by differences in 
glycosylation. The antibodies raised against plasma apo D cross -react against the 
GCDF apo D and its high molecular weight complex (data not shown). 
Routinely, 10 -12 mg of pure apo D were purified from 1 -2 ml of GCDF. 
4.4 Analysis of the cysteine residues 
The five cysteines present in the GCDF apo D were characterized into three 
possible chemical states: free -thiol, disulphide bridge, other unknown oxidized state. 
Ellman's reagent produces a chromophore allowing for the colorimetric 
determination of the number of free- thiols present in solution (see section 2.13.1). One 
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FIG. 4.4 SDS -PAGE of apo D from plasma and GCDF 
12.5% SDS -PAGE. Lanes 1 - apo D from plasma, lane 2 - apo D from 
GCDF. 
mole of chromophore is produced from the reaction with one mole of free- thiol. 
The results with and without guanidinium chloride are presented in TABLE 4.1. 
Papain and Blg were used as controls; papain is known to have one free -thiol in the 
active site and one disulphide bond while Blg has one free -thiol and two disulphide 
bonds. It was shown that the free -thiol of Blg was not accessible to the reagent in the 
native conformation, a result consistent with the X -ray crystal structure that shows the 
Cys121 semi -buried under the a -helix (Papiz, et al., 1986). On the other hand the 
cysteine in the active -site of papain was accessible to the reagent. Apo D behaves the 
same way as Blg, since no reaction was detected. 
Under denaturing conditions papain still only showed one free -thiol accessible, 
while in Blg the free -thiol was now accessible to the reagent. Denatured apo D, 
however, did not seem to have any free -thiol, as no production of chromophore was 
detected. An increase in incubation time with denaturant did not alter the results. 
An attempt to reduce the cysteines by incubating the proteins with DTT 
followed by extensive dialysis, before the colorimetric reaction, was not successful 
because the results were very dependent on the need for total removal of the reducing 
agent and the longer the dialysis time the greater the probability of the re- oxidation of 
the cysteines. 
The number of disulphide bridges present in the proteins was determined by the 
method described by Thannhauser, et al., (1984; 1987) (see section 2.13.2). By 
chemical modification of Ellman's reagent, 2- nitro -5- thiosulphobenzoate (NTSB) was 
obtained which when upon reaction with one mole of disulphide or one mole of free- 
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TABLE 4.1 Results of cysteine studies with Ellman's reagent 
DTNB native conditions 
moles of chromophore ratio moles of protein 
Papain 2 nmol 2.2 nmol 1.1 
4 nmol 4.4 nmol 1.1 
8 nmol 8.8 nmol 1.1 
Apo D 4 nmol 0 nmol 0 
8 nmol 0 nmol 0 
10 nmol 0 nmol 0 
Blg 4 nmol 0 nmol 0 
8 nmol 0 nmol 0 
8 nmol 0 nmol 0 
DTNB denaturing conditions 
moles of chromophore ratio moles of protein 
Papain 4 nmol 5.2 nmol 1.3 
8 nmol 9.6 nmol 1.2 
Apo D 4 nmol 0 nmol 0 
8 nmol 0 nmol 0 
10 nmol 0 nmol 0 
Blg 10 nmol 9.6 nmol 0.96 
10 nmol 9.6 nmol 0.96 
ratio- number of moles of chromophgre per mole of protein 
thiol produces one mole of chromophore. The results are presented in TABLE 4.2. The 
two moles of chromophore produced for papain under denaturing conditions are due to 
the presence of one free -thiol, as demonstrated with Ellman's reagent, and one 
disulphide bridge. Apo D under denaturing conditions, presented two reactive 
groups,possibly corresponding to the two disulphide bonds. For Blg, under denaturing 
conditions, it was expected that three moles of chromophore would be produced per 
mole of protein, however an average of 2.5 reactive groups were determined. A 
possible explanation is indicated in the literature (Thannhauser, et al., 1984; 1987), 
where the reactions that give rise to the chromophore are described as reversible at pH 
9.5. Thus if the denaturant was not totally effective with Blg, the local concentration of 
113 
TABLE 4.2 Results of cysteine studies with NTSB 
NTSB native conditions 
moles of chromophore ratio moles-of protein 






Apo D 4 nmol 2.2 nmol 0.55 
6 nmol 3.2 nmol 0.53 
NTSB denaturing conditions 
moles of protein moles of chromophore ratio 
Papain 6 nmol 12.0 nmol 2 
Apo D 4 nmol 7.3 nmol 1.8 
6 nmol 12.3 nmol 2.1 
10 nmol 21.0 nmol 2.1 
Big 4 nmol 9.4 nmol 2.4 
6 nmol 14.7 nmol 2.4 
12 nmol 30.1 nmol 2.6 
10 nmol 26.0 nmol 2.6 
ratio- number of moles of chromophore per mole of protein 
the cysteines that form one of the disulphides may have been high enough for the 
reactions not being totally drawn into the chromophore production. This averaged effect 
would result in the determination of half a mole of chromophore per mole of protein. 
Then the value 2.5 may include the free -thiol, detected above, one of the disulphide 
bonds and "half' of another disulphide bond. 
In non -denaturing conditions, Blg produced one chromophore per mole of 
protein. The chromophore was being produced from the reaction with one of the 
disulphide bridges and not from the free -thiol, because the latter was not detected with 
Ellman's reagent. This is acceptable from the point of view of the three -dimensional 
structure since one of the disulphide bonds (Cys66 -160) is exposed to the solvent. This 
conclusion when associated with the half chromophore detected under denaturing 
conditions leads to the argument that the "difficult" disulphide bridge (the one that is not 
totally detected) is the Cys106 -119. This bond is situated between adjacent (3- strands 
and so its stability is reinforced by the extensive hydrogen bonding characteristic of this 
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Secondary structure element. For apo D under non -denaturing conditions, only half of a 
chromophore was detected. The existing three -dimensional model, based on the X -ray 
structure of insecticyanin (Ins) (Peitsch and Boguski, 1990), shows that the 
arrangement of the disulphide bonds is different from Blg. In apo D the disulphides are 
supposed to form between residues in the C- and N- terminae and residues situated in 
the middle of the sequence (Cys8 -114 and Cys41 -165). Both of these disulphide 
bridges are exposed to the solvent in the model. The result above, however, seems to 
indicate that one of the disulphides is more exposed than the other, even if not fully 
reactive. 
The simple conclusion from these experiments is that the apo D has one cysteine 
not involved in disulphide bond and that under the conditions of purification used is not 
present as a free -thiol. Thus, in the crystallization of apo D from GCDF it would be 
advisable to include reducing agents during the purification and crystallization 
procedure so that this reactive group can be used for specific heavy -atom binding. It 
may happen of course, that the cysteine is oxidized in vivo, by being involved in thio- 
ester, thio-ether connections or simply is present as cysteic acid. Balbín, et al., (1990) 
have sequenced apo D from GCDF and all cysteines were detected as cysteic acids; no 
mention is made of any unusual behaviour of the cysteines. Thus the possibility of the 
fifth cysteine sulfur being involved in covalent bonds with other molecules is very low. 
Just as a note, 67% of apo D in the plasma seems to be involved in inter -protein 
disulphide bonds with other apolipoproteins (Blanco -Vaca, et al., 1990; 1992). In that 
work, none of the heterodimers was purified by hydroxylapatite column, which may 
explain why no such complexes were observed for apo D from GCDF during this 
work. 
4.5 Protein / lipid interactions 
The interations of apo D with lipid vesicles have been previously observed in 
the formation of the lipoprotein 'particle, Lp -D, by disruption of HDL (McConathy and 
Alaupovic, 1973) and in the association of apo D to lipid vesicles described by Steyrer 
and Kostner, (1988). 
Lipid vesicles, with DPPC and cholesterol, with or without apo D were 
prepared as described in section 2.14. Gel filtration trace of the vesicles (FIG. 4.5) 
prepared in the presence of apo D, is quite different from the one obtained from a 
sample with only apo D. In the sample with lipid vesicles plus protein, apo D emerged 
earlier than in the runs of protein only, as concluded from running the fractions from 
the peaks in SDS -PAGE. This seems to indicate that the protein was associated to the 
lipid vesicles. 
The procedure used for the preparation of the vesicles is ideal to obtain small 
homogeneous structures mainly because of the sonication step. However, it could be 
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FIG. 4.5 Gel filtration traces of the lipid /apo D interaction work 
Top: trace sample containing of vesicles prepared with apo D 
Bottom: trace of sample containing apo D only 
For experimental conditions see sections 2.14 and 2.12 
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considered that the formation of protein -lipid complexes was only caused by the 
denaturation of the protein during sonication, as the denatured . protein would expose 
hydrophobic residues that would mediate the interaction with the lipids. To check that 
the association did not depend on denaturation, two different experiments were 
done:the protein was extracted from solution by triton X -114 as described in section 
2.15, and the secondary structural elements were determined by circular dichroism 
(section 2.10). 
Triton X -114 has a phase change at 20 °C; below 4 °C the detergent forms clear 
micellar solutions but above 20 °C two phases separate, a very dense, detergent -rich 
phase and a detergent -poor phase (Sánchez- Ferrer, et al., 1990). Any protein that 
associates strongly to the lipids will be extracted from the aqueous phase above 20 °C. 
In this case, apo D and Blg were added separately to the mixture at 4 °C. When the 
temperature was raised to 30 °C, Blg remained in the detergent -poor phase while apo D 
was extracted and was found in the detergent -rich phase (FIG. 4.6). This indicates that 
apo D characteristically associates with the detergent or hydrophobic phase. 
FIG. 4.6 SDS -PAGE of extraction of apo D by triton X -114 
Lane 1 and 2 - supernatant of apo D experiment before incubation at 30 °C, 
15 and 5 pi. Lane 3 and 4 - supernatant of apo D experiment after incubation at 
30 °C, 15 and 5 µl. Lanes 5 and 6 - loaded with the pellet formed after 
incubation at 30 °C of experiment with apo D. Lanes 6 and 7 - supernatant of 
Blg experiment before incubation at 30 °C, 15 and 5 Lanes 8 and 9 - 
supernatant of Blg experiment after incubation at 30 °C, 15 and 5 pl. For all 
cases the 5 and 15 pl aliquots were removed from samples at a protein 
concentration of 100 and 10 pg/ml, respectively. 
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The analysis of apo D secondary structure when associated to lipids or free in 
solution was done with circular dichroism as described in section 2.10. The spectra of 
the protein without lipids, associated to DPPC and cholesterol vesicles and in the 
presence-of 4% ethanol are presented in FIG. 4.7. The spectrum of lipid vesicles 
without protein showed negligible signal (data not shown) and no correction was 
applied to the protein -lipid complexes. By comparing the spectra it is visible that they 
are very similar over all the range. By analysing the spectra with the CONTIN 
algorithm (Provencher and Glöckner, 1981) the values for the secondary structure 
content were produced and the changes between native and the other two sets of 
conditions are presented on TABLE 4.3. The analysis at the 190 to 260 nm range 
provides, generally, only reliable secondary structure information on the amount of a- 
helix (Johnson,Jr.,1990). From the analysis of the spectra it is shown that apo D kept 
its integrity when associated to lipids with a small increase in the a -helix content. The 
apo D- ethanol mixture showed an increase in the amount of a- helix, as well. This was 
not observed for Blg (Dufour and Haertlé, 1990), which is supposed to have a similar 
structure, an increase of 3% in 13-sheet was detected only at a 20% ethanol concentration 
while the a -helix content increased at 30% ethanol. For apo D, all the determined 
changes can, however, be attributed to increased noise level in the range 190 -195 nm, 
at which the CONTIN algorithm is particular sensitive. It seems thus, based on these 
results alone, incorrect to withdraw conclusions about the efffect of polarity changes on 
the medium. It is clear, however, that the protein associates to lipid vesicles without 
denaturation. 
TABLE 4.3 Changes in a -helix content relative to native apo D 
conditions a -helix change 
pH 7.0, 4% ethanol, 0.3 mg/ml apo D, 0.02 cm cell path +5 ±2.3% 
pH 7.0, 0.165 mg/m1 apo D (associated to lipid vesicles), 
0.05 cm cell path +3 ±2.3% 
The DPPC and cholesterol vesicles with and without protein were observed in 
the electron- microscope as described in section 2.16. The samples without protein 
(FIG. 4.8) presented structures with an homogeneous globular aspect, with most 
























































































































FIG. 4.8 Electron- microscope photograph of lipid vesicles 
without apo D. Scale - 1 cm for 0.26 µm. 
FIG. 4.9 Electron- microscope photograph of lipid vesicles with 
apo D. Scale - 1 cm for 7.7x10-2 gm. 
`..frammP 
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organization. The protein -lipid complex samples were observed (FIG. 4.9) after partial 
fractionation to homogeneous size by gel filtration. Discoidal structures just like the 
ones described for other apolipoproteins like apo AI (Tall, et al., 1977; Guo, et al., 
1980) were present. These structures, already observed for apo D by Segrest and 
Kostner, (1988), have less of a globular aspect and under the conditions used for 
electron- microscopy can stack together. A model (FIG. 4.10) for the macromolecular 
organization of apo M discoidal particles was presented by Tall, et al., (1977) based on 
thermodynamic and electron- microscope considerations and was later confirmed by 
small angle X -ray scattering (Atkinson, et al., 1980). In this model the discoidal 
particles are composed of a single bilayer arrangement of the lipid with protein 
ddisposed around the edge covering the hydrophobic tails of the phospholopid. 
Apo AI is a typical apolipoprotein, its primary structure allows for a maximum 
flexibility and maximum interaction with the lipid, so as to stabilize the formation of the 
complex lipid particles (Segrest, et al., 1974; Boguski, et al., 1986). Free -apo AI has a 
variable a -helix content (around 54 %) which increases to -70% when associated with 
lipids in the discoidal complexes (Wald, et al., 1990) and it is the existence of several 
stretches of amphipathic a -helix that permits the association with lipids. Apo D in the 
plasma is a minor component of HDL (section 1.3.4.1), forming tight complexes with 
apo AI and LCAT but is also a member of the lipocalin structural family, sharing 
therefore the globular characteristics of Blg and the 
FIG. 4.10 Discoidal particles model 
The particle here depicted corresponds to each of the "segments" that form the 
stacked structures of FIG. 4.9 
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others. These proteins are very different from apolipoproteins; the free- energy of 
denaturation of the apolipoproteins is less than 4 kcal/mol while for Blg that value is 
22.3 kcal/mole, which is a high value even when compared with other globular proteins 
like lysozyme (9 kcal/mol) and ribonuclease (16.3 kcal/mol) (Pace and Vanderburg, 
1979; Boguski, et al., 1986). This high value results from a rigid and compact 
structure, mainly 5-sheet, as opposed to flexible apolipoprotein molecules which are 
mostly a- helix. 
There are some other facts that may be related to the association of apo D to the 
lipid vesicles. A Kyte -Doolittle hydrophobicity plot (Kyte and Doolittle, 1982) of apo D 
shows that there is a stretch of roughly 10 residues (115 -135) which is much more 
hydrophobic than any other part of the sequence (FIG. 4.11). Peitsch and Boguski, 
(1990) have noticed, in their apo D three -dimensional model, that those residues and 
others form a cluster of solvent exposed hydrophobic residues (Phe3, Leu5, Ile117, 
I1e118, Leu120, Phe121, Va1123) in two closely positioned loops that are part of the 
"mouth" of the pocket. They have postulated that the interaction with the lipid particle is 
established by this arrangement of apolar residues. 
The apparently contradictory behaviour of apo D, associating with lipid vesicles 
to form the same, albeit smaller (Steyrer and Kostner, 1988), discoidal particles as apo 
AI while remaining a water soluble, globular protein is certainly worth studying further. 
FIG. 4.11 Kyte -Doolitle hydrophilicity plot for apo D 
Hydrophobic parts of the molecule are represented when the tracing is below 
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4.6 Some solution studies: CD and gel filtration 
The pH- dependent conformation of apo D was analysed by circular dichroism 
and gel filtration. 
The far UV (190 -260 nm) circular dichroism spectra for apo D between pH's 
4.5 and 8.5 (in one pH unit intervals) are shown in FIG. 4.12 . They are clearly very 
similar except for the pH 8.5 spectrum, but the application of the CONTIN algorithm 
(Provencher and Glöckner, 1981) applied to the spectra at pH 7.5 and 8.5 produced 
very similar values for the secondary structure elements content: 
pH 7.5 
pH 8.5 
15±1.6% a -helix, 57 ±3.1% a- sheet, 27±2.7% remainder 
14 ±3.6% a- helix, 60±3.7% ß- sheet, 26 ±6.4% remainder 
The a -helix content is generally the only reliable determination at this range 
(Johnson,Jr., 1990). The value of 15% a -helix content is in a agreement with what is 
expected from other members of the lipocalin family, for example, Rbp and Mup are 
constituted of 7% of a -helix, and in particular Ins, which is a closer "relative" of apo 
D, presents 12 %. 
The near UV spectra (260 -320 nm) provide information about the aromatic side - 
chain environment in the protein. The spectra shown on FIG. 4.13, demonstrate a 
difference between pH's 4.5, 5.5, 8.5 and pH's 6.5, 7.5. This seems to indicate that 
there are conformational changes between pH 5.5 -6.5 and pH 7.5 -8.5. The 
conformational characteristics at the lower and higher range of pH analysed seem to be 
similar since the spectra are similar. 
Changes at lower pH are visible by gel filtration too. The chromatograms 
shown on FIG. 4.14, were from FPLC runs of pure apo D at pH 5.5 and 7.5. It is 
clear that a lower molecular weight peak was present at pH 5.5 and not at pH 7.5. 
Balbín, et al., (1990) have isolated apo D from GCDF by gel filtration at pH 6.0, under 
those conditions the protein had a retention time corresponding to 100 kDa. Therefore, 
apo D close to physiological pH, is thought to be a tetramer. Thus, the conformational 
change detected by circular dichroism between pH 5.5 and 6.5 could be associated with 
a change from a state (pH 5.5) where an equilibrium exists between a tetramer and 
monomer to a state (pH 6.0) where the tetramer predominates. This pH effect is 
observed as well for Blg where a conformational transition between pH's 6.5 and 7.5 is 
associated with a change in the components of the aggregation equilibrium (see section 
1.2). 
It was observed as well, that if SDS (López -Otín - personal communication) or 









































































































































FIG. 4.14 Chromatograms of gel filtration experiments 
Top: apo D run at pH 7.5 
Bottom: apo D run at pH 5.5 
fiA- 
FA- 
Abs. 280 nm 




Abs. 280 nm 
(scaled to major peak) 
Q0- 
P- 






purification of apo D by gel filtration at pH 6.0, the peak containing apo D emerged at 
lower molecular weight. This suggests that the interactions beween the subunits in the 
tetramer are dependent on an hydrophobic component too. 
The close association reported for apo D and apo AI in the plasma (section 
1.3.1), led to the attempts to form a complex between these two proteins without the 
presence of lipids. The possibility of forming a complex was explored by a series of 
experiments described in section 2.11. In these experiments apo AI and apo D were 
mixed together at different pHs before or after previous denaturation by guanidinium 
chloride. In the latter case, step dialysis was carried out to remove the denaturant. The 
samples were run in a gel filtration column so that any new molecular complexes 
formed could be detected. No new peaks were observed in any of the differing sets of 
conditions. That is not totally unexpected because the reports mentioning an interaction 
between apo AI and apo D (see section 1.3.1) are not clear as to the nature of the 
interaction, whether it is protein -protein or a lipid mediated. These experiments are 
inconclusive and so do not favour any of the possibilities. 
4.7 Deglycosylation of apo D 
The initial intention of the work with apo D was its crystallization. It was 
expected to be a difficult problem since the sugar residues (18% in weight for plasma 
apo D) increase the heterogeneity of the protein samples and reduce the probability of 
obtaining crystals (Lorber and Giegé, 1992). Thus, it was neccessary to determine 
conditions for partial or total removal of the sugars. 
In the first instance, the removal of neuraminic acid was studied. This sugar is 
charged and is known to be responsible for the existence of several isoforms of plasma 
apo D (Kamboh, et al., 1989). Digestion with neuraminidase (section 2.9.1) resulted in 
a slight shift to lower molecular weight in SDS -PAGE (FIG. 4.15). 
To confirm this result, the chemical determination of the amount of sialic acid 
still present after enzymatic digéstion was carried out (section 2.9.1.1), and from two 
different assays it was concluded that 87% of the neuraminic acid was removed. 
Unfortunately, the removal of neuraminic acid does not result in a homogeneous band 
in SDS -PAGE. This may indicate that other factors, the rest of the sugar chain for 
example, cause the non -homogeneous behaviour of the protein in the gel and therefore 
the diffuse band. 
Total deglycosylation was attempted by both enzymatic and chemical 
procedures. The total enzymatic digestion of apo D sugars was tried (section 2.9.2) 
with a "cocktail" of two enzymes that were a priori the most suited, since they are 
relatively non -specific to the type of sugar structures. The initial trial with and without 
n- octylglucoside in the incubation mixture, resulted in a small migration change in 
SDS -PAGE (FIG. 4.16). The apo D band still presented a diffuse aspect and the 
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FIG. 4.15 SDS -PAGE of neuraminidase digested apo D 
Lane 1 - non -digested apo D, lane 2 - apo D digested with 
neuraminidase. 
1 2 
FIG. 4.16 Preliminary digestions with endoglycosidases 
Lane i- non -digested apo D, lane 2 - apo D digested with endoglycosidases, 
lane - 3 apo D digested with endoglycosidases in the presence of n- 
octylglucoside. Lane 4 - molecular weight markers. 94, 67, 43, 30, 20, 14 kDa 
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change in molecular weight was very small. Both facts indicate that the digestion is far 
from complete. In fact, it is not uncommon that steric hindrance will prevent effective 
action of the endoglycosidases and denaturation of the glycoprotein is recommended for 
a complete digestion (Biochemica Information, Boehringer Mannheim). 
In the following trial of conditions, guanidinium chloride or SDS was present in 
the incubation mixture. All of the trials were done under reductive conditions by adding 
mercaptoethanol. Apo D was boiled in the presence of SDS, after which n- 
octylglucoside was added before the enzyme to prevent its denaturation by 
SDS(Biochemica Information, Boehringer Mannheim). After incubation with 
guanidinium chloride, n- octylglucoside was added in an attempt to keep the protein 
denatured (stabilizing the solvent exposed hydrophobic regions) while the denaturant 
was removed by dialysis. The SDS -PAGE (FIG. 4.17) of both samples shows an 
improvement in the deglycosylation relative to the conditions where no denaturation 
occurred, because the decrease in molecular weight was larger. Another interesting 
point is that the the diffuse aspect of the protein bands was reduced, as can be seen by 
comparing SDS or guanidinium chloride lanes with the controls. These facts point to a 
digestion of the carbohydrate moiety when denaturation of the protein occurs; however 
the digestion does not seem to be total because, even in the trial where the protein was 
boiled in the presence of SDS and mercaptoethanol, the apparent molecular weight of 
the protein is far from that expected from the amino acid sequence (19 kDa). From this 
set of experiments, guanidinium chloride emerged as a promising starting point of the 
search for better conditions. 
On FIG. 4.18, an SDS -PAGE of several trials of different conditions is 
displayed. The conditions were: 
with native apo D 
lane 2) guanidinium chloride + n- octylglucoside 
lane 3) guanidinium chloride + chaps 
lane 4) guanidinium chloride + mercaptoethanol 
lane 5) guanidinium chloride + n- octylglucoside + mercaptoethanol 
lane 6) SDS + mercaptoethanol + n- octylglucoside 
with apo D after neuraminidase digestion 
lane 7) guanidinium chloride + n- octylglucoside 
lane 8) guanidinium chloride + chaps 
lane 9) guanidinium chloride + mercaptoethanol 
lane 10) SDS + mercaptoethanol + n- octylglucoside 
The conclusions from this set of conditions were: mercaptoethanol is essential 
for a successful deglycosylation because it facilitates the denaturation of the protein, 
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FIG. 4.17 SDS -PAGE of endoglycosidases digestion under 
denaturing conditions 
Lane 1 - apo D incubated with endoglycosidases after denaturation with SDS 
and boiling and reduction with mercaptoethanol, lane 2 - apo D incubated with 
endoglycosidases after denaturation with guanidinium chloride and reduction 
with mercaptoethanol, lane 3 - apo D incubated with no denaturant but reduced, 
lane 4 - apo D incubated in the same conditions as lane 3 but without enzyme. 
Lane 5 - molecular weight markers. 94, 67, 43, 30, 20, 14 kDa 
1 2 3 4 5 
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FIG. 4.18 SDS-PAGE of apo D deglycosylation 
Lane 1 - non -digested apo D, lane 2 - apo D + Guanidinium chloride (GnC1)+ 
n- octylglucoside, lane 3 - apo D + GnC1 + chaps, lane 4 - GnC1 + 
mercaptoethanol (SH), lane 4 - apo D + GnC1 + n- octylglucoside + SH, lane 6 - 
apo D + SDS + n- octylglucoside + SH, lane 7 - apo D pre -digested with 
neuraminidase (apo D N -) + GnCI +n- octylglucoside, lane 8 - apo D N- + GnC1 
+ chaps, lane 9 - apo D N- + GnC1 +SH, lane 10 - apo D N- + SDS + SH + n- 
octylglucoside. 
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detergents (besides stabilizing the enzyme) do not influence the outcome of the 
experiment and the previous removal of neuraminic acid does not influence the removal 
of the remaining sugars. 
The need for extensive denaturation and reduction of apo D to obtain reasonable 
deglycosylation, raises the problem of refolding the protein after deglycosylation. 
Further, the enzymatic deglycosylation seems not to be complete since the digested 
protein never presents in SDS -PAGE, the molecular weight expected from the 
sequence. It most be noted, as well, that the high cost of the enzymes makes the 
procedure almost prohibitive. 
The chemical approach was followed by using the trifluoromethane sulphonic 
acid (TFMS) method described in section 2.9.3. Edge, et al., (1981) have discussed 
the influence of temperature on the deglycosylation by TFMS, particularly on the 
degradation of the proteic part of the molecule. Based on that report, trials at room 
temperature, 0 °C and -10 °C were setup and incubated for different times. The samples 
were run in SDS -PAGE and two of the gels are shown on FIG. 4.19. The higher the 
temperature, the earlier the protein was observed to degrade, as is concluded by 
comparing the 3 hour trial at room temperature with the 4 hour incubation at 0 °C. 
Another fact observed was that no one set of conditions resulted in the formation of a 
single band. In fact, several populations were formed as seen by the many bands on the 
gels. One band was detected just below the 20 kDa standard that could have been the 
totally deglycosylated protein, but still the majority of the protein only showed a small 
molecular weight shift. 
It is not clear if the total removal of sugars occurred or not, in either of the two 
methods. Another procedure, more specific than SDS -PAGE for the presence of sugars 
will have to be used to determine if deglycosylation is effective or not. 
4.8 Apo D crystallization attempts 
The methods described in section 2.18 were applied on either native apo D or 
neuraminidase digested apo D, after neuraminidase extraction (see section 2.9.1.2). 
The "incomplete factorial experiment" should have provided information about 
the most favourable factors (type of precipitant, pH, importance of ions, etc.) for 
crystallization. The procedure is very dependent on the grading of the results and when 
no crystals appear it becomes "tea leaf reading" because distinctions between 
amorphous precipitate and crystalline precipitate, which are not always clear cut, have 
to be established. 
No crystals were observed with the "sparse matrix" method, either. 
For both types of samples the results were discouraging, no crystals were 
grown probably because these samples are still very non -homogeneous as seen by the 
diffuse bands formed in SDS -PAGE. 
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FIG. 4.19 SDS -PAGE of chemical deglycosylation trials 
Top gel: lanes 1 to 3 - apo D incubated at -10 °C for 48, 25 and 8 hours 
respectively. Lanes 5 to 7 - apo D incubated at 0 °C for 12, 8 and 6 hours, 
respectively. Lane 4 - molecular weight markers. 
Bottom gel: lanes 1 and 2 - apo d incubated at 20 °C for 3 and 1 hour, 
respectively. Lanes 4 to 6 - 5 µl of apo D incubated at 0 °C for 4, 2 and 1 hours 
respectively. Lanes 7 to 9 - the same as 4 to 6 but 1 p.1 of solution. Lane 10 - 
non- incubated apo D. Lane 3 - molecular weight markers. 94, 67, 43, 30, 20, 14 kDa 
1 2 3 4 5 6 7 
IV 
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4.9 Ligand binding studies 
Apo D has long been thought to be a small hydrophobic molecule carrier 
(Chajek and Fielding, 1978). This idea was reinforced by its inclusion in the lipocalin 
family (Drayna, et al., 1986) and finally confirmed by the discovery that the 
progesterone -binding protein from gross -cystic disease fluid was apo D (Balbín, et al., 
1990). The method chosen to evaluate the binding of molecules was fluorescence 
spectroscopy, in particular the detection of quenching of the protein fluorescence. This 
technique has been used for ligand- binding studies with many proteins (Ward, 1985) 
and in particular with Big (see section 1.2). In Blg, the existence of one tryptophan in 
the pocket provides a good reporting group of any change in its environment. Human 
apo D has four tryptophans, of which, according to the three- dimensional model 
(Peitsch and Boguski, 1990), two are situated inside the pocket. Because of this, it was 
thought that the signal obtained would be sensitive to the binding of ligands. The other 
reason for choosing fluorescence quenching was the speed of each titration. Like most 
spectrophotometric phenomena (Bagshaw and Harris, 1987), fluorescence changes 
may be detected instantaneously, which is particularly important in cases where 
degradation of any component of the system is probable, like the oxidation of the 
ligands tested in this work. 
The ethanol used to dissolve the ligands, was observed to quench the 
fluorescence of apo D (FIG. 4.20). In order to eliminate the possibility that the effect 
FIG. 4.20 Ethanol quenching 
Plotted is the ratio between initial protein fluorescence (no ethanol present) and 
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was associated with protein conformational changes, during which the binding 
properties would be altered, several controls were made. The emission spectra at 
different ethanol concentrations were measured (FIG. 4.21), and no wavelength shift 
of the maximum of emission with increasing ethanol concentration was observed, 
indicating that no major conformation change was happening since the solvent - sheltered 
fluorescent groups were not being exposed. The absorbance spectra of apo D (240 -350 
nm), registered in the presence of ethanol within the concentration range 0 -4 %, did not 
reveal any changes besides a rise in the overall base line. The circular dichroism 
spectrum of apo D in the presence of 4% ethanol was registered between 190 -260 nm 
and compared to the native spectrum (FIG. 4.7). The analysis of the spectra with the 
FIG. 4.21 Emission 









CONTIN algorithm produced a 5% increase in a -helix content. However, it was 
noticed that the spectra were superimposable except for the 190 -200 nm range, where 
noise was clearly greater. Thus, it was pointed out (Ms.S. Kelly and Dr.N. Price from 
the CD Scottish facility at Stirling University -personnal communication) that the 
differences determined by the analysis algorithm were most certainly due to the noise 
increase in that range. All these facts indicate that no major conformational change 
occurs in the range of ethanol concentrations to which apo D was exposed. The ethanol 
effect was removed from the ligand titration curves by subtraction of the ethanol 
quenching from the overall ethanol/ligand quenching. 
The titration curves for progesterone and cholesterol, after correction for ethanol 
and protein concentration, are presented in FIG. 4.22. These two molecules were used 
FIG. 4.22 Cholesterol and progesterone titration curves 
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to test the method because it was known that progesterone (Lea, 1988; Dilley, et al., 
1990) was a strong ligand and cholesterol (Lea, 1988) was demonstrated not to bind to 
apo D. The marked difference between the titration curves, showing that progesterone - 
quenched protein fluorescence reaches a saturation point while cholesterol did not affect 
the fluorescence at all, demonstrate that the method was adequate for detection of 
binding. 
By chance, (the molecule was available in the laboratory following an X -ray 
structure determination) EP092 was tested and shown to bind (FIG. 4.23). It is an 
analogue of prostaglandins (Wilson and Jones, 1985), an antagonist of thromboxane 
A2, and so led to the search among the prostaglandins and related compounds, for 
molecules with affinity for apo D. The titration curves of the few tested: prostaglandin 
El, prostaglandin F2a, prostaglandin D2, arachidonic acid, 12 -HETE and 5,15 - 
diHETE (hydroxy and dihydroxyeicosatetranoic acid) are presented in HG. 4.23. Only 
FIG. 4.23 Prostaglandins and related compounds titration curves 
1- EP092, 2- prostagl.D2, 3-prostagl.F2a, 4- prostagl.E1, 5-arachidonic acid, 
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arachidonic acid and EP092 demostrated affinity for apo D as judged by the quenching 
of apo D fluorescence. Leukotriene D4 was tried too, but this compound has a strong 
'absorption band at 280 nm and the emission spectra of the protein and small molecule 
are then superimposed. Not even with correction for the inner filter effect was it 
possible to separate the two signals. On the other other hand, the correction for the 
inner filter effect was necessary and successful in the case of EP092. In FIG. 4.24, the 
inner filter effects from several ligands are plotted from which the difference in the 
behaviour of EP092 from other ligands can be clearly seen. 
A small series of fatty acids (arachidonic (C20 :4), linoleic (C18:2), oleic 
(C18:1) and palmitic (C16:0)) and one phospholipid (dipalmitoyl phosphatidyl choline) 
were tested. Only arachidonic, as seen above, showed any affinity for apo D. 
The analysis of the data for the extraction of association constants and number 
of binding sites per protein molecule was done with the help of Dr.G. Atkins, 
Biochemistry Department, University of Edinburgh. The simplest model used to 
explain the binding, where one molecule of protein binds an unknown number of 
molecules of ligand with the same affinity and in a random order, fitted the data. This 
same model was tested with the data extracted from FIG.6 in Dilley, et al., (1990), 
where binding was determined by gel filtration separation of the bound from unbound 
ligand. The values obtained for number of binding of sites and association constant 
were very similar to the ones presented in that report, conferring validity to the chosen 
model. 
The calculated fluorescence drop, function of the number of binding sites (n), 
dissociation constant (Kd) and a concentration -fluorescence conversion factor (q) was 
fitted by a non - linear regression programme written by Dr.G. Atkins to the 
experimental data as function of the total concentration of ligand. It was observed, for 
all ligands, that q was highly correlated with n and no good estimation of these values 
could be obtained. On the other hand the value for the dissociation constant was 
invariable, within the experimental error. The reason for the "bad behaviour" of q and n 
can be understood by a non -constant fluorescence drop for each newly occupied site in 
the apo D tetramer. This sort of effect was observed for lactate dehydrogenase 
(Holbrook, 1972), where the fluorescence presented a non -linear relation with the 
fraction of occupied binding sites. In fact, if [Lig] /a versus 1 /(1- a) is plotted for the 
apo D titration with progesterone it results in a non -straight line ([Lig] is the total ligand 
concentration, a is the fraction of occupied binding sites which is equal to Fo-F/Fo- 
Fmin, with Fo being the protein fluorescence with no ligand bound, Fmin the protein 
fluorescence with all the sites occupied and F the fluorescence at each point of the 
titartion curve). This, according to Ward, (1985) and Bagshaw and Harris, (1987) is 
due either to non -linearity between a and F or to cooperativity effects. Since the latter 
effect was not observed by Dilley, et al., (1988) and an attempt to apply, to the 
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fluorescence data, a model that would account for the cooperative effect was 
unsuccessful, then the non -linear fluorescence quenching effect must be present and be 
the reason for the non -determination of the number of binding sites. 
The association constants determined for the ligands were the following: 
progesterone - 2.1 ±1x106 M -1 which is close to the value determined 
by Dilley, et al., (1990) - 1.0x106 M-1 and Lea, (1988) - 1.3x106 M -1. 
EP092 - 1.2 ±1x106 M -1 
arachidonic acid - 4.1 ±4x107 M-1 
FIG. 4.24 Inner filter effect 
1- EP092, 2- cholesterol, 3- prostagl.D2, 4- prostagl.F2a, 5- prostagl.E1, 6- 




































This study confirmed the affinity of apo D for progesterone, which was known 
to present the highest association constant among the steroids studied (see TABLE 1.6). 
Any of these steroids exist in the gross -cyst disease fluid at concentrations several fold 
higher than in plasma (Bradlow, et al., 1981), but progesterone is present at a 
concentration (1.5x10 -5 M) at which it will, probably, be the major ligand of the 
protein in the cyst fluid. 
The first role proposed for apo D was that it was involved in cholesterol 
metabolism in the HDL (see section 1.3.4.1), where the protein would either be an 
activator of LCAT or a transfer protein of the cholesteryl- esters formed. Peitsch and 
Boguski, (1990) have shown some evidence that cholesterol has low affinity for apo D 
and proposed, based on the three -dimensional model then presented, that the affinity 
for cholesteryl- esters would be weak too. The work of Lea, (1988) showed that apo D, 
as GCDF -24, had very little affinity for cholesterol. This result has now been 
confirmed by fluorescence quenching. Unfortunately, it was not possible to study 
cholesteryl- esters due to their low solubility in the solvent and another method will have 
to be used to determine the affinity of apo D for these molecules and to understand fully 
the role of apo D in the HDL. 
Two new ligands, arachidonic acid and EP092, were found for apo D. The 
latter is an analogue of prostaglandins and led to the testing of several of these 
compounds including arachidonic acid. This ligand, arachidonic acid, is a very 
important molecule because it is the precursor (FIG. 4.25) of prostaglandins, lipoxins, 
thromboxanes, leukotrienes and eicosatetraenoic acids. Interestingly, none of the 
metabolites of arachidonic acid that were tried demonstrated any affinity for apo D. This 
is not surprising, considering that the molecules tried are more hydrophilic than 
arachidonic acid. As a note, the close resemblance of EP092 and thromboxane A2 may 
indicate that this compound may bind too. The small series of fatty acids tried revealed 
a high specificity for arachidonic acid, which is most probably due to the "flat" part of 
the molecule induced by the four cis double bonds. The association constant determined 
for arachidonic acid is 10 -fold higher than the one for progesterone making it the 
strongest apo D ligand known to the moment. 
The relevance in vivo of a ligand found in vitro is difficult to establish without 
further experimental work but a small summary about the biology of the eicosanoids 
will now be presented and some points will emerge that can be considered to be 
relevant. 
These compounds, the eicosanoids, are involved in a wide variety of biological 
phenomena, from platelet aggregation, sensitization to pain, involvement in 
inflammation, neurotropic effects, chemotactic action on leukocytes, and many others 
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(von Euler, 1988). The full understanding of their action is far from clear and is 
impaired due to their multiple, complex, and sometimes contradictory, action. 
However, it is accepted that these compounds are produced locally, throughout the 
organism and are not pre - stored (Deby, 1988) and, because of that, the major step - 
dependent factor for their production is the presence of the precursors, arachidonic 
acid, eicosapentanoic acid and homo -y- linolenic acid. Arachidonic acid is produced 
from one of the essential fatty acids, linoleic acid, and is stored in the form of 
phospholipids (in any cellular membrane, and in lipoproteins), triglycerides (only in the 
renal medulla) and cholesteryl -ester (in lipoproteins). The release of arachidonic acid 
from these non -active forms depends mainly upon the regulation of the activity of 
phospholipases A2 and C on the membrane phospholipids, of LCAT (lecithin - 
cholesterol acyltransferase), and of a cholesterol- esterase (Behrman and Armstrong, 
1969). It is through its association with LCAT (section 1.3.1), that apo D may have a 
role to play in the metabolism of arachidonic acid. LCAT is known to be able to act as a 
phospholipase and as an esterase separately (Kitabatake, et al., 1979; Francone, et al., 
1993), but its usual role is a conjunction of the two activities by forming cholesteryl- 
esters from cholesterol and phosphatidylcholine. It is possible to envisage a role for apo 
D in the retention of arachidonic acid, avoiding further metabolisation and therefore 
resulting in a "fast" mobilization reserve. It is interesting too, that both apo D (see 
section 1.3) and the eicosanoids are involved in growth/regeneration processes. In fact, 
arachidonic acid metabolism has direct connections with cyclic adenosine 
monophosphate formation (Lagarde, 1988) in, for example, sensitization to pain, 
activity of nervous cells and cell proliferation. Apo D, on the other hand, is over - 
expressed during regeneration of peripherial rat nerve and during the non -growth stages 
of several cell lines, in particular cancerous cells. Thus, the presence of the two 
molecules can be related, apo D acting as a carrier of arachidonic acid to or from the 
"hot spot ". In conclusion, the binding of arachidonic acid by apo D constitutes the 
establishment of a connection between the many apparently non -related biological 
situations where the protein is found. 
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FIG. 4.25 Prostaglandins and related eicosanoids 
Diagram describing the metabolic conversion of these compounds. 
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5. Conclusions and prospects 
This chapter will repeat and summarize the observations and discussions 
already made in the previous sections. An attempt will be made to connect some aspects 
from different sections. 
5.1 Blg 
Bovine ß- lactoglobulin was studied by crystallographic techniques, and the 
structure of the crystal form B1gZ (space group P3221) was redetermined. The need for 
this redetermination arose from the inconsistencies between the medium resolution 
published structure (Monaco, et al., 1987) and the low resolution study by Green, et 
al., (1979), in particular the different packing of the protein molecules. By molecular 
replacement using the existing models of B1gY (model solved from crystal form in 
space group B2212) and Mup it was possible to confirm the low resolution findings 
that the protein crystallizes as a dimer and not as stated by Monaco, et al., (1987) in a 
high polymeric aggregation state. This led to the conclusion that the latter work was 
incorrectly approached which may have happened in the determination of the heavy 
atom positions using an unconventional origin choice and subsequent calculation of 
electron -density in the International Tables setting. Though improbable, it is possible 
that the crystals used in that work belong to yet another crystal form, different from the 
one studied here. 
The re- solution of BlgZ by the heavy atom replacement method, produced a 
new molecular model that is different from any of the models available for Blg and in 
particular from the BlgY model, from which all the other models have been obtained. 
The phases determined from the derivatives data were refined and extended by solvent 
flattening so that model building could be initiated. Further improvement of the 
electron- density map was achieved by partial model phase combination before a model 
including 158 residues was finished. 
This model was compared to the existing model of B1gY. It was clear that the 
overall folding was not changed but that sequence shifts or threading shifts were 
applied on two stretches of the structure. The first stretch includes the second and third 
13- strands and flanking loops (residues 29 to 65), where a five residue movement of the 
sequence towards the N- terminus took place. This resulted in the shortening of the loop 
between the third and fourth ß- strands while extending the loop between the first and 
second 13-strands. A similar change affected the last f3-strand, where a two residue 
sequence shift towards the C- terminus was applied. This strand is the one responsible 
for the monomer -monomer interaction and so the residues responsible for the integrity 
of the dimer have been changed. 
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The quality of the new model can be evaluated by a series of factors. A lower 
residual of the new model when compared to the B1gY molecular replacement solution 
after a dynamics procedure (23% versus 26 %) indicates a better fit of the new model to 
the data. The changes applied seem to be chemically reasonable like the movement of 
two charged side -chains (Asp53 and G1u51) from the inside (hydrophobic 
environment) to the outside of the pocket (a more solvent exposed position) and the 
sheltering of two of the three solvent exposed residues (11e56, Leu57 and Leu57) that in 
B1gY are present in the loop between the third and fourth strands. The programme 
PROFILE confirmed the improvement in the new model since the plot of the averaged 
environment score does not present stretches below or close to zero which are observed 
for the B1gY model. The "bad" B1gY stretches revealed by that plot, map the stretches 
where the two models are different therefore conferring certainty to the changes 
applied. It must be emphasised that the differences between the models resulted from 
the incorrect interpretation of the B1gY density and not from conformational changes or 
different crystal packing constraints. 
The structure still needs manual intervention at several points, in particular in 
some loops and the final refinement will take place in the near future, making use of a 
complete, high redundancy, 2.8 A resolution image plate data set, collected at the 
Daresbury synchrotron. If the refinement procedes as expected, confirming the validiy 
of this model then it may be used to correct B1gY and B1gX and therefore make use of 
the very high resolution diffraction data, typically 2.0 -1.9 A, available for these two 
crystal forms. 
The co- crystallization of Blg with ascorbic acid resulted in marked changes in 
the crystal structure, which have not yet been characterized. Future work will be based 
on the refinement of the model with the bound ligand, this will hopefully provide a 
clear picture of what residues are essential for binding and what conformational 
changes, if any, occur during binding. The extension of the same approach to other 
ligands will be important so that the relevance of the pocket and the possible existence 
of other binding sites can be evaluated. 
5.2 Apo D 
Apo D was purified both from plasma and gross -cystic disease fluid but the 
latter source was preferred for regular preparation of protein. The studies involving this 
protein covered several aspects of its biochemistry, in particular the analysis of cysteine 
residues, protein / lipid interactions, pH dependent conformational changes and ligand 
binding studies. Crystallization of native and partially carbohydrate -digested apo D was 
also attempted. 
The analysis of the cysteines revealed that from the five residues present in apo 
D, four seem to be forming disulphide bonds, and the remaining one is oxidized either 
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as cysteic acid or, more improbably, as a thio -ester or thio- ether. 
The association of apo D to lipid macro- structures was demonstrated for 
dipalmitoyl lecithin/cholesterol vesicles and Triton X -114. The observation by CD, that 
the content of a -helix does not increase very much upon lipid vesicle association 
clashes with the formation of discoidal particles which are typically the result of 
interaction between apolipoproteins and lipid vesicles. If apo D belongs to the lipocalin 
structural family then it will share their compact, mainly 0-sheet three -dimensional 
characteristics which are quite different from the apolipoproteins, a -helix structures 
responsible for the stabilization of the lipid particles. The interaction between apo D and 
the lipid structures could be established by the hydrophobic peptide clearly seen in 
Kyte -Doolittle hydrophobicity plots. Peitsch and Boguski, (1990) have also postulated 
that this same peptide forms an hydrophobic loop close to the mouth of the pocket, 
interacting with the HDL and allowing an easy access of any ligand from the lipid 
moiety to the protein. There is as well, the possibility of having a cysteine forming a 
thio-ester bond with a fatty acid, like the one observed for ADP- ribosylation factor, 
which would be in line with the oxidized cysteine and the formation of apo D -lipid 
complexes. More experimental work is necessary to establish the nature of the apo D 
binding to lipid vesicles, in particular the determination of what part of the molecule 
establishes the hydrophobic contacts and how does the apo D structure fit the model for 
the discoidal particles. 
The pH dependent conformational changes observed for apo D are similar to the 
ones observed for Blg, where the changes in CD spectra are associated with 
aggregation changes. But while in Blg these can be physiologically important because 
the protein when ingested as part of milk goes through a series of pH changes without 
denaturation, for apo D no immediate relevance can be seen for these conformational 
alterations since all the biological situations where apo D has been reported share the 
extracellular, controlled pH characteristic. 
Finally, the ligand binding studies using fluorescence quenching have produced 
a new molecule which seems to present a higher affmity for apo D than any other so 
far. The importance of arachidonic acid for the biological role of apo D is evident as 
well, since it could provide a link between the different and apparently unrelated 
biological phenomena with which apo D is involved. Thus, apo D might, stop 
convertion of this fatty acid to its cholesterol -ester in the HDL, forming a fast 
mobilization reserve. At the cellular level, it might be used to excrete the excess of 
arachidonic acid and therefore stop its action as a precursor of prostaglandins and 
related compounds. These hypotheses have to be confirmed by determining the nature 
of the molecules that apo D binds when associated to LCAT (lecithin- cholesterol 
acyltransferase) and apo AI in HDL and by analysing the effects of the presence of apo 
D on the growth processes of some cancer cell lines. 
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Another approach for the understanding of many of these aspects would be to 
_determine the three -dimensional structure of this protein. This would certainly provide 
information about the possible areas of interaction with lipids and would allow an 
examination of the pocket, determining the causes for a higher specificity for ligands 
than is found with Blg, for example. Unfortunately, it seems improbable that the 
protein will crystallize while the heterogeneity caused by the sugars has not been 
reduced. This can be achieved by cloning and expressing the protein in a organism that 
either does not insert sugars in proteins, like E. coli, or that adds carbohydrate chains 
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REMARK FILENAME= "slowc model3.pdb" 
REMARK Written by 0 version 5.8, Thu Nov 26 09:29:04 MET 1992 
REMARK Sun Mar 21 15:47:29 1993 
REMARK DATE:20- Apr -93 04:01 :51 created by user: 
ATOM 1 CB THR 4 20.781 20.073 15.153 1.00 15.00 
ATOM 2 OGl THR 4 20.263 19.851 13.804 1.00 15.00 
ATOM 3 HG1 THR 4 20.920 20.101 13.138 1.00 15.00 
ATOM 4 CG2 THR 4 22.105 19.297 15.407 1.00 15.00 
ATOM 5 C THR 4 18.497 20.549 16.225 1.00 15.00 
ATOM 6 0 THR 4 17.513 20.165 15.583 1.00 15.00 
ATOM 7 HT1 THR 4 19.689 17.471 16.096 1.00 15.00 
ATOM 8 HT2 THR 4 18.986 18.443 14.915 1.00 15.00 
ATOM 9 N THR 4 19.159 18.343 15.941 1.00 15.00 
ATOM 10 HT3 THR 4 18.185 18.283 16.312 1.00 15.00 
ATOM 11 CA THR 4 19.729 19.643 16.265 1.00 15.00 
ATOM 12 N GLN 5 18.517 21.715 16.878 1.00 15.00 
ATOM 13 H GLN 5 19.287 21.937 17.440 1.00 15.00 
ATOM 14 CA GLN 5 17.370 22.615 16.983 1.00 15.00 
ATOM 15 CB GLN 5 16.818 22.934 15.527 1.00 15.00 
ATOM 16 CG GLN 5 15.946 24.205 15.499 1.00 15.00 
ATOM 17 CD GLN 5 15.312 24.640 14.170 1.00 15.00 
ATOM 18 0E1 GLN 5 14.093 24.861 14.058 1.00 15.00 
ATOM 19 NE2 GLN 5 16.091 24.790 13.094 1.00 15.00 
ATOM 20 HE21 GLN 5 17.045 24.587 13.151 1.00 15.00 
ATOM 21 HE22 GLN 5 15.640 25.102 12.284 1.00 15.00 
ATOM 22 C GLN 5 16.329 21.961 17.928 1.00 15.00 
ATOM 23 0 GLN 5 15.765 20.893 17.753 1.00 15.00 
ATOM 24 N THR 6 16.294 22.528 19.107 1.00 15.00 
ATOM 25 H THR 6 16.889 23.273 19.325 1.00 15.00 
ATOM 26 CA THR 6 15.385 22.164 20.179 1.00 15.00 
ATOM 27 CB THR 6 16.080 21.347 21.270 1.00 15.00 
ATOM 28 0G1 THR 6 17.481 21.593 21.206 1.00 15.00 
ATOM 29 HG1 THR 6 17.934 20.974 21.797 1.00 15.00 
ATOM 30 CG2 THR 6 15.816 19.887 21.096 1.00 15.00 
ATOM 31 C THR 6 14.963 23.512 20.750 1.00 15.00 
ATOM 32 O THR 6 15.644 24.531 20.593 1.00 15.00 
ATOM 33 N MET 7 13.810 23.573 21.371 1.00 15.00 
ATOM 34 H MET 7 13.300 22.750 21.506 1.00 15.00 
ATOM 35 CA MET 7 13.267 24.822 21.861 1.00 15.00 
ATOM 36 CB MET 7 11.800 24.438 22.254 1.00 15.00 
ATOM 37 CG MET 7 10.759 25.515 22.519 1.00 15.00 
ATOM 38 SD MET 7 10.456 26.506 21.032 1.00 15.00 
ATOM 39 CE MET 7 11.601 27.865 21.129 1.00 15.00 
ATOM 40 C MET 7 14.109 25.463 22.991 1.00 15.00 
ATOM 41 0 MET 7 15.139 24.961 23.448 1.00 15.00 
ATOM 42 N LYS 8 13.704 26.652 23.418 1.00 15.00 
ATOM 43 H LYS 8 12.954 27.068 22.967 1.00 15.00 
ATOM 44 CA LYS 8 14.252 27.297 24.591 1.00 15.00 
ATOM 45 CB LYS 8 14.380 28.822 24.438 1.00 15.00 
ATOM 46 CG LYS 8 14.905 29.598 25.671 1.00 15.00 
ATOM 47 CD LYS 8 14.855 31.128 25.512 1.00 15.00 
ATOM 48 CE LYS 8 15.857 31.567 24.416 1.00 15.00 
ATOM 49 NZ LYS 8 15.807 32.994 24.097 1.00 15.00 
ATOM 50 HZ1 LYS 8 14.869 33.234 23.717 1.00 15.00 
ATOM 51 HZ2 LYS 8 16.537 33.216 23.390 1.00 15.00 
ATOM 52 HZ3 LYS 8 15.982 33.544 24.962 1.00 15.00 
ATOM 53 C LYS 8 13.133 26.984 25.550 1.00 15.00 
ATOM 54 0 LYS 8 12.769 25.819 25.638 1.00 15.00 
ATOM 55 N GLY 9 12.456 27.922 26.212 1.00 15.00 
ATOM 56 H GLY 9 12.556 28.872 26.019 1.00 15.00 
ATOM 57 CA GLY 9 11.502 27.583 27.233 1.00 15.00 
ATOM 58 C GLY 9 10.253 27.114 26.565 1.00 15.00 
ATOM 59 0 GLY 9 9.416 27.908 26.141 1.00 15.00 
ATOM 60 N LEU 10 10.191 25.819 26.359 1.00 15.00 
ATOM 61 H LEU 10 10.985 25.277 26.554 1.00 15.00 
ATOM 62 CA LEU 10 9.013 25.207 25.825 1.00 15.00 
o o o o o o o o o o o o o o o o o o o o o o o o o O




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ATOM 129 C GLY 17 -5.444 21.646 21.040 1.00 15.00 
ATOM 130 0 GLY 17 -4.931 20.526 21.170 1.00 15.00 
ATOM 131 N THR 18 -5.943 22.098 19.871 1.00 15.00 
ATOM 132 H THR 18 -6.133 23.045 19.739 1.00 15.00 
ATOM 133 CA THR 18 -6.065 21.323 18.639 1.00 15.00 
ATOM 134 CB THR 18 -7.395 21.631 17.905 1.00 15.00 
ATOM 135 001 THR 18 -7.601 23.047 17.990 1.00 15.00 
ATOM 136 HG1 THR 18 -8.130 23.315 17.221 1.00 15.00 
ATOM 137 CG2 THR 18 -8.573 20.886 18.502 1.00 15.00 
ATOM 138 C THR 18 -4.945 21.686 17.718 1.00 15.00 
ATOM 139 0 THR 18 -4.590 22.861 17.634 1.00 15.00 
ATOM 140 N TRP 19 -4.449 20.717 16.979 1.00 15.00 
ATOM 141 H TRP 19 -4.866 19.826 16.979 1.00 15.00 
ATOM 142 CA TRP 19 -3.442 20.969 15.964 1.00 15.00 
ATOM 143 CB TRP 19 -2.102 20.459 16.426 1.00 15.00 
ATOM 144 CG TRP 19 -1.487 21.368 17.438 1.00 15.00 
ATOM 145 CD2 TRP 19 -0.901 22.580 17.201 1.00 15.00 
ATOM 146 CE2 TRP 19 -0.572 22.962 18.460 1.00 15.00 
ATOM 147 CE3 TRP 19 -0.586 23.410 16.163 1.00 15.00 
ATOM 148 CD1 TRP 19 -1.520 21.012 18.735 1.00 15.00 
ATOM 149 NE1 TRP 19 -0.952 22.014 19.338 1.00 15.00 
ATOM 150 HE1 TRP 19 -0.876 22.125 20.318 1.00 15.00 
ATOM 151 CZ2 TRP 19 0.059 24.162 18.677 1.00 15.00 
ATOM 152 CZ3 TRP 19 0.045 24.601 16.364 1.00 15.00 
ATOM 153 CH2 TRP 19 0.364 24.971 17.625 1.00 15.00 
ATOM 154 C TRP 19 -3.828 20.231 14.696 1.00 15.00 
ATOM 155 0 TRP 19 -4.536 19.224 14.813 1.00 15.00 
ATOM 156 N TYR 20 -3.374 20.689 13.515 1.00 15.00 
ATOM 157 H TYR 20 -2.839 21.497 13.525 1.00 15.00 
ATOM 158 CA TYR 20 -3.537 19.988 12.227 1.00 15.00 
ATOM 159 CB TYR 20 -4.314 20.845 11.164 1.00 15.00 
ATOM 160 CG TYR 20 -5.784 20.592 11.385 1.00 15.00 
ATOM 161 CD1 TYR 20 -6.606 21.592 11.823 1.00 15.00 
ATOM 162 CE1 TYR 20 -7.900 21.290 12.231 1.00 15.00 
ATOM 163 CD2 TYR 20 -6.247 19.290 11.312 1.00 15.00 
ATOM 164 CE2 TYR 20 -7.532 18.967 11.717 1.00 15.00 
ATOM 165 CZ TYR 20 -8.367 19.972 12.191 1.00 15.00 
ATOM 166 OH TYR 20 -9.635 19.633 12.691 1.00 15.00 
ATOM 167 HH TYR 20 -10.068 20.421 13.050 1.00 15.00 
ATOM 168 C TYR 20 -2.184 19.623 11.638 1.00 15.00 
ATOM 169 0 TYR 20 -1.353 20.514 11.403 1.00 15.00 
ATOM 170 N SER 21 -1.893 18.340 11.423 1.00 15.00 
ATOM 171 H SER 21 -2.535 17.638 11.664 1.00 15.00 
ATOM 172 CA SER 21 -0.623 17.934 10.836 1.00 15.00 
ATOM 173 CB SER 21 -0.439 16.439 10.923 1.00 15.00 
ATOM 174 OG SER 21 -0.427 16.148 12.300 1.00 15.00 
ATOM 175 HG SER 21 0.478 15.848 12.485 1.00 15.00 
ATOM 176 C SER 21 -0.501 18.332 9.396 1.00 15.00 
ATOM 177 0 SER 21 -0.527 17.509 8.504 1.00 15.00 
ATOM 178 N LEU 22 -0.297 19.600 9.132 1.00 15.00 
ATOM 179 H LEU 22 -0.120 20.224 9.868 1.00 15.00 
ATOM 180 CA LEU 22 -0.228 20.070 7.784 1.00 15.00 
ATOM 181 CB LEU 22 -0.199 21.575 7.925 1.00 15.00 
ATOM 182 CG LEU 22 -0.040 22.653 6.861 1.00 15.00 
ATOM 183 CD1 LEU 22 1.369 23.141 6.833 1.00 15.00 
ATOM 184 CD2 LEU 22 -0.570 22.121 5.543 1.00 15.00 
ATOM 185 C LEU 22 0.944 19.471 7.026 1.00 15.00 
ATOM 186 0 LEU 22 0.881 19.566 5.817 1.00 15.00 















































































































ATOM 199 CE MET 24 0.837 13.416 8.659 1.00 15.00 
ATOM 200 C MET 24 6.630 14.835 6.753 1.00 15.00 
ATOM 201 0 MET 24 6.665 15.175 5.570 1.00 15.00 
ATOM 202 N ALA 25 7.654 14.148 7.259 1.00 15.00 
ATOM 203 H ALA 25 7.589 13.710 8.137 1.00 15.00 
ATOM 204 CA ALA 25 8.881 14.002 6.497 1.00 15.00 
ATOM 205 CB ALA 25 9.608 15.323 6.564 1.00 15.00 
ATOM 206 C ALA 25 9.830 12.899 6.931 1.00 15.00 
ATOM 207 0 ALA 25 9.444 11.926 7.572 1.00 15.00 
ATOM 208 N ALA 26 11.082 13.115 6.505 1.00 15.00 
ATOM 209 H ALA 26 11.163 13.717 5.740 1.00 15.00 
ATOM 210 CA ALA 26 12.329 12.432 6.865 1.00 15.00 
ATOM 211 CB ALA 26 12.935 13.187 8.068 1.00 15.00 
ATOM 212 C ALA 26 12.512 10.933 7.128 1.00 15.00 
ATOM 213 0 ALA 26 11.627 10.086 7.272 1.00 15.00 
ATOM 214 N SER 27 13.822 10.729 6.966 1.00 15.00 
ATOM 215 H SER 27 14.317 11.493 6.607 1.00 15.00 
ATOM 216 CA SER 27 14.571 9.493 7.103 1.00 15.00 
ATOM 217 CB SER 27 14.679 9.069 8.566 1.00 15.00 
ATOM 218 OG SER 27 15.388 10.041 9.323 1.00 15.00 
ATOM 219 HG SER 27 14.821 10.814 9.345 1.00 15.00 
ATOM 220 C SER 27 14.094 8.301 6.310 1.00 15.00 
ATOM 221 0 SER 27 14.820 7.978 5.350 1.00 15.00 
ATOM 222 N ASP 28 12.950 7.639 6.524 1.00 15.00 
ATOM 223 H ASP 28 12.237 8.038 7.081 1.00 15.00 
ATOM 224 CA ASP 28 12.694 6.466 5.725 1.00 15.00 
ATOM 225 CB ASP 28 12.799 5.253 6.607 1.00 15.00 
ATOM 226 CG ASP 28 13.535 4.070 5.994 1.00 15.00 
ATOM 227 OD1 ASP 28 12.968 3.379 5.155 1.00 15.00 
ATOM 228 OD2 ASP 28 14.674 3.819 6.379 1.00 15.00 
ATOM 229 C ASP 28 11.362 6.507 5.031 1.00 15.00 
ATOM 230 0 ASP 28 10.305 6.800 5.564 1.00 15.00 
ATOM 231 N ILE 29 11.501 6.204 3.765 1.00 15.00 
ATOM 232 H ILE 29 12.421 6.093 3.472 1.00 15.00 
ATOM 233 CA ILE 29 10.405 6.064 2.823 1.00 15.00 
ATOM 234 CB ILE 29 11.081 5.689 1.492 1.00 15.00 
ATOM 235 CG2 ILE 29 11.960 4.441 1.729 1.00 15.00 
ATOM 236 CG1 ILE 29 10.116 5.376 0.384 1.00 15.00 
ATOM 237 CD1 ILE 29 11.007 5.005 -0.839 1.00 15.00 
ATOM 238 C ILE 29 9.317 5.069 3.232 1.00 15.00 
ATOM 239 0 ILE 29 8.134 5.308 2.982 1.00 15.00 
ATOM 240 N SER 30 9.718 3.959 3.875 1.00 15.00 
ATOM 241 H SER 30 10.641 3.854 4.171 1.00 15.00 
ATOM 242 CA SER 30 8.798 2.902 4.233 1.00 15.00 
ATOM 243 CB SER 30 9.571 1.694 4.831 1.00 15.00 
ATOM 244 OG SER 30 10.652 2.033 5.681 1.00 15.00 
ATOM 245 HG SER 30 11.042 1.215 6.016 1.00 15.00 
ATOM 246 C SER 30 7.797 3.470 5.217 1.00 15.00 
ATOM 247 0 SER 30 6.611 3.601 4.910 1.00 15.00 
ATOM 248 N LEU 31 8.390 3.997 6.300 1.00 15.00 
ATOM 249 H LEU 31 9.368 4.034 6.295 1.00 15.00 
ATOM 250 CA LEU 31 7.696 4.500 7.449 1.00 15.00 
ATOM 251 CB LEU 31 8.613 5.192 8.407 1.00 15.00 
ATOM 252 CG LEU 31 9.935 4.566 8.802 1.00 15.00 
ATOM 253 CD1 LEU 31 10.460 5.451 9.953 1.00 15.00 
ATOM 254 CD2 LEU 31 9.817 3.065 9.111 1.00 15.00 
ATOM 255 C LEU 31 6.616 5.468 7.120 1.00 15.00 





















ATOM 259 CA LEU 32 5.437 7.137 5.863 1.00 15.00 









































ATOM 265 0 LEU 32 3.687 7.590 4.253 1.00 15.00 
ATOM 266 N ASP 33 4.905 5.738 3.877 1.00 15.00 
ATOM 267 H ASP 33 5.535 5.054 4.187 1.00 15.00 
ATOM 268 CA ASP 33 4.145 5.528 2.652 1.00 15.00 
ATOM 269 CB ASP 33 4.965 4.609 1.642 1.00 15.00 
ATOM 270 CG ASP 33 5.431 3.164 1.908 1.00 15.00 
ATOM 271 OD1 ASP 33 6.631 2.972 2.088 1.00 15.00 
ATOM 272 OD2 ASP 33 4.641 2.208 1.854 1.00 15.00 
ATOM 273 C ASP 33 2.744 4.972 2.948 1.00 15.00 
ATOM 274 0 ASP 33 2.569 3.840 3.402 1.00 15.00 
ATOM 275 N ALA 34 1.734 5.851 2.802 1.00 15.00 
ATOM 276 H ALA 34 2.004 6.792 2.782 1.00 15.00 
ATOM 277 CA ALA 34 0.309 5.520 2.931 1.00 15.00 
ATOM 278 CB ALA 34 -0.103 4.344 2.089 1.00 15.00 
ATOM 279 C ALA 34 -0.217 5.182 4.316 1.00 15.00 
ATOM 280 0 ALA 34 0.494 4.696 5.185 1.00 15.00 
ATOM 281 N GLN 35 -1.518 5.361 4.550 1.00 15.00 
ATOM 282 H GLN 35 -2.088 5.616 3.799 1.00 15.00 
ATOM 283 CA GLN 35 -2.114 5.232 5.874 1.00 15.00 
ATOM 284 CB GLN 35 -3.634 5.413 5.844 1.00 15.00 
ATOM 285 CG GLN 35 -4.428 6.473 5.028 1.00 15.00 
ATOM 286 CD GLN 35 -4.582 7.898 5.564 1.00 15.00 
ATOM 287 0E1 GLN 35 -4.383 8.898 4.864 1.00 15.00 
ATOM 288 NE2 GLN 35 -4.974 8.113 6.806 1.00 15.00 
ATOM 289 HE21 GLN 35 -5.125 9.052 7.018 1.00 15.00 
ATOM 290 HE22 GLN 35 -5.077 7.373 7.436 1.00 15.00 
ATOM 291 C GLN 35 -1.848 3.888 6.518 1.00 15.00 
ATOM 292 0 GLN 35 -2.183 3.701 7.672 1.00 15.00 
ATOM 293 N SER 36 -1.304 2.916 5.809 1.00 15.00 
ATOM 294 H SER 36 -1.142 3.009 4.853 1.00 15.00 
ATOM 295 CA SER 36 -0.919 1.628 6.377 1.00 15.00 
ATOM 296 CB SER 36 -0.681 0.566 5.273 1.00 15.00 
ATOM 297 OG SER 36 -1.375. 0.822 4.057 1.00 15.00 
ATOM 298 HG SER 36 -1.123 0.141 3.425 1.00 15.00 
ATOM 299 C SER 36 0.381 1.653 7.187 1.00 15.00 
ATOM 300 0 SER 36 0.776 0.648 7.798 1.00 15.00 
ATOM 301 N ALA 37 1.120 2.748 7.077 1.00 15.00 
ATOM 302 H ALA 37 0.721 3.578 6.752 1.00 15.00 
ATOM 303 CA ALA 37 2.472 2.767 7.569 1.00 15.00 
ATOM 304 CB ALA 37 3.210 3.779 6.733 1.00 15.00 
ATOM 305 C ALA 37 2.652 3.058 9.049 1.00 15.00 
ATOM 306 0 ALA 37 1.700 3.407 9.748 1.00 15.00 
ATOM 307 N PRO 38 3.863 2.870 9.581 1.00 15.00 
ATOM 308 CD PRO 38 4.818 1.876 9.127 1.00 15.00 
ATOM 309 CA PRO 38 4.271 3.347 10.882 1.00 15.00 
ATOM 310 CB PRO 38 5.731 2.992 10.938 1.00 15.00 
ATOM 311 CG PRO 38 5.690 1.617 10.345 1.00 15.00 
ATOM 312 C PRO 38 3.992 4.804 11.229 1.00 15.00 
ATOM 313 0 PRO 38 2.855 5.125 11.586 1.00 15.00 
ATOM 314 N LEU 39 4.925 5.742 11.110 1.00 15.00 
ATOM 315 H LEU 39 5.720 5.599 10.559 1.00 15.00 
ATOM 316 CA LEU 39 4.619 7.039 11.619 1.00 15.00 
ATOM 317 CB LEU 39 5.943 7.585 11.991 1.00 15.00 
ATOM 318 CG LEU 39 6.506 7.020 13.262 1.00 
15.00 














































































































/ tn 1n 
1l1 tn N
 tn tn N
































































































 ri ri ri ri ri ri ri ri ri ri ri ri 







































































































































































































































































































































































































































































































































































































































ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri 
ri ri ri ri ri 















































































































































































































































































































































































































































































 rl ri ri ri ri ri ri ri ri rl rl 
rl ri ri ri r-i ri ri rl r-i rl ri ri ri ri ri r-i ri r-i rl ri ri ri ri ri ri ri 
r-C

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































/ tn tn U
/ ln tf) N






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































r-1 ri ri ri ri r-i ri r) ri 
r-1 
r-I r-i ri rl rl ri N
 ri rl ri r-i rl rl rl 
r--i ri r-i 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 0 0 0 0 0 0 0 0 0
















































































































ATOM 536 CE2 TRP 61 -7.781 3.676 6.740 1.00 15.00 
ATOM 537 CE3 TRP 61 -7.974 5.761 7.862 1.00 15.00 
ATOM 538 CD1 TRP 61 -5.905 2.820 7.381 1.00 15.00 
ATOM 539 NE1 TRP 61 -6.952 2.644 6.624 1.00 15.00 
ATOM 540 HE1 TRP 61 -7.074 1.870 6.035 1.00 15.00 
ATOM 541 CZ2 TRP 61 -8.999 3.872 6.123 1.00 15.00 
ATOM 542 CZ3 TRP 61 -9.201 5.966 7.244 1.00 15.00 
ATOM 543 CH2 TRP 61 -9.717 5.027 6.376 1.00 15.00 
ATOM 544 C TRE' 61 -4.516 2.663 10.605 1.00 15.00 
ATOM 545 0 TRP 61 -3.568 2.297 9.894 1.00 15.00 
ATOM 546 N GLU 62 -4.883 1.890 11.620 1.00 15.00 
ATOM 547 H GLU 62 -5.692 2.100 12.134 1.00 15.00 
ATOM 548 CA GLU 62 -4.230 0.612 11.848 1.00 15.00 
ATOM 549 CB GLU 62 -3.500 0.539 13.204 1.00 15.00 
ATOM 550 CG GLU 62 -3.399 -0.816 13.988 1.00 15.00 
ATOM 551 CD GLU 62 -4.584 -1.199 14.897 1.00 15.00 
ATOM 552 0E1 GLU 62 -4.879 -2.405 15.015 1.00 15.00 
ATOM 553 OE2 GLU 62 -5.206 -0.280 15.473 1.00 15.00 
ATOM 554 C GLU 62 -5.423 -0.270 11.890 1.00 15.00 
ATOM 555 0 GLU 62 -6.460 0.087 12.472 1.00 15.00 
ATOM 556 N ASN 63 -5.173 -1.358 11.163 1.00 15.00 
ATOM 557 H ASN 63 -4.331 -1.377 10.660 1.00 15.00 
ATOM 558 CA ASN 63 -6.046 -2.518 11.046 1.00 15.00 
ATOM 559 CB ASN 63 -5.334 -3.647 11.791 1.00 15.00 
ATOM 560 CG ASN 63 -5.166 -4.856 10.893 1.00 15.00 
ATOM 561 OD1 ASN 63 -4.102 -5.051 10.295 1.00 15.00 
ATOM 562 ND2 ASN 63 -6.215 -5.667 10.750 1.00 15.00 
ATOM 563 HD21 ASN 63 -6.100 -6.454 10.184 1.00 15.00 
ATOM 564 HD22 ASN 63 -7.048 -5.423 11.214 1.00 15.00 
ATOM 565 C ASN 63 -7.532 -2.481 11.452 1.00 15.00 
ATOM 566 0 ASN 63 -8.115 -3.509 11.817 1.00 15.00 
ATOM 567 N GLY 64 -8.202 -1.334 11.321 A..00 15.00 
ATOM 568 H GLY 64 -7.727 -0.513 11.085 1.00 15.00 
ATOM 569 CA GLY 64 -9.593 -1.171 11.739 1.00 15.00 
ATOM 570 C GLY 64 -10.022 0.305 11.772 1.00 15.00 
ATOM 571 0 GLY 64 -10.369 0.920 12.793 1.00 15.00 
ATOM 572 N GLU 65 -10.001 0.784 10.522 1.00 15.00 
ATOM 573 H GLU 65 -9.708 0.168 9.826 1.00 15.00 
ATOM 574 CA GLU 65 -10.344 2.130 10.124 1.00 15.00 
ATOM 575 CB GLU 65 -11.814 2.387 10.560 1.00 15.00 
ATOM 576 CG GLU 65 -12.943 1.558 9.894 1.00 15.00 
ATOM 577 CD GLU 65 -13.891 0.834 10.872 1.00 15.00 
ATOM 578 OE1 GLU 65 -15.089 0.717 10.552 1.00 15.00 
ATOM 579 OE2 GLU 65 -13.416 0.376 11.934 1.00 15.00 
ATOM 580 C GLU 65 -9.355 3.146 10.710 1.00 15.00 
ATOM 581 0 GLU 65 -8.189 2.822 11.036 1.00 15.00 
ATOM 582 N CYS 66 -9.837 4.395 10.775 1.00 15.00 













































































































































ATOM 598 CB GLN 68 -8.761 7.536 18.444 1.00 15.00 
ATOM 599 CG GLN 68 -10.169 7.982 18.002 1.00 15.00 
ATOM 600 CD GLN 68 -11.251 7.980 19.122 1.00 15.00 
ATOM 601 0E1 GLN 68 -10.966 7.933 20.334 1.00 15.00 
ATOM 602 NE2 GLN 68 -12.550 8.031 18.766 1.00 15.00 
ATOM 603 HE21 GLN 68 -12.787 8.063 17.818 1.00 15.00 
ATOM 604 HE22 GLN 68 -13.193 8.040 19.504 1.00 15.00 
ATOM 605 C GLN 68 -6.623 6.325 18.294 1.00 15.00 
ATOM 606 0 GLN 68 -6.601 5.107 18.504 1.00 15.00 
ATOM 607 N LYS 69 -5.719 7.099 18.895 1.00 15.00 
ATOM 608 H LYS 69 -5.822 8.069 18.818 1.00 15.00 
ATOM 609 CA LYS 69 -4.575 6.649 19.686 1.00 15.00 
ATOM 610 CB LYS 69 -3.300 6.629 18.852 1.00 15.00 
ATOM 611 CG LYS 69 -3.125 5.600 17.727 1.00 15.00 
ATOM 612 CD LYS 69 -2.911 4.174 18.241 1.00 15.00 
ATOM 613 CE LYS 69 -1.716 3.986 19.210 1.00 15.00 
ATOM 614 NZ LYS 69 -2.003 4.405 20.583 1.00 15.00 
ATOM 615 HZ1 LYS 69 -2.847 3.906 20.930 1.00 15.00 
ATOM 616 HZ2 LYS 69 -2.165 5.431 20.617 1.00 15.00 
ATOM 617 HZ3 LYS 69 -1.189 4.171 21.187 1.00 15.00 
ATOM 618 C LYS 69 -4.372 7.682 20.792 1.00 15.00 
ATOM 619 0 LYS 69 -4.661 8.849 20.525 1.00 15.00 
ATOM 620 N LYS 70 -3.957 7.391 22.038 1.00 15.00 
ATOM 621 H LYS 70 -3.847 6.453 22.291 1.00 15.00 
ATOM 622 CA LYS 70 -3.542 8.412 23.042 1.00 15.00 
ATOM 623 CB LYS 70 -4.325 8.367 24.367 1.00 15.00 
ATOM 624 CG LYS 70 -5.549 9.272 24.548 1.00 15.00 
ATOM 625 CD LYS 70 -5.652 9.523 26.074 1.00 15.00 
ATOM 626 CE LYS 70 -6.815 10.395 26.578 1.00 15.00 
ATOM 627 NZ LYS 70 -8.033 9.610 26.757 1.00 15.00 
ATOM 628 HZ1 LYS 70 -8.305 9.178 25.852 1.00 15.00 
ATOM 629 HZ2 LYS 70 -8.798 10.228 27.094 1.00 15.00 
ATOM 630 HZ3 LYS 70 -7.857 8.866 27.461 1.00 15.00 
ATOM 631 C LYS 70 -2.074 8.076 23.401 1.00 15.00 
ATOM 632 0 LYS 70 -1.815 7.005 23.970 1.00 15.00 
ATOM 633 N ILE 71 -1.080 8.895 23.019 1.00 15.00 
ATOM 634 H ILE 71 -1.310 9.778 22.655 1.00 15.00 
ATOM 635 CA ILE 71 0.320 8.581 23.277 1.00 15.00 
ATOM 636 CB ILE 71 1.309 8.915 22.140 1.00 15.00 
ATOM 637 CG2 ILE 71 2.716 8.648 22.630 1.00 15.00 
ATOM 638 CG1 ILE 71 1.064 8.073 20.918 1.00 15.00 
ATOM 639 CD1 ILE 71 1.048 6.556 21.158 1.00 15.00 
ATOM 640 C ILE 71 0.636 9.510 24.392 '.00 15.00 
ATOM 641 0 ILE 71 0.613 10.718 24.225 1.00 15.00 
ATOM 642 N ILE 72 0.911 8.952 25.545 1.00 15.00 
ATOM 643 H ILE 72 1.071 7.987 25.575 1.00 15.00 
ATOM 644 CA ILE 72 1.222 9.765 26.703 1.00 15.00 
ATOM 645 CB ILE 72 1.031 8.933 27.945 1.00 15.00 
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ATOM 1060 CA GLN 115 20.957 9.171 12.151 1.00 15.00 
ATOM 1061 CB GLN 115 21.294 7.635 12.152 1.00 15.00 
ATOM 1062 CG GLN 115 20.760 6.770 10.952 1.00 15.00 
ATOM 1063 CD GLN 115 19.352 6.099 11.001 1.00 15.00 
ATOM 1064 0E1 GLN 115 18.353 6.476 10.373 1.00 15.00 
ATOM 1065 NE2 GLN 115 19.167 5.070 11.808 1.00 15.00 
ATOM 1066 HE21 GLN 115 19.903 4.779 12.382 1.00 15.00 
ATOM 1067 HE22 GLN 115 18.289 4.634 11.785 1.00 15.00 
ATOM 1068 C GLN 115 19.574 9.455 12.861 1.00 15.00 
ATOM 1069 0 GLN 115 19.447 10.425 13.649 1.00 15.00 
ATOM 1070 N SER 116 18.535 8.656 12.468 1.00 15.00 
ATOM 1071 H SER 116 18.624 8.241 11.593 1.00 15.00 
ATOM 1072 CA SER 116 17.171 8.510 13.024 1.00 15.00 
ATOM 1073 CB SER 116 17.300 8.229 14.557 1.00 15.00 
ATOM 1074 OG SER 116 18.244 7.231 15.007 1.00 15.00 
ATOM 1075 HG SER 116 19.054 7.708 15.234 1.00 15.00 
ATOM 1076 C SER 116 16.187 9.688 12.760 1.00 15.00 
ATOM 1077 0 SER 116 16.734 10.787 12.646 1.00 15.00 
ATOM 1078 N LEU 117 14.830 9.515 12.540 1.00 15.00 
ATOM 1079 H LEU 117 14.503 8.604 12.425 1.00 15.00 
ATOM 1080 CA LEU 117 13.835 10.583 12.416 1.00 15.00 
ATOM 1081 CB LEU 117 14.289 11.725 11.648 1.00 15.00 
ATOM 1082 CG LEU 117 14.391 13.013 12.390 1.00 15.00 
ATOM 1083 CD1 LEU 117 14.167 12.914 13.903 1.00 15.00 
ATOM 1084 CD2 LEU 117 15.763 13.490 12.027 1.00 15.00 
ATOM 1085 C LEU 117 12.494 10.385 11.796 1.00 15.00 
ATOM 1086 0 LEU 117 12.414 9.578 10.911 1.00 15.00 
ATOM 1087 N VAL 118 11.481 11.193 12.123 1.00 15.00 
ATOM 1088 H VAL 118 11.646 11.806 12.867 1.00 15.00 
ATOM 1089 CA VAL 118 10.150 11.193 11.491 1.00 15.00 
ATOM 1090 CB VAL 118 9.484 9.871 11.906 1.00 15.00 
ATOM 1091 CG1 VAL 118 9.215 9.839 13.384 1.00 15.00 
ATOM 1092 CG2 VAL 118 8.241 9.685 11.109 1.00 15.00 
ATOM 1093 C VAL 118 9.252 12.419 11.794 1.00 15.00 
ATOM 1094 0 VAL 118 8.126 12.385 12.265 1.00 15.00 
ATOM 1095 N CYS 119 9.789 13.591 11.566 1.00 15.00 
ATOM 1096 H CYS 119 10.635 13.608 11.081 1.00 15.00 
ATOM 1097 CA CYS 119 9.154 14.864 11.884 1.00 15.00 
ATOM 1098 C CYS 119 7.817 15.152 11.227 1.00 15.00 
ATOM 1099 0 CYS 119 7.464 14.532 10.230 1.00 15.00 
ATOM 1100 CB CYS 119 10.107 15.935 11.503 1.00 15.00 
ATOM 1101 SG CYS 119 11.759 15.374 11.932 1.00 15.00 
ATOM 1102 N GLN 120 7.091 16.137 11.725 1.00 15.00 
ATOM 1103 H GLN 120 7.473 16.670 12.461 1.00 15.00 
ATOM 1104 CA GLN 120 5.803 16.568 11.207 1.00 15.00 
ATOM 1105 CB GLN 120 4.613 16.029 11.948 1.00 15.00 
ATOM 1106 CG GLN 120 4.413 14.525 11.870 1.00 15.00 
ATOM 1107 CD GLN 120 3.000 14.141 12.235 1.00 15.00 
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ATOM 1194 OD1 ASP 129 2.803 30.340 7.707 1.00 15.00 
ATOM 1195 OD2 ASP 129 1.716 29.937 9.520 1.00 15.00 
ATOM 1196 C ASP 129 2.396 28.301 5.313 1.00 15.00 
ATOM 1197 O ASP 129 3.116 27.313 5.542 1.00 15.00 
ATOM 1198 N ASP 130 2.756 29.145 4.317 1.00 15.00 
ATOM 1199 H ASP 130 2.158 29.859 4.013 1.00 15.00 
ATOM 1200 CA ASP 130 3.980 28.822 3.633 1.00 15.00 
ATOM 1201 CB ASP 130 4.129 29.471 2.256 1.00 15.00 
ATOM 1202 CG ASP 130 5.058 28.568 1.402 1.00 15.00 
ATOM 1203 OD1 ASP 130 6.269 28.813 1.345 1.00 15.00 
ATOM 1204 OD2 ASP 130 4.598 27.574 0.818 1.00 15.00 
ATOM 1205 C ASP 130 5.105 29.277 4.518 1.00 15.00 
ATOM 1206 0 ASP 130 6.146 28.620 4.510 1.00 15.00 
ATOM 1207 N GLU 131 4.904 30.290 5.373 1.00 15.00 
ATOM 1208 H GLU 131 4.067 30.789 5.346 1.00 15.00 
ATOM 1209 CA GLU 131 5.959 30.694 6.297 1.00 15.00 
ATOM 1210 CB GLU 131 5.555 31.987 7.072 1.00 15.00 
ATOM 1211 CG GLU 131 5.622 33.333 6.262 1..00 15.00 
ATOM 1212 CD GLU 131 5.242 34.718 6.901 1.00 15.00 
ATOM 1213 0E1 GLU 131 4.526 35.468 6.210 1.00 15.00 
ATOM 1214 0E2 GLU 131 5.672 35.102 8.018 1.00 15.00 
ATOM 1215 C GLU 131 6.248 29.555 7.287 1.00 15.00 
ATOM 1216 0 GLU 131 7.257 29.603 7.961 1.00 15.00 
ATOM 1217 N ALA 132 5.439 28.498 7.462 1.00 15.00 
ATOM 1218 H ALA 132 4.617 28.448 6.943 1.00 15.00 
ATOM 1219 CA ALA 132 5.788 27.369 8.317 1.00 15.00 
ATOM 1220 CB ALA 132 4.617 26.887 9.167 1.00 15.00 
ATOM 1221 C ALA 132 6.175 26.221 7.410 1.00 15.00 
ATOM 1222 O ALA 132 7.265 25.690 7.513 1.00 15.00 
ATOM 1223 N LEU 133 5.J28 25.839 6.457 1.00 15.00 
ATOM 1224 H LEU 133 4.477 26.307 6.390 1.00 15.00 
ATOM 1225 CA LEU 133 5.564 24.751 5.520 1.00 15.00 
ATOM 1226 CB LEU 133 4.507 24.761 4.453 1.00 15.00 
ATOM 1227 CG LEU 133 3.619 23.552 4.415 1.00 15.00 
ATOM 1228 CD1 LEU 133 2.881 23.579 3.103 1.00 15.00 
ATOM 1229 CD2 LEU 133 4.397 22.254 4.467 1.00 15.00 
ATOM 1230 C LEU 133 6.921 24.706 4.814 1.00 15.00 
ATOM 1231 0 LEU 133 7.479 23.652 4.427 1.00 15.00 
ATOM 1232 N GLU 134 7.503 25.874 4.610 1.00 15.00 
ATOM 1233 H GLU 134 7.059 26.733 4.790 1.00 15.00 
ATOM 1234 CA GLU 134 8.809 25.853 4.023 í.00 15.00 
ATOM 1235 CB GLU 134 8.561 26.302 2.506 1.00 15.00 
ATOM 1236 CG GLU 134 7.391 25.727 1.544 1.00 15.00 
ATOM 1237 CD GLU 134 7.244 24.219 1.105 1.00 15.00 
ATOM 1238 0E1 GLU 134 6.177 23.588 1.301 1.00 15.00 
ATOM 1239 0E2 GLU 134 8.185 23.670 0.510 1.00 15.00 










































































































































































































ATOM 1261 CD2 PHE 136 7.738 20.519 6.589 1.00 15.00 
ATOM 1262 CE1 PHE 136 8.181 19.196 8.952 1.00 15.00 
ATOM 1263 CE2 PHE 136 7.386 19.210 6.722 1.00 15.00 
ATOM 1264 CZ PHE 136 7.602 18.552 7.891 1.00 15.00 
ATOM 1265 C PHE 136 10.995 22.842 7.425 1.00 15.00 
ATOM 1266 0 PHE 136 11.927 22.406 8.079 1.00 15.00 
ATOM 1267 N ASP 137 11.052 23.077 6.096 1.00 15.00 
ATOM 1268 H ASP 137 10.235 23.366 5.641 1.00 15.00 
ATOM 1269 CA ASP 137 12.223 22.788 5.294 1.00 15.00 
ATOM 1270 CB ASP 137 12.145 23.518 3.995 1.00 15.00 
ATOM 1271 CG ASP 137 11.092 22.926 3.047 1.00 15.00 
ATOM 1272 OD1 ASP 137 10.366 21.983 3.447 1.00 15.00 
ATOM 1273 OD2 ASP 137 11.021 23.409 1.898 1.00 15.00 
ATOM 1274 C ASP 137 13.473 23.183 6.001 1.00 15.00 
ATOM 1275 0 ASP 137 14.298 22.309 6.203 1.00 15.00 
ATOM 1276 N LYS 138 13.527 24.407 6.533 1.00 15.00 
ATOM 1277 H LYS 138 12.771 25.013 6.440 1.00 15.00 
ATOM 1278 CA LYS 138 14.691 24.850 7.304 1.00 15.00 
ATOM 1279 CB LYS 138 14.510 26.305 7.847 1.00 15.00 
ATOM 1280 CG LYS 138 15.561 27.357 7.337 1.00 15.00 
ATOM 1281 CD LYS 138 15.696 27.582 5.782 1.00 15.00 
ATOM 1282 CE LYS 138 14.608 28.372 5.003 1.00 15.00 
ATOM 1283 NZ LYS 138 14.487 29.772 5.426 1.00 15.00 
ATOM 1284 HZ1 LYS 138 13.778 30.250 4.833 1.00 15.00 
ATOM 1285 HZ2 LYS 138 15.406 30.247 5.322 1.00 15.00 
ATOM 1286 HZ3 LYS 138 14.188 29.806 6.421 1.00 15.00 
ATOM 1287 C LYS 138 15.036 23.947 8.476 1.00 15.00 
ATOM 1288 0 LYS 138 16.159 23.473 8.452 1.00 15.00 
ATOM 1289 N ALA 139 14.227 23.639 9.491 1.00 15.00 
ATOM 1290 H ALA 139 13.317 24.006 9.484 1.00 15.00 
ATOM 1291 CA ALA 139 14.642 22.729 10.564 1.00 15.00 
ATOM 1292 CB ALA 139 13.514 22.455 11.533 1.00 15.00 
ATOM 1293 C ALA 139 15.049 21.394 9.982 1.00 15.00 
ATOM 1294 0 ALA 139 16.154 20.874 10.113 1.00 15.00 
ATOM 1295 N LEU 140 14.153 20.939 9.149 1.00 15.00 
ATOM 1296 H LEU 140 13.409 21.520 8.893 1.00 15.00 
ATOM 1297 CA LEU 140 14.284 19.665 8.508 1.00 15.00 
ATOM 1298 CB LEU 140 12.940 19.379 7.829 1.00 15.00 
ATOM 1299 CG LEU 140 12.611 18.181 6.972 1.00 15.00 
ATOM 1300 CD1 LEU 140 12.715 16.870 7.708 1.00 15.00 
ATOM 1301 CD2 LEU 140 11.179 18.363 6.536 1.00 15.00 
ATOM 1302 C LEU 140 15.446 19.626 7.530 1.00 15.00 
ATOM 1303 O LEU 140 15.765 18.530 7.066 1.00 15.00 
ATOM 1304 N LYS 141 16.176 20.705 7.279 1.00 15.00 
ATOM 1305 H LYS 141 16.049 21.537 7.778 1.00 15.00 
ATOM 1306 CA LYS 141 17.119 20.677 6.172 1.00 15.00 
ATOM 1307 CB LYS 141 17.701 22.066 5.915 1.00 15.00 
ATOM 1308 CG LYS 141 17.994 22.402 4.451 i.00 15.00 







































































ATOM 1317 N ALA 142 18.728 19.404 7.565 1.00 15.00 
ATOM 1318 H ALA 142 18.265 19.754 8.355 1.00 15.00 
ATOM 1319 CA ALA 142 19.871 18.490 7.690 1.00 15.00 
ATOM 1320 CB ALA 142 20.969 19.079 8.578 1.00 15.00 
ATOM 1321 C ALA 142 19.541 17.133 8.272 1.00 15.00 
ATOM 1322 0 ALA 142 20.429 16.370 8.641 1.00 15.00 
ATOM 1323 N LEU 143 18.291 16.772 8.431 1.00 15.00 
ATOM 1324 H LEU 143 17.576 17.264 7.972 1.00 15.00 
ATOM 1325 CA LEU 143 18.040 15.449 8.949 1.00 15.00 
ATOM 1326 CB LEU 143 16.718 15.566 9.679 1.00 15.00 
ATOM 1327 CG LEU 143 16.644 16.739 10.633 1.00 15.00 
ATOM 1328 CD1 LEU 143 15.343 16.783 11.353 1.00 15.00 
ATOM 1329 CD2 LEU 143 17.680 16.590 11.666 1.00 15.00 
ATOM 1330 C LEU 143 18.055 14.507 7.718 1.00 15.00 
ATOM 1331 0 LEU 143 18.152 14.982 6.585 1.00 15.00 
ATOM 1332 N PRO 144 18.015 13.182 7.762 1.00 15.00 
ATOM 1333 CD PRO 144 18.489 12.372 8.858 1.00 15.00 
ATOM 1334 CA PRO 144 17.668 12.383 6.605 1.00 15.00 
ATOM 1335 CB PRO 144 17.646 11.014 7.175 1.00 15.00 
ATOM 1336 CG PRO 144 18.799 11.109 8.109 1.00 15.00 
ATOM 1337 C PRO 144 16.418 12.728 5.766 1.00 15.00 
ATOM 1338 0 PRO 144 15.345 13.283 6.071 1.00 15.00 
ATOM 1339 N MET 145 16.660 12.077 4.658 1.00 15.00 
ATOM 1340 H MET 145 17.403 11.441 4.653 1.00 15.00 
ATOM 1341 CA MET 145 15.913 12.192 3.437 1.00 15.00 
ATOM 1342 CB MET 145 16.997 11.803 2.324 1.00 15.00 
ATOM 1343 CG MET 145 17.748 10.422 2.344 1.00 15.00 
ATOM 1344 SD MET 145 16.788 8.877 2.482 1.00 15.00 
ATOM 1345 CE MET 145 17.473 8.257 3.994 1.00 15.00 
ATOM 1346 C MET 145 14.600 11.414 3.356 1.00 15.00 
ATOM 1347 0 MET 145 13.811 11.276 4.277 1.00 15.00 
ATOM 1348 N HIS 146 14.435 10.930 2.129 1.00 15.00 
ATOM 1349 H HIS 146 14.977 11.305 1.408 1.00 15.00 
ATOM 1350 CA HIS 146 13.447 10.055 1.595 1.00 15.00 
ATOM 1351 CB HIS 146 13.252 8.754 2.357 1.00 15.00 
ATOM 1352 CG HIS 146 13.960 7.529 1.723 1.00 15.00 
ATOM 1353 CD2 HIS 146 13.681 6.995 0.481 1.00 15.00 
ATOM 1354 ND1 HIS 146 14.863 6.715 2.285 1.00 15.00 
ATOM 1355 HD1 HIS 146 15.374 6.922 3.108 1.00 15.00 
ATOM 1356 CE1 HIS 146 15.105 5.731 1.456 1.00 15.00 
ATOM 1357 NE2 HIS 146 14.384 5.902 0.373 1.00 15.00 
ATOM 1358 HE2 HIS 146 14.248 5.230 -0.339 1.00 15.00 
ATOM 1359 C HIS 146 12.125 10.659 1.489 1.00 15.00 
ATOM 1360 0 HIS 146 11.731 10.627 0.331 1.00 15.00 
ATOM 1361 N ILE 147 11.445 11.246 2.456 1.00 15.00 
ATOM 1362 H ILE 147 11.817 11.473 3.338 1.00 15.00 
ATOM 1363 CA ILE 147 10.079 11.586 2.099 1.00 15.00 
ATOM 1364 CB ILE 147 9.298 10.300 2.547 1.00 15.00 
ATOM 1365 CG2 ILE 147 9.229 10.325 4.058 1.00 15.00 
ATOM 1366 CG1 ILE 147 7.938 10.169 1.866 1.00 15.00 
ATOM 1367 CD1 ILE 147 7.422 8.705 1.768 1.00 15.00 
ATOM 1368 C ILE 147 9.487 12.900 2.569 1.00 15.00 
ATOM 1369 0 ILE 147 9.788 13.277 3.704 1.00 15.00 
ATOM 1370 N ARG 148 8.738 13.656 1.749 1.00 15.00 
ATOM 1371 H ARG 148 8.580 13.364 0.830 1.00 15.00 



































































































































ATOM 1387 N LEU 149 5.617 14.896 2.767 1.00 15.00 
ATOM 1388 H LEU 149 5.914 15.197 3.654 1.00 15.00 
ATOM 1389 CA LEU 149 4.184 14.879 2.518 1.00 15.00 
ATOM 1390 CB LEU 149 3.508 13.839 3.364 1.00 15.00 
ATOM 1391 CG LEU 149 3.419 12.367 3.026 1.00 15.00 
ATOM 1392 CD1 LEU 149 2.500 12.294 1.853 1.00 15.00 
ATOM 1393 CD2 LEU 149 4.775 11.721 2.828 1.00 15.00 
ATOM 1394 C LEU 149 3.630 16.247 2.910 1.00 15.00 
ATOM 1395 0 LEU 149 4.114 16.807 3.879 1.00 15.00 
ATOM 1396 N SER 150 2.705 16.894 2.239 1.00 15.00 
ATOM 1397 H SER 150 2.402 16.507 1.391 1.00 15.00 
ATOM 1398 CA SER 150 2.121 18.163 2.650 1.00 15.00 
ATOM 1399 CB SER 150 2.576 19.350 1.784 1.00 15.00 
ATOM 1400 OG SER 150 3.964 19.672 1.690 1.00 15.00 
ATOM 1401 HG SER 150 4.323 19.737 2.581 1.00 15.00 
ATOM 1402 C SER 150 0.654 17.911 2.339 1.00 15.00 
ATOM 1403 0 SER 150 0.420 17.462 1.216 1.00 15.00 
ATOM 1404 N PHE 151 -0.400 18.068 3.120 1.00 15.00 
ATOM 1405 H PHE 151 -0.300 18.502 3.998 1.00 15.00 
ATOM 1406 CA PHE 151 -1.718 17.802 2.599 1.00 15.00 
ATOM 1407 CB PHE 151 -2.417 16.881 3.570 1.00 15.00 
ATOM 1408 CG PHE 151 -1.826 15.517 3.974 1.00 15.00 
ATOM 1409 CD1 PHE 151 -0.708 15.408 4.778 +.00 15.00 
ATOM 1410 CD2 PHE 151 -2.469 14.342 3.628 1.00 15.00 
ATOM 1411 CE1 PHE 151 -0.279 14.163 5.209 1.00 15.00 
ATOM 1412 CE2 PHE 151 -2.035 13.099 4.060 1.00 15.00 
ATOM 1413 CZ PHE 151 -0.935 13.004 4.856 1.00 15.00 
ATOM 1414 C PHE 151 -2.414 19.168 2.421 1.00 15.00 
ATOM 1415 0 PHE 151 -1.820 20.193 2.752 1.00 15.00 
ATOM 1416 N ASN 152 -3.641 19.337 1.918 1.00 15.00 
ATOM 1417 H ASN 152 -4.265 18.590 1.941 1.00 15.00 
ATOM 1418 CA ASN 152 -4.180 20.683 1.607 1.00 15.00 
ATOM 1419 CB ASN 152 -4.461 20.882 0.052 1.00 15.00 
ATOM 1420 CG ASN 152 -3.544 21.792 -0.858 1.00 15.00 
ATOM 1421 ODi ASN 152 -2.796 21.339 -1.750 1.00 15.00 
ATOM 1422 ND2 ASN 152 -3.568 23.128 -0.797 1.00 15.00 
ATOM 1423 HD21 ASN 152 -4.169 23.588 -0.184 1.00 15.00 
ATOM 1424 HD22 ASN 152 -2.948 23.578 -1.405 1.00 15.00 
ATOM 1425 C ASN 152 -5.505 20.840 2.359 1.00 15.00 
ATOM 1426 0 ASN 152 -6.170 19.827 2.566 1.00 15.00 
ATOM 1427 N PRO 153 -6.020 21.998 2.789 1.00 15.00 
ATOM 1428 CD PRO 153 -5.643 23.307 2.302 1.00 15.00 
ATOM 1429 CA PRO 153 -7.019 22.127 3.839 1.00 15.00 
ATOM 1430 CB PRO 153 -7.151 23.596 4.029 1.00 15.00 
ATOM 1431 CG PRO 153 -6.832 24.151 2.668 1.00 15.00 
ATOM 1432 C PRO 153 -8.368 21.455 3.640 1.00 15.00 
ATOM 1433 0 PRO 153 -9.022 21.049 4.611 1.00 15.00 
ATOM 1434 N THR 154 -8.823 21.269 2.403 1.00 15.00 
ATOM 1435 H THR 154 -8.318 21.549 1.615 1.00 15.00 
ATOM 1436 CA THR 154 -10.109 20.592 2.165 1.00 15.00 
ATOM 1437 CB THR 154 -10.585 20.761 0.670 1.00 15.00 
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ATOM 1515 01 HIS 161 -4.194 14.204 8.338 1.00 15.00 
ATOM 1516 02 HIS 161 -4.547 15.678 6.814 1.00 15.00 
